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Abstract 
There is a growing evidence of the potential health benefits of a diet rich in fruits 
and vegetables. National nutritional guidelines advise the consumption of at least five 
portions  (400 g ) of these foods per day with the goal being a reduction in the levels of 
coronary heart disease (CHD) strokes and certain cancers.  
The beneficial properties of fruit and vegetables may be ascribed, in part to the 
presence of antioxidants and recent attention in this regard has focused on phenolic and 
polyphenolic compounds. These compounds are present in a wide variety of commonly 
consumed foods and beverages. 
Onions are a rich source of the polyphenolic flavonol quercetin-4′-glucoside. For 
this compound to have some health effects it must be absorbed and reach target organs 
in a concentration and form where they can exert an effect. To-date interest has 
focussed on the levels of the intact quercetin aglycone circulating in plasma and 
excreted in urine. However, it is now known  that quercetin does not circulate in the 
plasma as the parent compound or the aglycone. However, at the outset of this project, 
the exact form(s) and concentration of metabolites circulating in plasma were unknown. 
The need to know what compounds are actually circulating, and at what 
concentration, is important if in vitro studies are to be made into the mechanisms by 
which quercetin could, potentially, exert a health benefit. 
The reasons why these issues have not been addressed are due to a number of 
factors. The main methodology used in studies into absorption, distribution, metabolism 
and excretion or (A.D.M.E) as it is know in the drug industry, is by use of 
chromatography coupled to various detection systems. This can range from a simple 
isocratic single pump linked to a single wavelength absorbance detector, to a gradient 
pumping system with an autoinjector linked in series to a diode array absorbance 
detector and mass spectrometer. The latter instruments, although initially expensive are 
now becoming more affordable. 
The original methodology used to determine the level of quercetin in plasma 
involved hydrolysis of the quercetin conjugates back to the aglycone. The information, 
which is lost by using this hydrolysis method, is vital if we are to gain a better   3
understanding of the A.D.M.E process. There have been a large number of feeding 
studies carried out using onions or the flavonol contained in them. However, very little 
additional information was gained after the initial investigations.  
The objectives of the studies presented in this thesis were to develop methodology 
to identify and quantify the major metabolites of quercetin in man after ingestion of 
onions. This would initially require the use of radiolabelled [2-
14C]quercetin-4´-
glucoside fed to rats to facilitate the development of the method. Having successfully 
developed methods that would work both in rats and in man, it was of great interest to 
establish the fate of the complete dose of  [2-
14C]quercetin-4´-glucoside in rats. 
In Chapter 2 radiolabelled quercetin-4´-glucoside was used as a tracer to follow 
the metabolism of the compound as it was acted on by the digestive system of the rat. 
After 1 h 93% of the ingested dose was recovered in the gastrointestinal tract (GIT). 
Analysis using HPLC with a photodiode array (PDA)  detector in series with a 
radioactivity monitor connected to an electrospray ion trap mass spectrometer facilitated 
the separation, quantification and partial identification of 18 out of 19 metabolites. The 
1 h sample was part of a larger study that investigated the fate of the radiolabelled 
compounds up to 5 h after dosing. The latter samples formed part of another study not 
reported on in this thesis. 
Having developed the methodology, using the radiolabelled compound, it was 
then applied to a feed of onions to healthy human volunteers to determine if metabolite 
detection, identification and quantification could be carried out without the use of the 
radioactive tracer. In Chapter 3 plasma samples collected 1 h after a feed of onions and 
urine collection from 0-4 h post feed were used to test if the method could be transferred 
to a non labelled assay. A total of 22 metabolites plus the parent compound were 
identified. The metabolic profile of the plasma and urine showed marked differences, 
again pointing to major post absorption metabolism. The successful transfer of the 
method from the initial radiolabelled study to the onion feed allowed pharmacokinetic 
data to be obtained from all plasma samples taken over a 24 h period, along with the 0-
24 h urine samples. In Chapter 4 it was seen that the metabolites are both rapidly 
absorbed and excreted, with plasma levels returning almost back to baseline by 6 h.    4
The total excretion in urine accounted for 4.5% of the ingested dose. These results were 
controversial, as the pioneer of this field had published that the elimination half life of 
quercetin was of the order of 18 h. The differences between the two methods employed 
are discussed in Chapters 3 and 4. 
The fact that only 4.5% could be accounted for in this study, which was in 
agreement with other studies, leaves the question of what happens to the other 95.5%. It 
is possible that the potential health benefit attributed to this compound may have 
nothing to do with the parent compound but could be coming from something in the 
other 95.5%. 
Studies using patients who have undergone an ileostomy have been used to 
provide further information into what happens to the majority of the dose. By collecting 
the ileal fluid after a flavonol feed the amount of intact compound can be measured in 
ileal fluid (Hollman et al., 1995b; Walle et al., 2000). This work and some results from 
a similar trial study are discussed in Chapter 4, with regard to the process of metabolite 
absorption and formation.  
 The only way to follow the parent compound throughout its passage through the 
body is by use of a labelled compound. In Chapter 5 a second feed of [2-
14C]quercetin-
4´-glucoside, which focuses on the overall fate of the compound, has samples collected 
for up to 72 h. The fate of the dose was monitored both in terms of the level of 
radioactivity excreted and found in the tissues and also the identity of the radioactive 
compounds detected in these samples.  
In Chapter 5 the results from this study and what impact they could have on 
quercetin’s potential ability to be the compound responsible for the health benefits are 
discussed.   5
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Aims of Study 
At the outset of this project all I wanted to do was to know more about the absorption, 
disposition, metabolism and excretion (A.D.M.E.) of the flavonol quercetin-4´-
glucoside. In a hypothesis driven environment this was not the accepted way to work. 
However, to form a hypothesis based on existing knowledge, to me, would be 
guesswork. I wanted to treat the flavonol as if it was a drug and carry out the sort of 
testing a drug company would put one of its compounds through.  
It was evident that without improvements in the analytical methodology used in 
A.D.M.E. studies there would be little chance of obtaining the information needed to 
ascertain if flavonols could have a health benefit.  
Therefore I set out the following aims: 
1.  To develop methods based on HPLC linked to a radioactivity detector and an ion 
trap mass spectrometer could identify and quantify the radiolabelled flavonol [2-
14C]quercetin-4′-glucoside and its metabolites in rats. 
2.  To develop, based on the rat work, methods using HPLC linked to diode array 
absorbance detection and ion trap mass spectrometry to positively identify and 
quantify onion derived flavonols and their metabolites in man. 
3.  To quantify flavonols and their metabolites and determine their pharmacokinetic 
profile in human plasma and urine following a meal of lightly fried onions. 
4.  To determine the fate (A.D.M.E.) of the total dose of  [2-
14C] quercetin-4´-glucoside 
fed to rats housed in metabolism cages over a time course of 1 to 72 hours.   16
Chapter 1  Introduction 
1.1  Diet and Health 
A diet rich in fruits and vegetables has long been recognised to protect against 
degenerative diseases like coronary heart disease (CHD) and stroke and certain cancers 
(WHO, 2003). The current dietary guidelines in the UK recommend a daily intake of at 
least 5 portions (each weighing 80 g). Although the protection afforded by fruits and 
vegetables can be partly explained by associated lifestyle factors including abstinence 
from smoking and increased physical activity (Lampe, 1999), specific bioactive dietary 
constituents are considered to be important to health. These include the known nutrients 
and also phytochemicals such as flavonoids. 
Flavonoids are made up of phenolic and polyphenolic compounds, they are 
secondary metabolites widespread in the plant kingdom and form an integral part of the 
human diet with fruits, vegetables, tea and red wine providing an especially abundant 
source. During the past decade, interest has arisen in these compounds, as there is some 
evidence to suggest that an increased consumption of phenolic rich foods/beverages 
may help prevent disease. Polyphenols are reducing agents and their potential health-
related properties have been ascribed to their powerful antioxidant abilities, which may 
protect the body from damaging oxidation reactions, caused by ‘free radicals’ (Kanner 
et al., 1994).  
Dutch investigators measured the levels of the flavonols quercetin, kaempferol 
and myricetin and the flavones apigenin and luteolin in a number of drinks, fruits and 
vegetables (Hertog et al., 1992a; Hertog et al., 1993c). This data was used to assess the 
flavonoid intake of a group of elderly men over a five year period. The flavonoid intake 
(measured in tertiles) was significantly inversely associated with mortality from 
coronary heart disease (Hertog et al., 1993a). Onions were one of three foods also 
associated with the reduction in CHD and strokes in the Zutphen elderly study. The 
common antioxidant/phytochemical link between the three foods cited, apples and tea 
being the other two, was the flavonol quercetin. The aglycone quercetin occurs only   17
rarely in nature and is normally found conjugated to various sugars, most commonly 
glucose, as is the case for the three foods mentioned here. Although the Zutphen elderly 
study showed a clear decrease in CHD and strokes, associated with an increase in the 
consumption of the three aforementioned foods, how this health benefit comes about is 
unclear. In fact it is a large leap of faith to jump from onions, tea and apples being 
associated with a health benefit to it then being attributed to a particular compound. 
Furthermore, the data upon which this epidemiological study was based were 
measurements of the aglycone of the flavonols in the food and drinks. The need to know 
the sugar conjugate of the flavonol is of great importance as this can have a major effect 
on absorption depending on whether hydrolysis occurs in the small intestine to facilitate 
absorption. 
1.2   Oxidative stress & chronic disease 
A wide range of chronic diseases have oxidation events as a major component of 
their pathophysiology and uncontrolled oxidative damage has been implicated in a 
number of degenerative diseases including cancer, atherosclerosis and chronic 
inflammatory diseases (Beckman & Ames, 1998a). Harman first proposed the ‘free 
radical theory of aging’, which stated that free radicals produced during metabolism and 
other biological reactions cause cumulative cell damage leading to ageing and eventual 
death (Harman, 1956). This theory has since been transformed into a more general 
premise which highlights that an over-production of reactive oxygen species (ROS) 
during normal metabolic processes, or a loss of the protective mechanisms that reduce 
the ability to withstand oxidative challenge is intricately connected to ageing and 
lifespan (Beckman & Ames, 1998b).  
The association between increased intake of foods containing antioxidants and a 
reduction in degenerative diseases would seem obvious. But is it the antioxidant 
property of these compounds that bring about this association or is it some other 
property? Are all these compounds equally beneficial for health or is it specific 
compounds for specific diseases? Unless we can find out more about what happens to 
these compounds in vivo we may never know the answers to these questions.  
1.3  Classification of Phenolics 
Phenolic compounds are secondary plant metabolites, characterized by having at 
least one aromatic ring with one or more hydroxyl groups attached. In excess of 8000 
phenolic structures have been reported, and they are widely dispersed throughout the 
plant kingdom (Strack & Wray, 1992). They are synthesized via the shikimate and 
phenylpropanoid pathways. Phenolics range from simple, low molecular weight, single 
aromatic-ringed compounds, like gallic acid to large and complex tannins, such as the 
polymeric proanthocyanidins (Lairon & Amiot, 1999). They can be classified by the 
number and arrangement of their carbon atoms and are commonly found conjugated to 
sugars and organic acids.  Phenolics can be classified into two groups, the flavonoids 
and the non-flavonoids.  
1.3.1  Flavonoids 
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Figure 1-1. Generic structures of the major flavonoids. 
  18Flavonoids are polyphenolic compounds comprising 15 carbons, with two 
aromatic rings connected by a three-carbon bridge (Figure 1-1). They are the most 
numerous of the phenolics and are found throughout the plant kingdom. They are 
concentrated mainly in the epidermis of leaves and the skin of fruits, and they have 
many important and varied roles as secondary plant metabolites. Their location in plants 
associates well with their functions, which include UV protection, pigmentation, 
stimulation of nitrogen-fixing nodules and disease resistance (Koes et al., 1994; 
Pierpoint, 2000).  
 The  C -C -C 6 3 6 flavonoid structure is the product of two separate biosynthetic 
pathways (Figure 1-2). The bridge and one aromatic ring, ring B, constitute a 
phenylpropanoid unit synthesized from phenylalanine, which itself is a product of the 
shikimic acid pathway. The six carbons of ring A originate from the condensation of 
three acetate units via the malonic acid pathway. The fusion of these two parts involves 
the stepwise condensation of a phenylpropanoid, 4-coumaryl CoA, with three malonyl-
CoA residues, each of which donates two carbon atoms, in a reaction catalysed by 
chalcone synthase (Figure 1-2). Tetrahydroxychalcone, the product of this reaction, 
gives rise to all the other types of flavonoids via the flavonoid biosynthetic pathway 
(Figure 1-3). 
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Figure 1-2. Basic structure and biosynthetic origin of the flavonoid skeleton. 
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The main sub-classes of flavonoids are the flavones, flavonols, flavan-3-ols, 
isoflavones, flavanones and anthocyanidins (Figure 1-1). The basic flavonoid skeleton 
can have numerous substituents.  Hydroxyl groups are usually present at the C-4´, 5 and 
7 positions. Sugars are very common with the majority of flavonoids existing naturally 
as glycosides. Whereas both sugars and hydroxyl groups increase the water solubility of 
flavonoids, other substituents, such as methyl ethers and isopentyl units give flavonoids 
lipophilic properties.    21
  
Figure 1-3. The Shikimatic acid, pheynlpropanoid & flavonoid biosynthetic pathways. 
  Enzyme abbreviations: PAL-phenylalanine ammonia-lyase; C4H-cinnamate 4-hydroxylase; 4C3H-4-
coumarate 3-hydroxylase; CMT-caffeate methyl transferase; 4CL-4-coumarate: CoA ligase; SS-stilbene 
synthase; CHS-chalcone synthase; CHI-chalcone isomerase; IFS-2-hydroxyisoflavone synthase; IFD-2-
hydroxyisoflavanone dehydratase; FNS-flavone synthase; FHT-flavanone 3-hydroxylase; FLS-flavonol 
synthase; DFR-dihydroflavonol 4-reductase; ANS-anthocyanidin 4-reductase; LAR- leucoanthocyanidin 
4-reductase. 
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C4H1.3.1.1 Flavonols 
Flavonols are arguably the most widespread of the flavonoids, being dispersed 
throughout the plant kingdom with the exception of fungi and algae. Flavonol 
distribution and the wide structural variations have been comprehensively described 
(Williams, 1992; Wollenweber, 1992). Within the plant, flavonols such as myricetin, 
quercetin, isorhamnetin and kaempferol (Figure 1-4) are most commonly found as O-
glycosides. Conjugation occurs most frequently at the 3 position of the C ring but 5, 7, 
4′, 3′ and 5′ substitutions also occur (Herrmann, 1976).  Although the number of 
aglycones are limited there are numerous flavonol conjugates with more than 200 
different sugar conjugates of kaempferol alone (Strack & Wray, 1992). There is 
information on the levels of flavonols found in commonly consumed fruits, vegetables 
and beverages (Hertog et al., 1992a; 1993c). However, large differences are often found 
in the amounts present in seemingly similar produce, possibly due to seasonal variation 
and varietal differences (Crozier et al., 1997). In addition this information is based on 
the level of the aglycone present and not on the conjugate, which can have a major 
effect on the pharmacokinetics and bioavailability of the compound (Hollman et al., 
1999; Erlund et al., 2000e) 
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Figure 1-4. The flavonols, kaempferol, quercetin, isorhamnetin and myricetin.
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1.3.1.2 Anthocyanidins 
Anthocyanidins, principally as their conjugated derivatives, the anthocyanins, 
are a group of water-soluble compounds responsible for most floral, fruit and leaf 
pigmentation in nature (Clifford, 2000). The most common anthocyanidins are cyanidin, 
found in raspberries (Mullen et al., 2002c), delphinidin in blackcurrants (Rechner et al., 
2002), malvidin in red wine (Burns et al., 2002a) and pelargonidin found in strawberries 
(Mullen et al., 2008b). Two other abundant anthocyanidins are petunidin and peonidin, 
both found in red wine (Burns et al., 2002a). Naturally occurring anthocyanins are 
normally found as 3-O-glycosides. Structurally anthocyanins consist of an 
anthocyanidin bound to one or more sugar moieties, and with a sugar always present at 
the C3 position and frequently on carbons 7, 3' and 5'. They can also form conjugates 
with hydroxycinnamates and organic acids such as malic acid and acetic acid, which are 
both found in red wine (Burns et al., 2002a). Anthocyanins are responsible for the red, 
blue or violet colour of edible fruits including grapes, plums and berries, with levels 
increasing during fruit maturation (Peterson & Dwyer, 1998) 
1.3.1.3 Flavan-3-ols 
Flavan-3-ols range from the simple monomers (+)-catechin and its isomer (-)-
epicatechin, to the oligomeric and polymeric procyanidins, more correctly called 
proanthocyanidins. In addition to forming complexes with other flavan-3-ols, they are 
hydroxylated to form the gallocatechins, and also undergo esterification with gallic acid. 
Furthermore, methylation, prenylation and O-glycosylation reactions have all been 
reported (Porter, 1992). (+)-Catechin and (-)-epicatechin are found in various fruits and 
vegetables such as apples, pears, grapes and peaches (Arts et al., 2000a), with the 
highest concentrations of catechins found in tea and red wine (Arts et al., 2000b). 
Flavan-3-ols are the only flavonoids found in abundance in foods that are not naturally 
conjugated to sugars. 
1.3.1.4 Flavones 
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at position C3. A variety of substitutions are possible providing a wide array of natural 
and synthetic compounds; these include hydroxylation, methylation, O- and C-
alkylation and O and C-glycosylation. Most flavones occur as 7-O-glycosides (Bohm, 
1998). Flavone distribution appears to be limited to only a few plant families, with the 
main flavones in the diet being apigenin and luteolin. They have been identified in 
celery (apigenin), sweet red pepper (luteolin), parsley and other herbs (Hertog et al., 
1992a).  
1.3.1.5 Flavanones
Flavanones are mainly represented by taxifolin, naringenin and hesperetin. 
Flavanones are characterized by the absence of the C2-C3 double bond and the presence 
of a chiral center at C2. The flavanone structure is highly reactive and they have been 
reported to undergo hydroxylation, glycosylation and O-methylation reactions. The 
main dietary source of flavanones is citrus fruit and the most commonly consumed is 
hesperetin from oranges (Rouseff et al., 1987) in the form of heperetin-7-rutinoside 
(hesperidin) and naringenin-7-rutinoside (narirutin). Naringenin is also found in 
tomatoes and tomato-based products. Fresh tomatoes, especially tomato skin, also 
contain naringenin chalcone, which is converted to naringenin during processing to 
tomato ketchup (Krause & Galensa, 1992). 
 
1.3.1.6 Isoflavones
Isoflavonoids are characterised by having the B ring attached at the C3 of the 
phenylchromane structure. Isoflavonoids are derived from the biosynthetic pathway and 
can be converted into a wide range of different isoflavonoids including isoflavanones 
and isoflavonols (Dewick, 1993). Isoflavones are mainly represented by daidzein and 
genistein. The main dietary source is soybeans and soy products, with soy typically 
containing around 1 g of genistein and daidzein per kg of wet weight (Mazur et al., 
1998; Liggins et al., 2000). These compounds have received much attention due 
estrogenic activity and to their putative role in the prevention of breast cancer and 
osteoporosis (Tapiero et al., 2002), which has not been linked to any antioxidant effect. 
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The main non-flavonoid phenolics found in the diet are the C6-C1 
hydroxybenzoates,  C6-C3  hydroxycinnamates and polyphenolic C6-C2-C6  stilbenes. 
Phenolic acids exist primarily as conjugates and are rarely found in their acidic forms, 
often found bound to alcohols, sugars, polysaccharides, or organic acids through ester 
bonds.  
1.3.1.6 Hydroxybenzoates 
Hydroxybenzoates also referred to as phenolic acids include benzoic acid and 
derivatives including salicylic acid. Gallic acid is the major hydroxybenzoate and is 
synthesised from phenylalanine via 3-dehydroshikimic acid. It is found in large 
quantities in red wine. It can be converted to ellagic acid and a range of gallotannins, 
with the formation of hydrolysable tannins (polymers of gallic and ellagic acids). Black 
tea and red wine provide rich dietary sources of gallic acid (Soleas & Goldberg, 1999; 
Dunfrense & Fransworth, 2001). Fruits such as raspberries contain high concentrations 
of Sanguuin H6 and Lambertianin C, large hydrolysable tannins with molecular weight 
1870 and 2804 respectively (Mullen et al., 2002d; 2003b). 
1.3.1.7 Hydroxycinnamates 
Hydroxycinnamic acids: p-coumaric, ferulic, sinapic, caffeic acids and their 
derivatives are the most important subclass of phenolic acids.  Cinnamic acid is 
produced by the deamination of the amino acid phenylalanine by phenylalanine 
ammonia lyase (PAL), with p-coumaric acid being produced by hydroxylation of 
cinnamic acid. In addition to being found in their free form hydroxycinnamates are also 
found esterified to sugars, organic acids and choline (Strack, 1997). Caffeic acid occurs 
in foods mainly as an ester with quinic acid, chlorogenic acid (5-caffeoylquinic acid). 
Coffee is a major dietary source of chlorogenic acid in the diet with dietary intakes 
estimated at 0.5-1 g/day (Clifford, 2004).   
 
1.3.1.8  Stilbenes 
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class of antibiotic compounds produced as a part of a plant's defense system against 
disease.  Trans-resveratrol (trans-3,5,4'-trihydroxystilbene) is synthesised by 
condensation of 4-coumaroyl CoA with three units of malonyl CoA, each of which 
donates two carbon atoms, in a reaction catalysed by stilbene synthase. Resveratrol 
exists as two isomers; cis and trans with trans-resveratrol-3-O-glucoside commonly 
found in various families of plant tissues such as eucalyptus, spruce, and lily. Grapes, 
peanuts and their products are considered the most important dietary sources of the 
resveratrol, with levels of 0.02-1.8 µg/g and 0.6-8 µg/mL reported in peanuts and red 
wine (Sanders et al., 2000). However, should resveratrol prove to have health benefits 
the best source would be from the Japanese knotweed Polygonum cuspidatum (Burns et 
al., 2002b)  
1.4  Dietary Sources and Intake of Phenolics 
The ubiquitous nature of phenolic compounds in plants ensures that they are 
found in significant levels in the diet. However, the information available on the levels 
of phenolics in foodstuff is somewhat mixed. Unlike well-known dietary components, 
such as vitamin C and E, comprehensive food tables are not available for phenolic 
compounds. As these compounds, unlike vitamins and minerals, are not essential 
components of our diet, there are no dietary reference values.  
 Kuhnau, (1976) used the Folin Ciocalteau method (Singleton & Rossi, 1965) to 
estimate the total polyphenols in a wide variety of foods consumed in the USA (Table 
1-1). Based on these results and the daily food intake tables in the USA a figure of 1.0 
to 1.1 g/day of polyphenols was calculated. Hertog et al., (1992b) used a 
chromatographic method with absorption detection to estimate the aglycone content of 
flavonols and flavones of 28 vegetables and 9 fruits commonly consumed in the 
Netherlands. Justesen et al., (1997c) also used this method to estimate the average daily 
intake of flavonols and flavones in the Danish diet. The figures arrived at by these two 
groups were 23 and 28 mg/day, well short of Kuhanu’s estimate.  
Two reasons for the discrepancy are possible. In any analysis the more selective 
and specific the measurement is the less chance there is of interference and thereby 
overestimates being made. Therefore the chromatographic system of the Dutch and 
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procyanidins, which do not chromatograph, anthocyanins and isoflavones would also go 
undetected thereby giving an actual underestimate.  
Table 1-1. Total polyphenol estimates of (Kuhnau, 1976) taken from (Bravo, 1998) 
The method used by Kuhnau is based on the reduction of the Folin reagent 
causing a colour change. Reducing agents like vitamin C are present in many foodstuffs 
and this can have a marked and varied effect on the estimates.  
Other factors that can contribute to inaccuracy and variation in estimates of 
dietary intake of phenolics lie in the nature of the foods analysed, as well as the methods 
used. Seasonal variations can dramatically influence the phenolic contents of fruits and 
vegetables, as can varietal differences (Crozier et al., 1997; 2000). In the case of onions,  
(Kuhnau, 1976) the free polyphenol content ranged from 100-2025 mg/100g fresh 
weight. Whereas varietal variation, white or yellow onions, produced a range from 185 
to 650 µmole/g fresh weight  
  27 The estimation of consumption by (Hertog et al., 1993a) applies not to 
flavonoids but is restricted to only three flavonols and two flavones, and the calculation 
is based on aglycones rather than conjugates. It is, therefore, almost certainly a serious 
under estimate of flavonoid ingestion, as would be the Danish intake, calculated using 
the same method for the same compounds (Justesen et al., 1997a). At the other end of 
the scale Kuhnau, (1976) estimated the intake in the USA as being over 1000 mg per 
day for the total polyphenol intake. This figure is based on all phenols being 
glycosides/conjugates and, due to the previously discussed factors, is likely to be an 
over estimate of flavonoid consumption. 
Berries, along with other fruits can contribute significantly to the dietary 
consumption of phenolics by their anthocyanin content. A regular daily consumption 
can readily increase the intake of a variety of phenolics. In addition people who 
consume large quantities of tea or coffee will also have much higher intake of 
flavonoids and related compounds. Two of the three aforementioned phenolics were not 
taken into account in the Dutch and Danish studies. In fact if the dietary sources are 
examined in the Danish study it is clear that only 6 foods contribute 98% of the 
estimated phenolic intake (Table 1-2), an unlikely supposition. 
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 Table 1-2. Flavonoid intake in Denmark taken from Justesen et al 
 
 
In summary, the estimate of the daily dietary intake of polyphenols depends on a 
number of factors. 
1.  Which analytical method has been used to obtain data to calculate the 
content in the foodstuffs.  
2.   The content of the food can vary from year to year due to climatic factors, 
over and above seasonal variation. 
3.   The variety of food can also have a marked influence on the content.  
4.    The daily dietary intake of these foods is taken from food consumption 
tables and or diary record. 
The problem of estimating the daily intake of polyphenols is only one part of the 
puzzle. There are also problems with these estimates as flavonoid absorption is 
dependant on many other factors, which will be discussed in Section 1.6. However, one 
of the biggest issues in coming to an understanding of polyphenols and health is being 
able to make accurate measurements of the compounds of interest. 
One point that should not be overlooked when examining the accuracy of either 
the dietary intake tables or the flavonoid content of the food is that this data cannot 
prove that any particular food does have a health benefit. All they can do is show an 
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be made that they are the responsible for it. If we want to be able to prove a compound 
is responsible for a health effect, more must be known about what happens to it when it 
is absorbed, what it is metabolised to, what concentration it is in the body at, what 
tissues it accumulates in and in what form it is excreted.  
 
1.5  Analytical measurement of flavonols 
“I often say that when you can measure what you are speaking about, and 
express it in numbers, you know something about it; but when you cannot 
measure it, when you cannot express it in numbers, your knowledge is of a 
meagre and unsatisfactory kind”  A quotation from Lord Kelvin. 
Measuring the level of quercetin-based compounds in, for example, onions is not 
a simple task, as outlined in previous section. The most common method used involves 
a number of processes. Firstly, extraction using an organic solvent, typically methanol, 
followed by concentration of the extract and, if deemed necessary purification. An 
aliquot of the concentrated extract can then be processed by HPLC, to separate it into its 
individual components. These compounds on elution from the HPLC column pass 
through various detectors, which can selectively measure the analytes of interest.  
The four processes, extraction, purification, separation and detection all have an 
influence on the outcome of the result. Failure to give sufficient attention to any one of 
these processes can lead to inaccurate results. This topic will be expanded upon 
throughout the thesis. 
In chromatographic analysis the identity of a compound can be determined only 
if there is an authentic standard with which to compare it. In chromatography, retention 
time is a major identifying property of a compound. (i.e. how long it takes a compound 
to pass through the chromatographic system and produce a peak in the detection 
system). If a peak in an extract has the same retention time as that of a previously run 
standard, it can be argued, with some justification, that they are the same compound. 
Co-chromatography of the standard and the extract can further strengthen the claim. 
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that another compound could, by chance, co-elute with the compound of interest. 
Although there are only a few flavonol aglycones the number of conjugates of 
kaempferol is in excess of 200, and a similar number or more, due to the additional 
hydroxyl group, must be expected for quercetin. This leaves the researcher with a 
difficult problem. There are no standards available for the majority of these compounds. 
Therefore, how do they identify and measure the levels present in foods? 
One method that has been employed is to use acid hydrolysis to cleave the sugar 
moiety leaving only the aglycone, which can be readily quantified against a standard 
obtained from commercial suppliers. This has enabled quasi-quantitative estimates of 
flavonol content to be obtained for a wide variety of fruit, vegetables and beverages 
(Hertog et al., 1992a). Such databases, as seen in Table 1-2, have been used in several 
epidemiological studies to estimate the flavonol intake by different populations. 
However, while potentially useful in this context, this simplified method of flavonol 
analysis has limitations. 
Studies have shown that, for the same dose, five times more quercetin-4'-
glucoside is absorbed than quercetin-3-rutinoside (Hollman et al., 1999). These two 
compounds make up a major part of quercetin intake in the diet of the western world. 
Furthermore, the site of absorption would also seem to differ as the time to reach peak 
plasma concentration is significantly longer for the rutinoside conjugate (Hollman et al., 
1999). The glucoside is absorbed in the small intestine, whereas the rutinoside is from 
the large intestine (Hollman et al., 1995b). What impact this has on the levels and forms 
of metabolites and catabolites has only recently been ascertained (Jaganath et al., 2006). 
Such differences could have a major influence on the potential health effects of these 
flavonols. 
Measuring the levels of flavonol metabolites in biological samples after a feed 
of flavonol glucosides is even more problematic than when measuring the flavonol 
content of fruit and vegetables. Even the use of authentic standards as a means of 
identification of metabolites has been called into question. For example, (Aziz et al., 
1998) identified quercetin-4'-glucoside in human plasma after a meal of lightly fried 
onions using HPLC with co-chromatography of a standard. However, it was thought 
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glucoside and it therefore could in fact be this compound that was being detected in 
plasma. At the time the analysis was being carried out no standards of quercetin 
glucuronides were available to test this hypothesis and no chromatographic detection 
system could uniquely identify them. 
Returning to the theme of four processes that affect the probability of a 
successful outcome of an analysis. With hindsight, the study by Aziz et al., (1998) 
could have increased the separating powers of the analysis to try and minimise the 
chance of two compounds co-eluting. However, the gradient reverse phase analysis 
could separate a far greater number of compounds than the isocratic systems used to 
analyse the aglycone, though no one so far has suggested that there may be compounds 
co-eluting with the quercetin peak. Only once standards of the glucuronides or a 
detection system that could differentiate between the two compounds became available 
would the problem encountered by Aziz et al., (1998) have become apparent. 
With the use of the limited number of standards being called into question, 
hydrolysis to the aglycone became the standard method of analysis. However, this 
simplification also leaves many questions unanswered. Does the type of metabolite 
formed vary from different foods and are certain metabolites more bioactive than 
others? Moreover, it is still possible to have major errors using this method if 
insufficient care has been taken with the four processes needed to ensure that the 
aglycone is free from potential interfering compounds. 
Recent advances in analytical instrumentation, in particular tandem mass 
spectrometers, now allow structural information to be obtained for individual HPLC 
peaks, so it is possible for instance, to distinguish between quercetin glucuronides and 
quercetin glucosides without the need for reference compounds. Even if these two 
compounds co-elute in the chromatographic system they have different molecular 
weights and therefore would be seen as individual peaks in the mass spectrometer. The 
selectivity of MS-MS systems is such that two potential metabolites with the same 
molecular weight, as is the case of methyl quercetin glucoside and quercetin 
glucuronide, can be detected in the same peak due to their MS
2 spectra. However, this 
increase in selectivity comes with a price. In full scan mode the ability to accurately 
quantify is lost. 
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looks for predetermined parent ions fragmenting to known daughter ions, to detected 
five quercetin monoglucuronides in human plasma after ingestion of 800 g of onions. 
This would indicate all free hydroxyl groups have been conjugated with a glucuronic 
acid. Though some doubt has been cast on this possibility by Day et al., (2000), who 
showed that the C-5 position was not a site for conjugation by human liver extracts. A 
possible explanation for this result shows one of the limitations of this technique. The 
mass spectrometer was set up to monitor the fragmentation of the [M+H]
+ parent ion at 
m/z 479 (quercetin glucuronide) to a daughter ion at m/z 303 (quercetin). However, 
partial fragmentation of a quercetin diglucuronide will produce an ion at m/z 479 which 
would also then yield an ion at m/z 303. Thus, a quercetin diglucuronide could give a 
false positive response for a quercetin monoglucuronide. In fact any compound that 
produces a transition from m/z 479 to m/z 303 will give a positive response in this 
analysis. This, and other potential sources of misidentification are discussed in detail in 
Chapter 3. 
In a later study by this group (Graefe et al. 2001) no sulphate metabolites were 
found in plasma after a supplementation with onions. This is in keeping with work 
reported by Watson & Oliveira, (1999) using a GC-MS method. By chemically 
synthesising quercetin glucuronides and use of fast atom bombardment (FAB)-MS 
Moon et al., (2001) were able to identify quercetin-3-glucuronide (Figure 1-5) as being 
a major metabolite circulating in rat plasma. In another human study twelve metabolites 
of quercetin were detected in pooled plasma samples after an onion feed (Day et al., 
2001). Contrary to the work of Graefe et al., (2001) and Watson & Oliveira, (1999), one 
of the main metabolites was quercetin-3'-sulphate (Figure 1-5). Identification was 
achieved by a combination of co-chromatography with standards, enzyme hydrolysis 
procedures and HPLC-MS in the SIM mode. This facilitated the identification four of 
the twelve quercetin metabolites, namely a quercetin-diglucuronide, quercetin-3-
glucuronide, 3'-methylquercetin-3-glucuronide and quercetin-3'-sulphate (Figure 1-5). 
No quantitative data came from these studies. 
The need to have analytical methods to allow identification of the actual 
metabolites and accurately measure their levels is paramount to being able to understand 
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investigation. 
This topic is of importance and it will be revisited all the way through this 
thesis. 
To take Lord Kelvin’s quote “Only when we can measure it can we say something 
about it”. 
1.6  Absorption of polyphenols 
Polyphenols in general and flavonols in particular are poorly absorbed. 
Measured by urinary excretion in humans Aziz et al., (1998) reported less than 1% 
recovery of the flavonol dose from onions. If flavonols are to have an impact on health 
then more must be known about what happens to the absorbed dose. 
1.6.1  Factors affecting absorption 
The rate and extent of intestinal absorption and metabolism of polyphenols are 
influenced by a number of factors including their chemical structure, molecular weight, 
solubility, glycosylation and esterification. 
1.6.2 Glycosylation 
Most polyphenols (flavonols, isoflavones, flavones, anthocyanins) are found in 
plants in a glycosylated form and this influences their chemical, physical and biological 
properties. The sugar moiety makes them much more hydrophilic, thus reducing their 
ability to passively diffuse across a biological membrane. Therefore, if absorption is to 
occur in the small intestine either an active transport mechanism must operate or the 
compound must undergo deglycosylation to allow passive absorption. In the case of 
flavonols the most noticeable difference is in the case of quercetin-3-rutinoside and 
quercetin-3-glucoside (Hollman et al., 1999). This is due to the enzymes, lactase 
phloridzin hydralase (LPH) and or cytosolic β glucosidase (CβG), in the small intestine 
being unable to hydrolyse the rutinoside sugar from the flavonol. The estimate of 
flavonoid content in foods being reported as aglycone levels gives no information as to 
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onions are absorbed 5 times more than quercetin-3-rutioside (Hollman et al., 1999) the 
need for food intake tables that contain information on the sugar conjugate can be 
appreciated.  
1.6.3 Molecular  weight 
High molecular weight (MW) compounds including tea theaflavins (MW ≥ 568) 
and proanthocyanidins (MW ≥ 578) are unlikely to be absorbed in the GI tract (Donovan 
et al., 2002). However, the procyanidin dimer B2 has been detected in human plasma 
following consumption of a flavan-3-ol rich cocoa (Holt et al., 2002). Procyanidin 
dimers and trimers were also found in rat urine after a feed of grape seed extract (Tsang 
et al., 2005). The absorption of the ellagitanin punicalagin has also been reported by 
(Seeram et al., 2006). As the Tmax of the ellagic acid metabolite was under 1 h, it can be 
assumed that initial absorption must have occurred in the stomach and small intestine. 
However, ellagic acid and urolithin metabolites have of a much lower molecular weight 
suggesting the punicalagin had been broken down prior to absorption.  
1.6.4 Esterification 
Hydroxycinnamates, such as caffeic acid, are commonly esterified to sugars, organic 
acids and lipids. Caffeic acid is better absorbed than chlorogenic acid, which is made 
from an esterification of caffeic acid with quinic acid. Olthof et al (2003) reported 95 % 
intestinal absorption for caffeic acid compared with only 35 % for chlorogenic acid in 
ileostomy subjects. In an in vitro study using an isolated rat intestine absorption of 
caffeic acid was approximately ten times that of chlorogenic acid (0.115 nmole) 
(Spencer et al., 1999). 
1.6.5 Matrix  effects 
Some studies into the effect of consumption of a flavonol in the presence of another 
food substance have been investigated. Hollman et al., (1997a) investigated the 
influence of milk on flavonol absorption with tea and found it had no effect. In a study 
on what influence milk had on the absorption of flavn-3-ols from milk and dark 
  35 chocolate Serafini et al., (2003) found that there was a reduction due to the milk. This 
paper was quickly criticized by a number of scientists (Halliwell, 2003; Schroeter et al., 
2003) which was then replied to in an exchange in the journal Nature (Serafini & 
Crozier, 2003). The possible conflicting results may be due to the levels of flavan-3-ols 
in the dose relative to the amounts of protein in the milk. The studies quoted by 
Halliwell and also by Schroeter used very high doses of flavan-3-ols whereas Serafini 
used nutritionally relevant ones.  
The British tennis meeting at Wimbledon inspired the study into the influence of 
cream on the absorption of anthocyanins from strawberries. In this study the overall 
outcome was no effect but the plasma Tmax was significantly delayed and 0-2 h urinary 
excretion was lower in the feed with cream. In keeping with these observations, 
measurement of plasma paracetamol and breath hydrogen revealed that cream delayed 
gastric emptying and extended mouth to caecum transit time (Mullen et al., 2008b). 
1.7  Bioavailability of flavonols 
In Section 1.4 the difficulty in obtaining accurate data on the level of polyphenols in 
food was discussed. Therefore it can be imagined how difficult it is to measure the 
bioavailability of the onion flavonols quercetin-4´-glucoside and quercetin-3,4´-
diglucoside (Figure 1-5). The analytical methods must be highly selective, to prevent 
overestimates, but also able to detect all metabolites, to prevent underestimates. 
Quantitative analysis of quercetin in acid hydrolysed human urine collected over a 24 h 
period after eating a meal of lightly fried onions accounted for only 0.8% of the amount 
ingested and extrapolations from the amounts present in the bloodstream at peak plasma 
concentration also yielded a figure of 1.0% (Aziz et al., 1998). These results are in 
keeping with those obtained by Gugler et al., (1975) at just over 1% after the ingestion 
of a massive 4 g of the aglycone. Other studies have found 2.6% and 3% for intake of 
quercetin-3-glucoside and quercetin-4'-glucoside (Table 1-3) respectively Olthof et al., 
(2000). However, it is evident from the data in Table 1-3 that despite the widely ranging 
levels reported in plasma that over 95% of the ingested flavonols remain unaccounted 
for.  
In an attempt to investigate the missing flavonols, studies were carried out with 
ileostomy volunteers. Analysis of ileal fluid after ingestion of onions indicated that 47-
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al., 2000). However, the difference between the quantity of flavonols ingested and the 
level recovered in ileal fluid does not necessarily indicate the amount absorbed. What 
should have been the conclusion of this study was that 47-76% of the flavonol dose 
could not be accounted for. 
What happens to these compounds when they pass from the small to the large 
intestine is also under investigation. The large intestine is a major site of flavonol 
catabolism due to the action of colonic bacteria. 
It was reported as long ago as 1956 that the bacteria in the colon break down 
quercetin, by cleavage of the C-ring to various phenoxyacetic acids (Booth et al., 1956). 
However, many of these acids are also products of metabolic pathways unrelated to 
flavonol degradation.  
In colonic fermentation experiments (Aura et al., 2002) the faecal microflora 
rapidly deconjugated rutin, isoquercitrin and a mixture of quercetin glucuronides. Rutin 
also underwent ring fission and dehydroxylation. This report points out that because the 
faecal matter used is derived from components of the diet it does contain relatively high 
background levels of phenolic compounds. This was also evident in the work of Olthof 
et al., (2003) who fed 20 healthy volunteers chlorogenic acid, rutin and black tea 
powder in a crossover study. Urine was collected and analysed for 60 potential phenolic 
acid metabolites using GC-MS. Similar feeds were given to seven volunteers who had 
had a colostomy and the data obtained from the two groups compared. In the case of 
rutin, the colostomy volunteers had only traces of phenylacetic acids in urine compared 
with those of the volunteers with an intact GIT. This implies that the colonic microflora 
convert flavonols to phenolic acids, which then pass into the circulation and are 
subsequently excreted in the urine. The measurements of phenolic acids were made 
against a high background of these compounds.  This makes it very difficult to obtain an 
accurate quantitative picture of flavonol catabolites. The only way to circumvent this 
problem is to use a labelled substrate. 
14 Samples from a study, in which 3 mg of [2- C]quercetin-4'-glucoside (Hartley 
et al., 2000) was fed to rats were used to develop a method to identify the quercetin 
metabolites, formed up to five hours after dosing. In this investigation, reported in 
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flavonol structure with metabolism restricted to methylation, sulphation and 
glucuronidation. 
Chromatographic detection methods rely on the behavioural properties of 
compounds under investigation remaining constant. One of these properties is retention 
time another is absorbance spectrum. A change in the compound conjugated to the 
aglycone will change the retention time. Flavonols have an absorbance spectrum with 
maxima at around 360 nm. Hydrolysis of the metabolite to the aglycone can restore the 
retention time property. However, if the digestive process changes the absorbance 
property then it is no longer possible to detect this compound. What form the “missing” 
flavonols take and to which extent they are bioavailable remains to be determined.  The 
most obvious approach to answer this question is to feed a radiolabelled flavonol, as 
mentioned above, but monitor over a longer timescale.  
As ethical considerations preclude the use of 
14C-labelled flavonols with 
humans, such experiments are typically carried out with rats. The one exception to this 
rule has been a US based study, Walle et al., (2001a). An intravenous and oral intake of 
1.85 MBq (50 µCi) [4-
14C]quercetin was administered to human volunteers in 30 µg 
and 100 mg of quercetin respectively. It was reported that 23-81% of the radioactivity 
was exhaled as 
14CO2  over a period of 72 h in both the intravenous and oral 
experiments. However, the results do not necessarily indicate high levels of absorption 
as the position of the radiolabel in the flavonol skeleton would allow release of the 
14C-
labelled carbonyl group. Fission of the C ring will leave two main catabolites and the 
carbon at the 4 position, which is likely to form CO2. This study was carried out with 
the quercetin aglycone, not a dietary flavonol. Although the authors wrote  “.of key 
importance is to attempt to define the nature of the radioactivity in plasma”, no further 
data have been published. A feed with [2-
14C] quercetin-4'-glucoside to humans would 
have overcome these problems but as mentioned earlier ethical permission for such a 
study would not be granted. However, stable isotope experiments with (
13C)-labelled 
substrates would allow a great deal of information to be obtained with regard to the 
compounds we already know or suspect would be formed from feeds of quercetin sugar 
conjugates. 
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metabolism cages, for up to 3 days, was carried out. This was to answer some of the 
questions regarding the bioavailability of quercetin glucosides. Measurement of the 
radioactivity contained in the urine allowed an estimate of the minimum level of 
absorption to be obtained. Combined measurement of the radioactivity in the faeces, 
urine and body tissue gave an estimates of recovery of the dose. A low recovery would 
have indicated 
14CO2 is a product of catabolism of quercetin-4'-glucoside as found by 
Walle et al., (2001b)  in the feed with [4
14C] quercetin. However, this was not what 
occurred. In fact, over 70% of the dose was recovered in urine, 19% in faeces and the 
remainder in the liquid used to wash the cages after completion of the experiment. The 
radioactivity in the cage washes was from both the urine and faeces. The results of this 
experiment are discussed in Chapter 5. Analysis of urine and extracts of faecal and other 
tissues by HPLC-MS
n with on line radio-detection also allowed identification of the 
metabolite/catabolites of the [2-
14C]quercetin-4'-glucoside. The results of this study are 
also reported in Chapter 5. 
1.8 Potential  bioactivity 
As previously mentioned, methods for the qualitative and quantitative analysis 
of quercetin conjugates have relied on acid/enzyme hydrolysis of samples followed 
HPLC analysis of the released quercetin. However, this leaves questions as to whether 
the actual metabolites present have any biological activity (Manach et al., 1998; Day et 
al., 2000).  
The first attempt to identify the circulating metabolites was reported by Paganga 
& RiceEvans, (1997) using HPLC and diode array detection. They claimed to have 
identified quercetin-3-rutinoside in a single analysis of a single plasma sample after an 
undetermined feed. This and their claims of three other quercetin glucosides, an 
anthocyanin and an unknown aurone must be treated with some scepticism. It was a 
single analysis of a single plasma extract and only two volunteers were recruited. The 
peak seen in the sample was 0.4 min different from that of the quercetin-3-rutinoside 
standard and no co-chromatography was reported. No internal standard was used in the 
extraction process. The meal the volunteers consumed was also not reported. Therefore, 
it must be assumed that it is tomato based if they are looking for quercetin-3-rutinoside. 
  39 The meal must also have included a large amount of berries or red wine for an 
anthocyanin to found in the plasma. Anthocyanin absorption can be as low as 0.004% of 
the dose (Wu et al., 2002) 
Further work using HPLC with electrochemical detection after hydrolysis of the 
sample with a specific enzyme pointed to the fact that no quercetin glucosides were 
present in human plasma after a flavonol supplement (Sesink et al., 2001). Plasma was 
collected from six human volunteers after feeds with quercetin-3-glucoside and 
quercetin-4'-glucoside. Samples were extracted and analysed by HPLC with an 
electrochemical detector, which it was claimed was able to distinguish between flavonol 
glucosides and glucuronides. No peaks in the chromatogram corresponded with that of 
the quercetin glucoside standards. However, peaks that co-eluted with quercetin 
glucuronide standards were present. These peaks disappeared after treatment of the 
sample with bovine glucuronidase and a peak corresponding to quercetin appeared.   
Glucuronide standards have been produced enzymatically from incubation of quercetin 
with pig liver (O’Leary et al 2001). However, they are not commercially available as 
authenticated standards. 
Clearly much progress has been made since Aziz et al., (1998) first attempted to 
identify the circulating metabolites. However, no method is available that can identify 
and quantify all the possible metabolites in a single analytical analysis. Without the 
identity of the main metabolites being known and their concentration in the circulatory 
system, in vitro studies will not be able to ascertain whether these compounds could 
have potential health benefits. Knowing the structures of the metabolites in the small 
intestine, the circulatory system and the forms that are excreted, will allow theories of 
how they interact with the body to be put forward. 
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Figure 1-5. Structure of naturally occurring flavonols and potential metabolites 
 
1.9  Pharmacokinetics of flavonols 
One way to measure the bioavailability of a compound is to measure the concentration 
it circulates in the plasma and is excreted into the urine. The majority of the 
pharmacokinetic studies carried out after feeds of flavonol containing onions and apples 
or various quercetin glucosides, have all relied on the aforementioned method of simply 
measuring the quercetin aglycone after acid or enzyme hydrolysis However, the data 
obtained by Hollman et al., (1996a) indicated that quercetin is present in plasma for 
more than 50 h after supplementation. In contrast the study of Aziz et al., (1998), using 
the same hydrolysis method, showed that the quercetin levels returned to baseline 
within 24 h. 
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Table 1-3. Summary of Human Feeding Studies Involving the Acute Ingestion of a Lightly Fried Onion  
Supplement or pure compound. 
Plasma C Study Meal  (g) 
onions 
Quercetin 
ingested 
Urinary excretion         
(µmol)      (% of intake) 
Analysis 
method 
max 
(µmol/L) 
Plasma 
T  (h)  max
Hollman et al., (1996a)*  215  206  0.6  2.9  n.q.  n.q.  A, D 
Hollman et al., (1997a)*  n.q.  225  0.7  0.7  3.2  1.4  A, D 
Olthof et al., (2000)*  Q4G  331  5.0  0.6  10.3  3.1  A.D. 
Aziz et al., (1998).   300  411  1.3  1.9  3.1  0.8  A, D 
Erlund et al., (2000)  Q  166  0.3  4.9  n.q  n.q.  A.E. 
Graefe et al., (2001)  Q4G  331  7.0  0.7  10.0  3.3   
Graefe et al., (2001)  160  331  7.1  0.7  14.6  4.4  B, E 
Present study  270  275  1.3  0.5-1.0  12.9  4.7  C, F 
n.q. – not quantified; C - maximum concentration of quercetin metabolites in plasma; T  – time to reach C max max max.  Method of 
HPLC analysis:  A – acid hydrolysis of samples prior to analysis, B – enzyme hydrolysis of samples prior to analysis, C – 
samples not hydrolysed prior to analysis, D – post-column derivatization and fluorescence detection, E – photodiode array and 
electrochemical detection, F – photodiode array and full scan MS
2 detection. Q4G is quercetin-4´-glucoside, Q is quercetin 
aglycone. * same laboratory.
  42 In spite of this difference both studies produced similar quercetin peak plasma 
concentrations at 0.6 and 1.3µmole/L respectively Table 1-3. Two other groups have 
carried out studies to investigate the pharmacokinetic characteristics of quercetin 
conjugates accumulated in plasma after oral feeds (Graefe et al., 1999; Erlund et al., 
2000d). As shown in Table 1-3, the Hollman group have carried out three studies 
(Hollman et al., 1996a; Hollman et al., 1997b); (Olthof et al., 2000).  The investigations 
by Manach et al., (1998) was not a pharmacokinetic study though it did provide peak 
plasma levels of 0.4 µmole/L and the time required for plasma levels to return to 
baseline was 20 h. Table 1-3 summarises the results of all these studies.  
Detailed examination of the pharmacokinetic profiles obtained in these studies 
reveals some interesting points. If we examine work from Hollman’s laboratory it 
would appear that feeds of quercetin glucosides reach peak plasma concentrations of 
quercetin almost ten times higher than those obtained with apples or onions Table 1-3. 
However, this is not the case in studies by the Graefe group, where similar peak plasma 
quercetin levels were obtained in feeds with quercetin-4'–glucoside and onions, 
containing both quercetin-4'–glucoside and quercetin-3,4'–glucoside. The work by Aziz, 
Erlund, Manach, and Hollman’s earlier studies, all produced similar results. Graefe and 
Hollman’s recent studies both appear to show a 10-fold increase in peak plasma 
quercetin levels. There are always laboratory-to-laboratory differences, even using the 
same methodologies, and biological variation can also be added to explain such 
differences. However, in the case of Hollman’s studies, it is hard to believe that the 
same laboratory could produce results that are an order of magnitude different using the 
same methodology, without some comment from the author to explain the increase.  
The methods employed in these studies rely on there being no interference from 
unknown compounds that co-chromatograph with the peak of interest. The methodology 
used by Hollman would appear to be very susceptible to this problem. When relying on 
a HPLC to separate one compound contained in a complex mixture of compounds, 
adequate resolving power must be used to minimise the chance of possible interference 
from other compounds. Especially when the other analytical processes of extraction, 
purification and identification are not maximised. The isocratic HPLC method used by 
Hollman, where quercetin elutes after 8 min of a 20 min analysis was claimed to have 
“adequate resolution”. However, the signal has not returned to baseline before the 
  43 quercetin peak elutes. Therefore, the quantification of quercetin is measured on top of 
another signal. No sample clean-up is performed on the hydrolysed plasma prior to 
chromatography. Although it may seem that by carrying out an acid or enzyme 
hydrolysis the sample has only one compound of interest, which simplifies the analysis, 
in fact by adding a strong acid or an enzyme mixture to the sample it is increasing the 
number of potential co-eluting compounds. This problem was seen by Erlund et al., 
(1999) who reported that without additional purification steps there were compounds 
from the enzyme preparations from Helix pomatia that coeluted with the quercetin peak.  
One of the problems with the methods employed is that they can only view the 
compounds in one dimension. It is not possible for any of the detection systems, 
whether it is absorbance, fluorescence, electrochemical or mass spectrometry operated 
in SRM or SIM mode, to determine with absolute certainty if there is another compound 
co-eluting with the compound of interest. 
A re-examination of pharmacokinetic analysis should be carried out using 
analytical methods developed to accurately identify and quantify individual metabolites 
not measured in the studies by (Hollman et al., 1996a; 1997c; 1999; Aziz et al., 1998; 
Erlund et al., 2000c; Olthof et al., 2000) and (Graefe et al., 2001). These methods must 
allow for the detection of co-eluting compounds and be able to provide quantification 
even in the presence of such compounds. With this methodology it will be possible to 
seriously reduce erroneous measurements and overestimates due to interfering 
compounds and to further our knowledge in A.D.M.E. studies of quercetin glucosides. 
 
 
 
 
 
  44 Chapter 2  Detection and identification of 
14C-
labelled flavonol metabolites by HPLC radio-counting 
and tandem mass spectrometry in rats 
 
2.1 Introduction 
The aim of the work in this chapter was to develop a method to allow the 
identification and quantification of the intact metabolites formed in vivo from the 
flavonol quercetin-4′-glucoside. This involved the use of [2-
14C]quercetin-4'-glucoside 
to allow these metabolites to be followed both in terms of levels found in tissues, by 
scintillation counting and with regard to their identities and quantities, by mass 
spectrometry with on-line radioactivity detection.. 
Epidemiological studies have highlighted a positive correlation between high 
flavonol intake and a reduction in the risk of contracting coronary heart disease and 
strokes (Hertog et al., 1995; Duthie et al., 2000). This may reflect the diverse ability of 
flavonols such as quercetin to show potentially anti-atherogenic effects in model 
systems. For example, in relation to heart disease some flavonols can prevent the 
oxidation  in vitro of low-density lipoprotein to a potentially atherogenic form 
(Dewhalley et al., 1990), inhibit platelet aggregation and dilate blood vessels (Di Carlo 
et al., 1999). Potential anticancer effects include the modulation of enzyme activities 
associated with carcinogen activation and detoxification (Musonda et al., 1997) and the 
prevention of oxidative DNA damage (Duthie et al., 1997).  
If these flavonols, that show protective effects in vitro, are to have health effects 
in vivo they must reach the appropriate tissues in concentrations and forms that are 
effective. However, at the outset of this work the form and concentration of quercetin 
metabolites circulating in plasma was not known.  
Flavonols exist almost exclusively as sugar conjugates in plant-derived foods 
and beverages, and HPLC is usually the method of analysis in quantitative studies.   
Unfortunately, very few of the many hundreds of characterised flavonol conjugates are 
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problem, extracts are subjected to acid hydrolysis and the amounts of flavonol 
aglycones released, typically myricetin, quercetin, kaempferol and isorhamnetin, are 
quantified by reverse phase HPLC with detection at 365 nm. This analytical approach, 
pioneered by Hertog and co-workers in the early 1990’s, (Hertog et al., 1992a) has been 
used to measure flavonol levels in a wide variety of fruits, vegetables and beverages 
(Hertog et al., 1992a; 1993b; McDonald et al., 1998; Crozier et al., 2000). Improved 
sensitivity and selectivity, necessary for the analysis of flavonols in plasma, urine and 
body tissues can be achieved through the use of either an electrochemical detector 
Erlund et al., (1999) or post-column chelation with methanolic aluminium nitrate to 
form highly fluorescent flavonol derivatives (Hollman et al., 1996b).  
Irrespective of the detection system used, HPLC of hydrolysed extracts provides 
no information on the identity of the parent conjugate(s) and, therefore, provides 
quasiquantitative estimates of flavonol levels. Some investigators have used enzymes, 
such as glucosidases, glucuronidases and sulphatases, to release flavonol aglycones 
Erlund et al., (1999; 2000), thereby giving some indication of the type of metabolites 
present. This approach suffers similar problems to acid hydrolysis and is compounded 
as the substrate specificities of the enzymes utilised are far from absolute and ensuring 
complete hydrolysis is not straightforward (Gu et al., 2005b; Donovan et al., 2006).  
The HPLC and post-column derivatization of flavonols with methanolic 
aluminium nitrate, referred to above, provides sensitive and selective detection of 
flavonols with a free 3-hydroxyl group (Hollman et al., 1996b). A number of studies 
(Ader et al., 2000; Erlund et al., 2000b) claim to have detected “flavonols and their 
metabolites” in plasma and urine of human subjects following consumption of pure 
compounds and flavonol-rich foods. Although there is wide individual variation in 
absorption, possibly reflecting the type of flavonol, degree of conjugation and assay 
methodology, the presence of conjugates in body fluids provides necessary evidence for 
the potential to exert effects in vivo analogous to those observed in model systems. 
However, the claim of “detecting flavonols and their metabolites” is somewhat 
misleading. The methodology used by these investigators can quantify quercetin only 
after hydrolysis has been carried out. Thus any glucuronide conjugates would be 
detected, but only as an increase in the quercetin concentration from the pre-hydrolysis 
  46 results. This is not measuring the actual quercetin metabolite concentration (Hollman et 
al., 1997b). It was claimed that methyl metabolites would not be detected by this 
method as they would not hydrolyse.  
The methodology used by Aziz et al., (1998) was based on the same detection 
system as used by Hollman but with a gradient HPLC method run over 40 minutes that 
would allow the separation of individual metabolites. No acid or enzyme hydrolysis was 
carried out on the sample prior to analysis. Co-chromatography with the available 
standards identified the main circulating metabolites in plasma as isorhamnetin-4´-
glucoside and quercetin-4´-glucoside.  
Graefe et al., (1999) used HPLC-MS
2 to detect the presence of five quercetin 
glucuronides, but then measured the level of quercetin present after enzyme hydrolysis 
using HPLC with electrochemical detection.  
Of these three studies only Aziz actually attempted to measure the level of intact 
metabolites present. The results, however, were not in keeping with emerging proposals, 
based on in vitro studies, that during passage through the gut wall flavonol glucosides 
are subjected to the action of hydrolases and glucuronidases and as a consequence 
flavonol glucuronides rather than glucosides appear in the bloodstream (Williamson et 
al., 2000). It has been proposed by Sesink et al., (2001) that the peak identified by Aziz 
et al., (1998) as quercetin-4'-glucoside was a quercetin glucuronide. It is most likely that 
the compound seen was not a glucoside, as originally proposed, but it was the first time 
direct quantification of the circulating metabolites was attempted.  
 This highlights the problem of the methodology to date. A method that can be 
used to quantify a compound cannot tell the intact structure of it. The intact structure 
can be found by another method but this cannot be used to quantify it. 
A good analogy is with the Heisenberg uncertainty principle. A simplified 
interpretation is, the more certain you are of a particles position the less you can say 
about its energy, The greater the information known about its energy the less is known 
about its position.  However, unlike this principle it is possible, by using two 
complementary detectors, to determine both types of information at the same time. 
  47 The aim of this study was to identify the metabolites of quercetin-4'-glucoside, a 
major flavonol conjugate in onions (Tsushida & Suzuki, 1995) which are one of the 
main sources of flavonols in the Dutch diet (Hertog et al., 1993a). Rats were fed [2-
14C]quercetin-4'-glucoside and the radiolabelled components in plasma and body tissues 
were analysed by high performance liquid chromatography (HPLC) with detection 
using an on-line radioactivity monitor and a tandem mass spectrometer with an 
electrospray interface. This methodology can provide structural information on the 
compounds under investigation thereby eliminating disputes about analytical accuracy 
and prevent protracted discussions about whether an HPLC peak has been misidentified. 
Full scan MS
2 is an extremely powerful and flexible tool for the analysis of trace levels 
of natural products in impure extracts as interpretation of fragmentation patterns, 
coupled in some instances with knowledge of HPLC retention properties, can facilitate 
the partial identification of components where reference compounds are not available 
(Mullen et al., 2002a). When these mass spectra coincide with peaks in the radioactivity 
detector’s response it can be assumed with some degree of surety that the metabolite 
present originated from the parent compound in the feed. In addition the level of 
radioactivity gives a direct measure of the quantity of the compound present. 
2.2  Material and methods 
14 Synthesis of [2- C]quercetin-4'-glucoside (specific activity 3.75 mCi/mmole) 
was carried out in the Chemistry Department of Glasgow University using a modified 
version of the method previously reported for the synthesis of [2-
13C]quercetin-4'-
glucoside (Caldwell et al., 2000) except that the intermediate ester was not purified by 
filtration through alumina.  The compound was pure by 
1H NMR spectroscopy and only 
one radioactive species was detected by HPLC-radiocounting (RC). 
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Figure 2-1. Radiochemical purity of [2-
14C]quercetin-4′-glucoside with MS
2 of parent ion 
2.2.1  Animals and sample preparation 
After an overnight fast, three male rats of the Rowett Hooded Lister strain (mean 
weight 430 ± 4 g) were offered 1 g of stock rat feed (CRM, Special Diet Services, 
Witham, Essex, UK) containing 3.26 mg of [2-
14C]quercetin-4'-glucoside to give a dose 
of 58.5 x 10
6 dpm. Rats consumed 99.3% of the ration within 2 min, as measured by 
residual radioactivity on the feeding dish. After 60 min, animals were terminally 
anaesthetised with isofluorane and their gastrointestinal tract, comprising the stomach, 
small and large intestines and their contents removed intact. The intestines and all other 
major organs were frozen in liquid nitrogen and lyophilized after which they were 
ground to a powder using a mortar and pestle and stored at –80
oC prior to extraction. 
All tissues were weighed before and after lyophilization. Blood samples were 
  49  o centrifuged at 2,000 g and the plasma and red blood cells separated and stored at -80 C. 
All tissues and fluids collected are reported in Table 2-1. 
2.2.2  Measurement of radioactivity 
Ten-mg aliquots of freeze-dried tissue, plasma and red blood cells were treated 
with 0.5-mL tissue solubiliser (National Diagnostics, Hull, UK) for 3 h at 50 
oC in a 
shaking water bath. With the exception of red blood cells, which were bleached using 
1.75 mL of a 25% solution of sodium hypochlorite, the solublization treatment 
produced clear solutions and 150 µL  aliquots were taken and added to 5 mL 
scintillation cocktail (Optiflow Safe One, Fisons, Loughborough, UK) before 
determination of radioactivity using a Wallac 1409 liquid scintillation counter 
(Pharmacia, Uppsala, Sweden).   
2.2.3  Extraction of samples 
One g aliquots of freeze-dried tissues were extracted by continuous shaking with 
15 mL 50% methanol in 100 mmole/L phosphate buffer (pH 7.0) containing 20 mmole 
sodium diethyldithiocarbamate. After 30 min the mixture was centrifuged for 20 min at 
2000 g. The methanolic supernatant was decanted and the pellet re-extracted a further 
two times. The three methanolic supernatants were combined and the methanol removed 
in vacuo. The remaining aqueous phase was adjusted to pH 3.0 and partitioned three 
times with an equal volume of ethyl acetate. The ethyl acetate extracts were combined 
and reduced to dryness in vacuo prior to the measurement of radioactivity and analysis. 
A gentle stream of nitrogen was used to remove residual ethyl acetate from the aqueous 
phase before it was loaded onto a 2 g C18 Sep Pak cartridge (Waters, Milford, MASS, 
USA) which was washed with 15-mL distilled water adjusted to pH 3.0 with H SO 2 4. 
The cartridge was then eluted with 30 mL methanol to remove polar radiolabelled 
metabolites. The methanolic extract was dried in vacuo and aliquots taken for 
radioactivity measurements and analysis. 
2.2.4  HPLC with diode array detection and tandem mass 
spectrometry 
  50 Samples were analysed on a Surveyor HPLC system comprising of a HPLC 
pump, diode array absorbance detector, scanning from 250 to 700 nm and an 
autosampler cooled to 4°C. (Thermo Finnigan, San Jose, USA). Separation of 
quercetin metabolites was carried out using a 250 x 4.6 mm i.d. 4 μm Synergi RP-Max 
column (Phenomenex, Macclesfield, UK) eluted with a gradient over 60 min of 5-40% 
acetonitrile in 1% formic acid at a flow rate of 1 mL/min and maintained at 40°C. 
After passing through the flow cell of the absorbance monitor, the column eluate was 
directed to a radioactivity monitor (Reeve Analytical Model 9701, Lab Logic, 
Sheffield, UK) fitted with a 500 µL heterogeneous flow cell packed with cerium-
activated lithium glass scintillant, after which it was split and 0.3 mL/min was directed 
to a LCQ DecaXP ion trap mass spectrometer (Thermo Finnigan, San Jose, USA). 
Analysis with an electrospray interface (ESI) in negative ion mode provided the best 
limits of detection for quercetin based metabolites.  This was carried out using full 
scan, data dependant MS-MS scanning from m/z 100 to 1000. Capillary temperature 
was 350°C, sheath gas and auxiliary gas were 60 and 10 units respectively, source 
voltage was 4 kV.   
 
2.3 Results 
2.3.1  Distribution of radioactivity in rat tissues and extracts 
Each rat consumed 1 g of stock rat feed containing 58.5 x 10
6 dpm  [2-
14C]quercetin-4'-glucoside. An aliquot of the feed was extracted with methanol and 
analysed by HPLC-RC-MS-MS which demonstrated that the [2-
14C]quercetin-4'-
glucoside was radiochemically pure (Figure 2-1A). Full scan MS analysis was also 
carried out (Figure 2-1B) which shows a molecular ion [M-H]
- at m/z 463. The [M+2-
H]
- ion at m/z 465, from the 
14C label, can also be seen. Calculated abundance of the 
M+2 ion is 11.4% from the specific activity of the label. MS-MS was carried out on the 
m/z 463 molecular ion (Figure 2-1C) rather than the smaller M+2 ion. This yielded a 
secondary spectrum with the major ion at m/z 301, which corresponds to the aglycone 
quercetin. 
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 Table 2-1. Distribution of radioactivity in rats 60 min after ingestion of [2-
14C]quercetin-
4'-glucoside.   
Tissue/fluid        Total radioactivity  Concentration of radioactivity 
63184 ± 3902 (93.6%) Intestine and contents  2117 ± 106 
1644 ± 39 (2.5%)  Plasma  110 ± 3 
4 ± 1 (-)  Red blood cells  0 ± 0 
684 ± 61 (1.2%)  Liver  37 ± 3 
468 ± 76 (0.8%)  Kidneys  147 ± 31 
6 ± 0 (-)  Spleen  7 ± 0 
1 ± 0 (-)  Brain  0 ± 0 
38 ± 3 (0.07%)  Lungs  21 ± 1 
18 ± 1 (0.03%)  Heart  14 ± 1 
839 ± 113 (1.4%)  Muscle  4 ± 1 
25 ± 1 (0.04%)  Testes  8 ± 1  
 
Radioactivity measured by liquid scintillation counting after dissolving tissues with a solubilizer. 
Radioactivity expressed as dpm x 10
3 per tissue/fluid per rat ± standard error (n = 3) and in 
parenthesis as a percentage of the recovered [2-
14C]quercetin-4'-glucoside. Concentration of 
radioactivity expressed as dpm x 10
3  per g (fresh weight) or per ml. 
The sample of rat intestines and contents, obtained 60 minutes after dosing, 
contained 93.6% of the ingested radioactivity. When fractionated 92% of the recovered 
radioactivity was associated with the ethyl acetate extract and 8% with the aqueous 
fraction.  Aliquots of both extracts, each containing 30 x 10
3 dpm of radioactivity were 
analysed by reverse phase HPLC with on line radioactivity detection and data dependant 
full scan MS-MS. The radioactivity and A365 nm chromatograms obtained from the 
plasma, liver and kidney are illustrated in Figure 2-2. In total there are 18 significant 
radioactive peaks. It was seen that not all the peaks in the A365 nm traces were 
radiolabelled components, data not shown. The mass spectral data, which are 
summarised in Table 2-2 facilitated the identification of 17 of the 18 radiolabelled 
peaks. The relative amounts of these compounds, based on the amount of radioactivity 
in each peak, are also shown in Table 2-3
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Figure 2-2. Gradient HPLC-RC traces of 30 x 10
3
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After passing though the flowcell of a diode array detector (data not shown)’ the column eluate was directed to a radioactivity monitor operating in 
heterogeneous mode, after which it was split and 30% directed to a tandem mass spectrometer with an electrospray interface in negative ion mode. 
After passing though the flowcell of a diode array detector (data not shown)’ the column eluate was directed to a radioactivity monitor operating in 
heterogeneous mode, after which it was split and 30% directed to a tandem mass spectrometer with an electrospray interface in negative ion mode. 
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2.3.2  Identification of metabolites 
- Peak 1 (retention time [R] 16.7 min) had an [M-H] t  at m/z 653 which 
fragmented to produce ions at m/z 477 (M-176, loss of a glucuronyl unit) and m/z 301, 
which corresponds with the aglycone quercetin, and results from a further neutral loss 
of 176, indicating that the metabolite was a quercetin diglucuronide with the glucuronyl 
moieties attached at different positions on the flavonol ring (Figure 2-3-2). If the two 
glucuronyl residues had been attached at the same position it is unlikely that an M-176 
fragment would have been produced at m/z 477 as it has been shown that anthocyanin 
disaccharide conjugates fragment with loss of the intact disaccharide unit (Giusti et al., 
1999) 
Peak 2 (R 20.6 min) was not identified, as it did not yield mass spectral data.  t
Peak 3 (R 21.6 min) had an [M-H]
-
t  at m/z 667, 14 mass units higher than the 
quercetin diglucuronide in peak 1. It fragmented to produced two M-176 fragments at 
m/z 491 and m/z 315, the latter being the [M-H]
- of a methylated analogue of quercetin. 
Peak 3 therefore contains a methylquercetin diglucuronide (Figure 2-3-1). The most 
likely methylated quercetin derivative is 3'-methylquercetin, isorhamnetin. However, as 
a methylation at other positions cannot be ruled out, and there is an absence of reference 
compounds, the aglycone cannot be identified definitively. MS
3 may have been able to 
show if the methylation was on the A or B ring but MS
3 was not available on this 
instrument at the time of running these samples. 
Peak 4  (Rt 23.7 min), like peak 1, was a quercetin diglucuronide as it produced 
an MS-MS spectrum with an [M-H]
- at m/z 653, which fragmented to produce m/z 477 
(M-176) and m/z 301 (quercetin). 
Peak 5 at (Rt 24.3 min), like peak 3, was a methyl quercetin diglucuronide as it 
produce an MS-MS spectrum with a [M-H]
- at 667, which fragmented to produce m/z 
491 (M-176) and m/z 315 (methyl quercetin) 
Peaks 6-8  (Rts 25.1, 26.4 and 28.3 min) were quercetin diglucuronides as they 
all had an [M-H]
- at m/z 653 and which yielded fragment ions at m/z 477 and 301.  
54 - Peak 9 at R 29.6 min had an [M-H] t  at m/z 477 which fragmented to produce an 
M-176 ion at m/z 301 indicating the presence of a quercetin monoglucuronide, probably 
quercetin-3-glucuronide as it co-chromatographed with a standard of this compounds 
(Figure 2-3-6). 
Peak 10 (R 30.3 min) had an [M-H]
-
t  at m/z 557 which ionised yielding fragment 
ions at m/z 477 (M-80, loss of SO3), m/z 381 (M-176, loss of glucuronyl unit) and m/z 
301 (quercetin) (Figure 2-3-4).  This metabolite is therefore a quercetin glucuronide 
sulphate conjugate.  
Peak 11 (Rt 32.6 min) was a methylquercetin glucuronide sulphate as indicated 
by an [M-H]
- at 571 that produces an M-80 fragment at m/z 491 which with a further 
loss of m/z 176 yields an m/z 315 methylquercetin ion (Figure 2-3-3). 
Peak 12 (Rt 34.5 min) was the parent compound quercetin-4'-glucoside.  Its mass 
spectrum had an [M-H]
-  at m/z 463 which fragmented to produced m/z 301 (quercetin, 
M-162, loss of a glucosyl unit).   
Peaks 13-15 (R 35.6, 36.5 and 37.4 min) all of which have a [M-H]
-
t  at m/z 491 
and fragmented to produce an M-176 ion at m/z 315, are methylquercetin glucuronide 
regio-isomers (Figure 2-3-5). 
Peak 16 (R 37.4 min) was a quercetin glucuronide on the basis of an [M-H]
-
t  at 
m/z 477 which fragments yielding m/z 301 (quercetin, M-176, loss of glucuronyl unit) 
- at m/z 301 m/z.   44.6 min) was quercetin with a [M-H] Peak 17 (Rt
Peak 18 (R 51.1 min) with a [M-H]
-
t  at 395 m/z that produces an M-80 fragment 
at m/z 315 was a methylquercetin sulphate conjugate. 
 51.2 min) yielded a mass spectrum with ions at m/z 381 [M-H]
- Peak 19 (Rt  and 
m/z 301 (M-80) and was a quercetin sulphate derivative.    
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Table 2-2. Identification of Metabolites of [2-
14C]Quercetin-4'-Glucoside Detected in Rats. 
 
 
Peak  Rt (mins)     Compound    M
- (m/z)    Fragment ions (m/z)  
1 16.7     Quercetin diglucuronide  653     477 (M
--GlcUA), 301[Q](M
--GlcUA-GlcUA)    
 
 
 
2  20.6     Unknown      
3  21.6     Methylquercetin diglucuronide  667     491 (M
--GlcUA), 315 [MQ](M
--GlcUA-GlcUA) 
4  23.7     Quercetin diglucuronide  653     477 (M
--GlcUA), 301[Q](M
--GlcUA-GlcUA) 
5  24.3     Methylquercetin diglucuronide  667     491 (M
--GlcUA), 315 [MQ](M
--GlcUA-GlcUA 
6  25.1     Quercetin diglucuronide  653     477 (M
--GlcUA), 301[Q](M
--GlcUA-GlcUA) 
7  26.4     Quercetin diglucuronide  653     477 (M
--GlcUA), 301[Q](M
--GlcUA-GlcUA) 
8  28.3     Quercetin diglucuronide  653     477 (M
--GlcUA), 301[Q](M
--GlcUA-GlcUA) 
 
 
 
 
 
9  29.6     Quercetin-3-glucuronide  477     301 [Q], (M
--GlcUA) 
10  30.3     Quercetin glucuronide sulphate  557     477 (M
--SO3), 381 (M
--GlcUA), 301 [Q](M
--SO3-GlcUA  )    
11  32.6     Methylquercetin glucuronide sulphate  571     491 (M
--SO3), 315 [MQ](M
--SO3-GlcUA) 
12  34.5     Quercetin-4'-glucoside  463     301 [Q](M
--Glc) 
13  35.3     Methylquercetin glucuronide  491     315 [MQ](M
--GlcUA) 
14  36.5     Methylquercetin glucuronide  491     315 [MQ](M
--GlcUA) 
15  37.4     Methylquercetin glucuronide  491     315 [MQ](M
--GlcUA) 
16  37.4     Quercetin glucuronide  477     301 [Q](M
--GlcUA) 
17  44.6     Quercetin  301      
18  51.1     Methylquercetin sulphate  395     315 [MQ](M
--SO3) 
19  51.2     Quercetin sulphate  381     301 [Q] ](M
--SO3) 
HPLC  -  RC   retention times, negative ion MS-MS fragmentation patterns and identities of metabolites detected in rat tissues 60 min  
after oral ingestion  of  [2-
14C]quercetin-4'-glucoside.  Peak number refer to peaks in Figure 1. Q – quercetin, MQ –methylquercetin,  
 
 
 
GlcUA   –   glucuronyl unit; Glc – glucosyl unit; M  molecular ion.  -
- -   
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14 Figure 2-3. Tandem mass spectra of [2- C]quercetin-4´-glucoside metabolites. Spectrum 1: MS-MS of ion m/z 667, methylquercetin 
diglucuronide. Spectrum 2:MS-MS of ion m/z 653 ,quercetin diglucuronide. Spectrum 3: MS-MS of ion m/z 571, methylquercetin glucuronide 
sulphate. Spectrum 4: MS-MS of ion m/z 557, quercetin glucuronide sulphate. Spectrum 5: MS-MS of ion m/z 491, methylquercetin 
glucuronide. Spectrum 6: MS-MS of ion m/z 477, quercetin glucuronide. 
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2.3.3  Amount of radioactivity incorporated into [2-
14C] quercetin-4´-
glucoside metabolites 
The data presented in Figure 2-2 is a qualitative representation of the metabolites found, 
the identities of which are listed in Table 2-2. The overall levels of radioactivity 
associated with [2-
14C]quercetin-4'-glucoside and its metabolites are presented in Table 
2-3. These values were calculated from the peak areas in Figure 2-2, the amount of 
radioactivity in the ethyl acetate and aqueous extracts from the intestine, plasma, liver 
and kidneys. 
The information in Table 2-3 shows clearly that the majority of the radioactivity 
was recovered from the intestine and that, within the 60 min period since ingestion, the 
[2-
14C]quercetin-4'-glucoside had undergone extensive metabolism as it represented 
only 26.2% of the recovered radioactivity as reported in Table 2-3. The major 
metabolites in the intestine, which comprised the stomach and gastrointestinal tract 
along with their contents, were quercetin-3-glucuronide (peak 9, 10.6%), quercetin 
glucuronide sulphate (peak 10, 6.9%), methyl quercetin glucuronide (peaks 13 and 14, 
6.5 and 4.9%) quercetin (peak 17, 7.2%). There were two significant peaks both 
containing two unresolved compounds. Peaks 15/16 (12.2%) contained methyl 
quercetin glucuronide and quercetin glucuronide and peaks 18/19 (17.9%) contained 
methyl quercetin sulphate and quercetin sulphate. Although these compounds could be 
identified by MS
2 within each peak, radiochemically they appeared as one peak and 
were therefore quantified as such.  
The intestine contained other methylated derivatives, diglucuronides and 
sulphate conjugates. Quercetin-4'-glucoside and its aglycone quercetin were not 
detected in extracts from plasma, liver or kidney (Table 3). The intestine contained, in 
varying amounts, all 18 metabolites of [2-
14C]quercetin-4'-glucoside with the exception 
of quercetin diglucuronide (peak 6) which was detected only in plasma. 
The main metabolites in plasma were peak 11 (methylquercetin glucuronide 
sulphate, 43.6% of radioactivity recovered in plasma), peak 7 (quercetin diglucuronide, 
20.5%) and peak 10 (quercetin glucuronide sulphate, 13.8%). The quercetin 
diglucuronide in peak 7 (33.5%) was the main metabolite in the liver while a range of 
58 low level metabolites were detected in the kidneys, the largest being methylquercet
glucuronide (peak 14 , 21.7
in 
%). 
  Figure 2-4 summarizes the types of metabolites that were detected in the rat 
ts obtained 60 
min after the ingestion of [2-
14C]quercetin-4'-glucoside.  
  I – querce
samples. Diglucuronides were major components in all samples out with the intestine. 
Plasma had the simplest metabolic profile, having only two major metabolite groups. 
The kidney and liver contained all the metabolite groups found in the intestine, with the 
exception of the parent compound. 
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Figure 2-4. Metabolite profile of the plasma and tissue extracts of ra
tin diglucuronides, II – quercetin monoglucuronides, III – methylquercetin 
diglucuronides, IV – methylquercetin monoglucuronides, V - methylquercetin glucuronide 
sulphates and quercetin glucuronide sulphates, VI – methylquercetin sulphates and quercetin 
sulphates, VII – quercein-4'-glucoside. 
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Table 2-3. Radioactivity Incorporated into Metabolites in Plasma and Tissues After Ingestion of [2-
14C]Quercetin-4'-Glucoside by Rats 
 as dpm x 10
3 and in parentheses as a percentage of the overall level of recovered radioactivity per organ/pl
entifie  below level of quantification. n.d. – not detected. 
 Peak number/compound  Intestine  Plasma  Liver  Kidneys 
Dat
– Id
a expressed
d, but
asma.  n.q. 
 1.    Q iglucuronide     223.0 (0.8%)    n.d.     20.3 (6.4%) 13.4    (7.4%)  uercetin d
 2.    
 3.    
 4.    
 5.    
 6.    
 7.    
 8.    
 9.    
 10.  
 11.  
 12.  
 13.  
 14. M
 15/1
 17. Q
 18/1
U    223.0 (0.8%)    n.d.     n.d. 
M rcetin diglucuronide     364.4 (1.3%)    n.d.     40.8 (13.0%) 
Q iglucuronide       59.8 (0.2 %)    54.5 (6.4%)     n.q. 
M rcetin diglucuronide     163.2 (0.6%)    n.d.     n.q. 
Q iglucuronide     n.d.    31.8 (3.7%)     n.d. 
Q iglucuronide    685.4 (2.5%) 174.8  (20.5%) 105.4  (33.5%) 
Q iglucuronide    152.3 (0.6%)    70.4 (8.2%)     12.6 (4.0) 
Q -glucuronide  2876.6 (10.6%)    18.0 (2.1%)     21.5 (6.9%) 
Q lucuronide sulphate  1893.3 (6.9%) 118.0  (13.8%)      9.2 (3.0%)  
M cetin glucuronide sulphate    201.3  (0.7%) 372.3  (43.6%)     40.4  (12.8%)  
Q '-glucoside  7133.9 (26.2%)     n.d.     n.d.   
M cetin glucuronide  1783.5 (6.5%)     4.5 (0.5%)     42.1  (13.4%) 
cetin glucuronide  1323.2 (4.9 %)     3.7 (0.4%)     17.6  (5.6 %) 
6 uercetin/quercetin glucuronides  3336.8 (12.2%)     6.6 (0.8%)     n.d.   
u 1956.1 (7.2%)     n.d     4.6 (1.5%)  
9  Met uercetin/quercetin sulphates  4890.1 (17.9%)     n.d.     n.d.   
  8.2 (4.5 %) 
31.0  (17.0%) 
  n.d. 
22.7 (12.5%) 
  n.d. 
21.4  (11.7%) 
15.3  (8.4%) 
14.4  (7.9%) 
  n.d. 
  5.6  (3.1%) 
  n.d. 
14.1  (7.7%) 
30.6  (16.8%) 
 5.7 (3.1%) 
  n.d. 
 n.d. 
nknown 
ethyl que
uercetin d
ethyl que
uercetin d
uercetin d
uercetin d
uercetin-3
uercetin g
ethylquer
uercetin-4
ethylquer
ethylquer
  Methylq
ercetin 
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60 2.4 Discussion 
The work presented in this chapter was carried out with the aim of developing a 
method that could positively detect and identify intact metabolites of quercetin-4´-
glucoside and also, at the same time, allow quantification of these co unds. This was 
the first step in the progression to human (A.D.M.E.) studies of flavonols. 
The feed of a custom-synthesised, high specific activity [ C]quercetin-4'-
glucoside to rats was at an amount equivalent to a 70 kg human subject consuming 250 
g fresh weight of onions (Tsushida & Suzuki, 1995; Crozier et al., 2000). HPLC with an 
on-line radioactivity monitor and tandem MS with an electrospray  rface was then 
used to provide detailed identification of radiolabelled metabolites in plasma and body 
tissues. 
Sixty min after feeding [2-
14C]quercetin-4'-glucoside  to rats, 93.2% of the 
ingested radioactivity was recovered from the intestine. However, this radioactivity 
comprised only 26.2% unmetabolised [2-
14C]quercetin-4'-glucoside, the remainder 
having undergone deglycosylation and varying degrees of glucuronidation, sulphation 
and/or methylation in the process of being incorporated into 18 metabolites. The extent 
of this metabolism, both in terms of the number of metabolites an ceptionally 
high levels of radioactivity incorporated into the metabolites, is on  far greater 
than might have been envisaged from previous feeding studies with unlabelled 
flavonols. However, as no other studies have attempted to identify and quantify intact 
metabolites any predictions would have been mere guesswork.  
Quercetin glucosides from onion have been reported to be converted to 
glucuronide conjugates in human intestinal epithelial cells after hydrolysis with β-
glucosidase (Day et al., 1998) and conjugation catalysed by uridine-5-
diphosphoglucuronyl transferase (UDP-GT) (Cheng et al., 1999). The extensive 
formation of 
14C-labelled metabolites observed in rat intestine in the present study may 
occur by similar mechanisms, as rat intestinal mucosal preparations also have cytosolic 
β-glucosidase activity with broad specificity (Ioku et al., 1998) and UDP-GT activity 
(Piskula & Terao, 1998). Such transformations are likely to have occurred in the small 
intestine as substantial quantities of glucuronide and sulphate conjugates of quercetin 
and methylquercetin accumulated within 60 min of ingestion of [2-
14C]quercetin-4'-
mpo
2-
14
inte
d the ex
 a scale
  61 glucoside. The study here looked at the samples only at 1 h. However, the experiment 
was run up to 5 h and is reported in Graf et al., (2005). If the radiolabelled flavonol 
metabo
stesen et al., 
2000) all of which would have retained the 
14C-label and thus have been readily 
detecte
e after dose that has been shown in human studies to be when the maximum 
concentration of the compound(s) are circulating in plasma (Hollman et al., 1996a). 
Moreov
er, the extremely high 
levels o
lites had reached the large intestine, the available evidence indicates that colonic 
bacteria would have induced ring fission leading to the formation of compounds such as 
4-hydroyxphenylacetic acid, 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-
methoxyphenyl acetic acid (Kim et al., 1998; Schneider et al., 1999; Ju
d. 
The results obtained in the present study with rats suggest that absorption of 
quercetin-4'-glucoside from the gut is relatively poor, as 60 min after consumption only 
6.4% of the recovered radioactivity was detected outside the gastrointestinal tract. This 
is the tim
er, extensive deglycosylation, glucuronidation, sulphation and methylation had 
occurred and no [2-
14C]quercetin-4'-glucoside was found in plasma, liver and kidneys. 
Consequently, cell culture and in vitro studies investigating the effects of this flavonol 
on systemic cellular processes and gene expression should apply the metabolites rather 
than the parent compound. Moreover, as 73.8% of the [2-
14C]quercetin-4'-glucoside was 
metabolised within 60 min in the intestine, the data indicate that flavonol glucosides are 
not absorbed per se but undergo extensive metabolism, primarily involving 
deglycosylation and glucuronidation, prior to passage into the blood stream. It has been 
proposed that such metabolism occurs during passage across the gut wall (Scalbert & 
Williamson, 2000; Day et al., 2001; Hollman, 2001). Howev
f metabolites in the gut compared to plasma and body tissues suggests that most 
of the observed metabolism of [2-
14C]quercetin-4'-glucoside occurs independently of 
movement into the blood stream. The fact that different spectra of metabolites were 
detected in plasma, liver and kidneys (Figure 2-4, Table 2-3) and the relatively high 
proportion of sulphated metabolites in plasma, compared to the intestine, liver and 
kidneys (Figure 2-4) indicate that some post-absorption metabolism also occurred. 
Human liver cells contain both β-glucosidase Day et al., (1998) and UDP-GT 
activity Day et al., (2000) so further hepatic modification of flavonol metabolites after 
entering the blood stream cannot be excluded, although in the present study this would 
  62 be a relatively minor event compared to metabolism occurring in the gut. Some 
enterohepatic circulation of the metabolites may have occurred, though it would need to 
have happened very quickly. It is not possible to identify enterohepatic circulation in 
this system as the rat does not have a gall bladder and this makes the collection of bile 
difficult. 
On the basis of in vitro studies with cell-free systems, it has been proposed that 
circulating quercetin glucuronides are subject to the action of β-glucuronidase in liver 
and other human tissues resulting in the release of quercetin (O'Leary et al., 2001). The 
current
ound 
93.6% of the radiolabelled flavonol consumed, and its metabolites, were found in the 
stomac
 in vivo study with rats provides no support for this hypothesis as glucuronide 
conjugates and quercetin represented > 98% and 1.5%, respectively, of the radioactivity 
recovered from the liver, and the aglycone was not detected in either plasma or kidneys 
(Table 2-3).  
The biological significance of the extensive metabolism of [2-
14C]quercetin-4'-
glucoside that occurred so rapidly in the intestine of rats, and the relatively small 
amounts of the quercetin glucuronide, sulphate and methyl conjugates that pass into the 
blood stream and body tissue, is far from clear. It has been shown that quercetin-3-
glucuronide, which was detected as a minor metabolite in the present study (Table 2-3), 
exerts a considerable inhibitory effect on lipid peroxidation in phospholipid membranes 
induced by reactive oxygen species and peroxidative enzymes (Shirai et al., 2001). 
Although the effectiveness of the glucuronide conjugate was less than that of quercetin, 
it should be noted that the aglycone is not a genuine dietary component. It was also 
established that quercetin-3-glucuronide exhibited an affinity to phospholipid 
membranes that was significantly higher than that of ascorbic acid. This may reflect the 
fact that it is more lipophilic than abscorbic acid but less than the aglycone. On the basis 
of these observations it was suggested that quercetin glucuronides and other 
metabolites, claimed to accumulate in plasma after the consumption of food rich in 
quercetin glucosides, contribute to the antioxidative defences against membranous 
phospholipid peroxidation occurring in vivo (Shirai et al., 2001). However, as ar
h and intestines after one hour, the major site of potential protection against 
oxidative damage must be in the gastrointestinal tract itself. 
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administration of the aglycone (Moon et al., 2001). There are also two reports on the 
use of HPLC-MS to analyse human plasma after the consumption of onions (Wittig et 
al., 2001; Day et al., 2001) and neither of these studies were able to obtain full scan 
mass spectral data on the putative metabolites that were detected. The present study, in 
which 18 metabolites of quercetin-4'-glucoside were detected, and 17 identified, 
provide
or indeed any other flavonol, has been revealed. The sample analysis, by 
on line radioactivity detection linked to the mass spectrometer, showed 73.8% of the 
origina
”. The selected ion is then 
fragmented and a specific fragment ion monitored. In the case of a quercetin 
s a far more detailed picture of the metabolism and absorption of a flavonol 
glucoside than any previous reports that have appeared in the literature to date.  
2.4.1 Detection  system 
This is the first study in which the extensive and varied metabolism of quercetin-
4'-glucoside, 
l compound had been deglycosylated and further metabolised by varying 
combinations of methylation, glucuronidation and/or sulphation. Full scan MS-MS 
proved suitable for the identification of all of these metabolites. Further information 
about the position of the various substituent groups could be achieved by the use of 
NMR.  However, NMR requires not only high sample purity but also the presence of 
substantially more analyte than the low ng quantities required for MS
2.  
HPLC linked to a tandem mass spectrometer is becoming more widely available 
and provides the most powerful tool currently available for the identification of flavonol 
conjugates in biological samples. However, a mass spectrometer can be used in many 
ways depending on the circumstances of the analysis and the samples under study. At 
one extreme, to increase the sensitivity and selectivity of the analysis, the mass 
spectrometer can be set up to detect only one ion, selected ion monitoring (SIM). 
Alternatively when limited availability of sample is not a problem, full scan analysis 
can provide detailed structural information at the expense of sensitivity.  Selected 
reaction monitoring (SRM) is another mode of analysis that offers high selectivity and 
sensitivity. However, SRM can be carried out only with triple quadrupole or ion trap 
mass spectrometers. With these types of mass spectrometers, the “parent ion” of the 
compound of interest is “focused on or selectively trapped
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entation 
of the parent ion. For example it would be possible to scan the parent ion of a quercetin 
77 down to just under m/z 200 with the same level of 
sensitivity as that if only ion m/z 301 was monitored. This method allows better 
discrim
onitor four ions 
per analysis.  Although a total of 12 putative quercetin glucuronide peaks (P1-P12) were 
suspect
lucuronide, the mass spectrometer would be set up, in negative ion mode, to 
detect the m/z 301 quercetin ion resulting from the fragmentation of the [M-H]
- at m/z 
477. Wittig et al., (2001) used this method to identify five quercetin monoglucuronide 
metabolites in human plasma after ingestion of an eye watering 800 g onion 
supplement. The limitation with SRM is that it can only be used to detect what you 
already know or suspect to be present in a sample. It is not suitable for the identification 
of novel metabolites. An advantage of an ion trap mass spectrometer is that there is no 
loss in sensitivity if a range of ions are selected to be monitored from the fragm
monoglucuronide from m/z 4
ination of false positive peaks, which may contain additional ions not seen in the 
compound of interest. This will be discussed later. 
Using a triple quadrupole mass spectrometer set up in the positive ionisation 
mode, (Day et al., 2001) employed LC-MS, as opposed to MS-MS, to identify 
metabolites of quercetin in human plasma after the consumption of a more manageable 
200 g of onions. However, this study did not produce full scan spectra but used the SIM 
data to support identifications based on chromatographic retention times and enzyme 
hydrolysis data. In the SIM mode the mass spectrometer was set up to m
ed to be present on the basis of HPLC-A365 nm traces and enzyme hydrolyses, the 
presence of only three was confirmed by SIM.  From our findings one of the 
compounds in the group P1-P3 may be a methylquercetin diglucuronide. However, the 
molecular ion of this compound was not monitored so, if present, it went undetected. In 
addition, as methylquercetin glucoside has the same molecular ion as quercetin 
glucuronide, the distinct possibility of a misidentification by SIM exists. Choice of the 
ionisation mode is critical in any mass spectrometric analysis. With our ion trap mass 
spectrometer the limit of detection for flavonols is at least an order of magnitude better 
in negative ion mode than positive ionisation and absorbance peaks as small as 3 mAU 
routinely provide full scan MS-MS data (Figure 2-5). 
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Figure 2-5. HPLC trace of 950 dpm of [2-
14C]quercetin-4’-glucoside.  
   Analysis by SIM is much less selective than SRM and more likely to produce 
false positive identifications. Conversely, the secondary fragmentation that operates 
with both SRM and full scan MS-MS enables identifications to be made that would be 
missed or be more doubtful when analysed by SIM. The extracted ion chromatograms 
in, (Figure 2-6) which are taken from the 20-50 min HPLC full scan MS analysis of the 
ethyl acetate extract in Figure 2-2, are the equivalent of what is produced in a SIM 
analysis. It can be used to show some of the limitations of SIM analysis when compared 
to MS-MS. The m/z 653 trace, the [M-H]
- of quercetin diglucuronide, shows only a 
weak peak at Rt 26.4 min and no fragment peaks are present at either m/z 477, the 
monoglucuronide or m/z 301, the aglycone (Figure 2-6). This would be poor evidence 
for the presence of a quercetin diglucuronide. However, the full scan MS-MS spectrum 
of this ion showed that it is indeed a quercetin diglucur
0
onide (Table 2-3 peak 6). 
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Figure 2-6. HPLC trace of ethyl acetate extract showing extracted ion chromatograms of  
molecular ions of quercetin diglucuronide (653), quercetin monoglucuronide (477) 
quercetin glucoside 463 and quercetin 301. (B) MS-MS of peak at 30.2 minutes shows it is 
not quercetin derived. (C) MS-MS of peak at 44.6 which is quercetin. 
At the other extreme, the ion traces from m/z 477 and 301 indicate the presence 
of a quercetin-based monoglucuronide at Rt. 30.2 min (Figure 2-6). However, full scan 
MS-MS of the m/z 301 fragment revealed that this was not the case as it yielded an MS
2 
spectrum with major ions at m/z 283 and 265, which is quite distinct from the MS
2 
spectrum of quercetin which has prominent ions at m/z 179 and 151 arising from the 
Retro-Diels-Alder fission of the heterocyclic flavonol ring. In contrast, MS-MS of the 
small m/z 301 peak at Rt 44.6 min Figure 2-6 yielded an MS
2 spectrum with major 
fragment ions at m/z 179 and 151, confirming the presence of free quercetin. In addition 
when the full scan MS-MS of the parent ion m/z 477 was examined it contained other 
ions in additional to that of the aglycone. There should not be any other ions present as 
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  67 the loss of the glucuronide, like glucosides, occurs at O bond between it and the 
aglycones (Giusti et al., 1999).  
The mass spectrometric method used in this study is known as data dependent 
MS-MS.  The ion trap is set up to select the most significant ion found in each full scan, 
expel all other ions from the ion trap, then fragment it and scan out the fragment ions 
thereby yielding a secondary mass spectrum. The secondary spectrum, therefore, 
contains only ions originating from the “trapped” parent ion. A further refinement to 
this analytical technique is the ability to program the detector to only look at the same 
ion a limited number of times (e.g. three) over a set time window, (e.g. 30 s) depending 
on the peak width in the chromatographic setup. This enables full scan MS
2 of 
individual components in merged peaks to be obtained, as seen in peaks 14 and 15 and 
also minor peaks in the presence of larger ones, as in peak 13 on the shoulder of peak 12 
(Figure 2-2.). A further advantage is that the system can be programmed not to carry out 
MS-MS on background ions so that “bleed” from the column or the mobile phase can 
also be rejected from the analysis.  
Our study illustrates the power and simplicity of MS-MS analysis for the partial 
identification of low levels of natural products. This point is well illustrated with the 
nalysis of peak 7 where an uninformative full scan mass spectrum (Figure 2-7) yielded 
a clean seco
sing er, 
m/z 477 ( -H]
--176-
176, lo
a
ndary spectrum. The primary mass spectrum, equivalent to that obtained by 
le stage MS, contained numerous ions and has no diagnostic value. Howev
fragmentation of the m/z 653 ion produced a daughter spectrum comprised of ions at 
[M-H]
--176, loss of a glucuronyl unit) and m/z 301 (quercetin, [M
ss of two glucuronyl units). All the fragments in a secondary spectrum must 
come from the parent ion and as a consequence the MS-MS spectrum illustrated in 
Figure 2-7 represents convincing evidence for the presence of a quercetin diglucuronide. 
The value of HPLC with full scan MS
2  for the structural elucidation of 
metabolites has also been demonstrated in a recent report on the identification of 17 
isoflavone conjugates in the urine of female rats fed on a soya-rich diet (Fang et al., 
2002). The daughter mass spectra obtained are in keeping with those seen in the present 
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Figure 2-7. Data dependant MS
2 preferentially selects m/z 653 in full scan to carry out 
MS-MS on which shows the presence of quercetin diglucuronide. 
study with the initial fragmentation resulting in cleavage of the bond linking the 
aglycone and the conjugating sugar as outlined by (Giusti et al., 1999). However, this is 
2 not the case in the claimed HPLC-MS  identifications of an epicatechin glucuronide and 
3'-O-m
presence of these ions and to base identifications on the presence of 3 or 4 known ions, 
some of very low relative intensity, is a highly subjective interpretation of mass spectral 
data.  The unexplained ions in the MS-MS spectra of (Abd El Mohsen et al., 2002) may 
ethyl epicatechin glucuronide in rat brains after oral ingestion of high doses of (-
)-epicatechin (Abd El Mohsen et al., 2002). In this report the illustrated MS-MS spectra, 
in marked contrast to the MS-MS spectrum in Figure 2-7, contained 20-30 unexplained 
ions, some at 10-20% relative abundance and one exceeding 50%. To ignore the 
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  69 be due to the presence of sizable amounts of co-eluting compound(s) with the same 
molecular weight or fragment ions, which could impact on the quantitative estimates. 
The studies of (Wittig et al., 2001) et al. and (Day et al., 2001) and the data presented in 
this chapter all demonstrate the value of various modes of mass spectrometric detection 
for the analysis of flavonols and their metabolites. 
2.5 Conclusion 
The combination of radiolabelled quercetin-4´-glucoside and HPLC RC-MS-MS is an 
extremely powerful tool in establishing the identity of metabolites present. The level of 
radioactivity per µL can easily be measured using conventional liquid scintillation 
techniques. Quantification of the resulting metabolic profile is a simple matter of 
calculating the percentage each peak makes to the total. The absorption detector, 
scanning at 365 nm, also saw the majority of the compounds reported. It should be 
possible in future work using non labelled flavonols to use this detection method to 
quantify the major compounds present. However, the need for the mass spectrometer to 
positiv entify the peaks in the absorbance trace will still be necessary. 
Having established the identity of these metabolites in rats the next step was to use this 
information to determine whether the methodology used in the rat study could be 
transferred to use in human studies using flavonol rich foods such as onions. This will 
be discussed in the following chapter. 
ely id
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Chapter 3  Flavonoid metabolites in human plasma 
and urine after the consumption of red onions: analysis 
by HPLC with photodiode array and full scan tandem 
As it is not possible to use radiolabelled compounds in human studies, the aim in 
, which contained high levels 
of both flavonols and anthocyanins were used to test this method. The samples chosen 
were those thought to contain the highest levels of the compounds of interest, collected 
as part of a full bioavailability study (Mullen et al., 2004). 
As discussed in Chapter 1 onions are a rich source of flavonols Crozier et al. 
(1997), in particular quercetin-3,4'-diglucoside, quercetin-4'-glucoside and 
isorhamnetin-4'-glucoside, (Figure 1-5) Tsushida & Suzuki, (1995) and have been used 
widely in human feeding studies. Taking the figures from the Danish diet data (Justesen 
et al., 1997b), onions are a major source of flavonols in the Danish diet accounting for 
16% of their daily intake.  
In early investigations into the fate of quercetin glucosides after an onion feed, 
plasma and urine samples were acid hydrolysed and the amount of quercetin released 
mass spectrometric detection 
 
3.1 Introduction 
In the previous chapter a method was developed using radiolabelled quercetin-
4´-glucoside to detect and identify metabolites. A large number of metabolites were 
detected (19). These were quantified based on the level of radioactivity contained in 
each peak.  
this chapter, from the knowledge acquired in Chapter 2, was to develop a method to 
identify the metabolites using gradient HPLC with MS
2 with subsequent quantification 
by absorbance detection using a photodiode array detector (PDA). Samples from human 
plasma and urine collected after the ingestion of red onions
  71 was then determined by reversed-phase HPLC following post-column reaction with 
methanolic aluminium nitrate. This method facilitates selective, sub-nanogram 
. 
quantified fluorescent peaks in unhydrolysed plasma and urine that co-chromatographed 
 
etin glucuronides rather than the parent 
glucosides appear in the bloodstream after the consumption of onions (Sesink et al., 
that the HPLC peaks identified and quantified by Aziz et 
al (1998) as flavonol glucosides were probably glucuronide conjugates, which can have 
 times (Day & Williamson, 2001). In-keeping with this 
possibility, an investigation using HPLC with tandem mass spectrometry in the SRM 
mode d
cal detection. A further study used gradient HPLC-MS and selected ion 
monitoring to support identifications based on chromatographic retention times and 
enzyme
ass spectrometry. If 
successful this method could be used to produce, for the first time, pharmacokinetic data 
on the 
fluorescence detection of flavonols with a free 3-hydroxyl (Hollman et al., 1996a)
Using this post-column procedure with gradient HPLC, Aziz et al., (1998) detected and 
with quercetin-4'-glucoside and isorhamnetin-4'-glucoside. As discussed in Chapter 2
results from other studies indicated that querc
2001).  It has been suggested 
very similar HPLC retention
etected five quercetin glucuronides but no glucosides in human plasma after 
ingestion of an onion supplement (Wittig et al., 2001). However, in this study the MS-
MS analysis was carried out separately from the quantitative analysis, which used 
electrochemi
 hydrolysis data. In total, 12 putative quercetin glucuronide peaks were detected 
in plasma by HPLC-A365nm and selected ion monitoring/co-chromatography identified 
three of these components as quercetin-3-glucuronide, isorhamnetin-3-glucuronide and 
quercetin-3'-sulphate (Figure 1-5), (Day et al., 2001). No quantitative data were 
reported in this study.  
The aim in this chapter is to develop a method based on the use of a PDA 
absorbance detector to quantify metabolites identified by m
actual metabolites of quercetin.  
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3.2  Materials and methods 
3.2.1 Study  design 
Six volunteers (4 males and 2 females), who were healthy, non-smokers and not 
on any medication, participated in this study and gave their written consent. They were 
aged between 23 and 45 years and had a mean body mass index of 23.7 (range 20.9-
27.6). Subjects were required to follow a low flavonoid diet for two days and to fast 
overnight prior to supplementation. This diet excluded most fruits, vegetables and 
beverages such as tea, coffee, fruit juices, and wine. On the morning of the study red 
onions (Allium cepa) were skinned, chopped into small slices, and fried for 4 min in 
margarine. Aliquots of the fried onions were taken for qualitative and quantitative 
analysis of their anthocyanin and flavonol content.  
All subjects consumed 270 g of red onions fried in margarine. Venous blood 
samples used were those prior to and 1 h post-ingestion. Twelve ml of blood was 
collected in heparinised tubes at each time point and immediately centrifuged at 4000 g 
for 10 min at 4°C.  The plasma was separated from the red blood cells and 500 µL 
aliquots were acidified to pH 3 with 15 µL of 50% aqueous formic acid and 50 µL of 
ascorbic acid (10 mmol) was added to prevent oxidation.  The plasma samples were 
then stored at -80°C prior to analysis. The urine samples used were those collected 
before 
Committee. 
3.2.2 Materials 
Onions were purchased from a local supermarket (Safeway Stores plc, Byres 
Road, Glasgow G12, UK).  HPLC grade methanol and acetonitrile were obtained from 
Rathburn Chemicals (Walkerburn, Scotland). Formic acid was purchased from Riedel-
DeHaen (Seeize, Germany) and acetic acid from BDH (Poole, UK). L-(+)-ascorbic acid, 
quercetin and isorhamnetin-3-glucoside were purchased from Extrasynthese (Genay, 
and over the initial 4 h period after the consumption of the fried onion 
supplement.  The volume of each sample was recorded prior to acidification to pH 3.0 
and the storage of aliquots at -80°C. The study protocol was approved by the Glasgow 
Royal Infirmary Local Research Ethics 
73- France).  AASC Ltd (Southampton, England) supplied quercetin-3,4'-diglucoside, 
quercetin-4'-glucoside, quercetin-3-glucoside, isorhamnetin-4'-glucoside, malvidin-3-
'-glucoside was synthesised in four steps from barium 
[ C]carbonate (specific activity 3.75 mCi/mmole) by a method previously reported for 
the syn
 Dr Paul Kroon (Institute of Food 
Resear
s in vacuo.  The dried extract was 
f methanol and 1200 µL of 5% formic acid in water, before being 
centrifuged 25,000 g at 4°C for 10 min. Twenty µL aliquots of the supernatant were 
analyse
glucoside and cyanidin-3-glucoside. 
14 [2- C]Quercetin-4
14
thesis of [2-
13C]quercetin-4'-glucoside (Caldwell et al., 2000) except that the 
intermediate ester was not purified by filtration through alumina. The compound was 
pure by 
1H NMR spectroscopy and only one radioactive peak was detected by HPLC-
radio counting. 
Quercetin-3-glucuronide was extracted from French beans (Phaseolus vulgaris) 
and purified by partitioning against ethyl acetate and fractionation using preparative 
reversed phase HPLC.  Quercetin-3'-glucuronide, quercetin-4'-glucuronide, quercetin-7-
glucuronide, quercetin-3'-sulphate, isorhamnetin-3-glucuronide and isorhamnetin-4'-
glucuronide were donated by Dr. Paul Needs and
ch, Norwich, UK). 
3.2.3  Extraction of onions 
Aliquots of fried onions were taken for quantitative analysis of their flavonol 
content. Prior to the extraction, they were frozen in liquid nitrogen, lyophilised and 
powdered.  Triplicate samples were extracted as follows: 35 mg of dry powder was 
homogenized in 3 ml of 70% methanol in water for 1 min using an Ultra-Turrax T 25 
(IKA
R-Werke, Staufen, Germany). During the homogenization, the samples were kept 
on ice. The mixture was then centrifuged at 3000 g at 4°C for 15 min. The supernatant 
was collected and the pellet further extracted and centrifuged twice. The three 
supernatants were combined and reduced to drynes
dissolved in 300 µL o
d by HPLC-MS
2 (Figure 3-1). 
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75 
mples were vortexed for 30 s every 2 min over a 
10 min period, before centrifuging the mixture at 4000 g at 4°C for 10 min. The 
supernatant was collected and the pellet re-extracted as described above but with 
methanol instead of acetonitrile. Experiments with [
14C]quercetin-4'-glucoside and 
malvidin-3-glucoside showed recoveries of ca. 75% with the initial acetonitrile 
 
Figure 3-1. HPLC absorbance trace of red onion extract at (A) 520 nm and (B) 365 nm 
 
3.2.4  Extraction of plasma 
Triplicate samples of plasma collected 1 h after the ingestion of the fried onion meal 
were treated according to the method of Day et al., (2001). This involved adding 1.5 ml 
of acetonitrile to 500 µL of plasma. Sa
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Bextraction which increased by a further 10-12% with the second methanolic extraction. 
The acetonitrile and methanol supernatants were combined and reduced to dryness in 
vacuo. Extracts were then dissolved in 25 µL  of methanol plus 225 µL of 1% formic 
acid in water and centrifuged at 25000 g at 4°C for 10 min prior to the analysis of 100 
µL  aliquots of the supernatant by HPLC-PDA-MS
2 on the day of extraction. 
 
3.2.5  Extraction of urine 
The acidified frozen urine was defrosted, methanol added to make the solution 
5% aqueous methanol, which resulted in any precipitated material being redissolved, 
and 100 µL aliquots were analysed directly by HPLC-MS
2 without further processing. 
 
3.2.6  HPLC with diode array and MS
2 detection 
Samples were analysed on a Surveyor HPLC system comprising of a HPLC 
pump, PDA absorbance detector, scanning from 250 to 700 nm and an autosampler 
cooled to 4°C. (Thermo Finnigan, San Jose, USA). Separation was carried out using a 
250 x 4.6 mm I.D. 4 μm Synergi Max-RP column (Phenomenex, Macclesfield, UK) 
eluted with a 60 min gradient of 5-40% acetonitrile in 1% formic acid at a flow rate of 1 
m  
detector the column eluate was split and 0.3 mL/min was directed to a LCQ DecaXP ion 
trap mass spectrometer fitted with an electrospray interface. (Thermo Finnigan). 
n mode for flavonols and positive ionisation for 
anthocyanins as this provided the best limits of detection. Analysis was carried out 
L/min and maintained at 40°C. After passing through the flow cell of the diode array
Analyses utilised the negative io
using full scan, data dependant MS
2 scanning from m/z 100 to 1000. Capillary 
temperature was 350°C, sheath gas and auxiliary gas were 60 and 10 units respectively, 
and the source voltage was 4kV.  
Additional analyses were carried out specifically for the separation of quercetin-
3-glucuronide from quercetin-7-glucuronide. These used the same MS
2 conditions and 
negative ionisation, with a 250 x 4.6 mm I.D. 4µm Synergi Polar-RP column 
 
76 (Phenomenex, Macclesfield, UK), maintained at 40°C, eluted with a 60 min gradient 
10-18% acetonitrile in 1% formic acid at a flow rate of 1 ml/min.  
30 
 
Figure 3-2. HPLC absorbance trace at 365 nm of (A) plasma and (B) urine after a feed 
of red onions 
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77   Anthocyanins: Gradient reverse phase HPLC with absorbance detection and full 
scan data dependent MS
2 was used to identify and quantify the flavonol and 
anthocyanin content of the red onion meals. The anthocyanins were monitored at 515 
nm and the HPLC trace presented in Figure 3-1 indicates the seven peaks (A1-A7) for 
which positive ion full scan MS
2 data were obtained.  All these peaks had a λmax at 515 
to 520 nm and their identifications, based on a combination of MS
2 fragmentation 
patterns, co-chromatography and previous characterisation of anthocyanins in red 
onions (Terahara et al., 1994; Fossen et al., 1996; Donner et al., 1997) are summarised 
in Table 3-1.  
 
Peak A1 (retention time [tR] - 15.2 min) had a positively charged molecular ion 
[M+H]
+ at m/z 449 which, on MS
2 yielded a fragment ion at m/z 287 (cyanidin, M-162, 
loss of a glucosyl unit). On the basis of the mass spectra data and co-chromatography 
with a standard, peak A1 was identified as cyanidin-3-glucoside.  
Peak A2 (tR - 16.1 min) had a [M+H]
+ at m/z 611 and the MS
2 spectrum 
produced fragment ions at m/z 287 (cyanidin, M-324, loss of a diglucosyl unit). In this 
system the cyanidin diglucoside, cyanidin-3-sophoroside elutes before cyanidin-3-
glucoside as does cyanidin-3,5-diglucoside (Donner et al., 1997; Mullen et al., 2002b). 
Furthermore, the mass spectrum of cyanidin-3,5-diglucoside contains an additional MS
2 
fragment ion at m/z 449. However red onions have been shown to contain the 
disaccharide, cyanidin-3-laminaribioside, which elutes after cyanidin-3-glucoside under 
similar reverse phase HPLC conditions to those used in the current study (Donner et al., 
1997). Based on this earlier identification, its MS
2 spectrum and HPLC properties, peak 
A2 was identified as cyanidin-3-laminaribioside. 
Peak A3 (tR - 17.7 min) had a [M+H]
+ at m/z 697 and MS
2 produced fragment ions at 
pectral data and previously published characterisations (Fossen et al., 
1996) this peak was identified as cyanidin-3-(3''-glucosyl-6''-malonylglucoside).  
Peak A4 (tR - 18.5 min) had a [M+H]
+ at m/z 535, MS
2 produced a fragment ion 
malonic acid) and at m/z 287 (cyanidin, M-248, loss of 
n the basis of the mass spectral data, elution order and previously 
published data (Fossen et al., 1996) peak A4 was identified as cyanidin-3-(3"-
m/z 449 (M-248, loss of malonylglucoside) and 162 amu lower at m/z 287. On the basis 
of the mass s
at  m/z 449 (M-86, loss of 
malonylglucoside). O
malonylglucoside). 
 
78 Peak A5 (t  - 20.7 min) was the main anthocyanin in the red onion extract  R
Figure 3-1 and like peak A4 had a [M+H]
+ at m/z 535 and yielded a similar MS
2 
fragmentation pattern. On the basis of the concentration of this compound relative to 
peak 4, the elution order and previously published data (Fossen et al., 1996; Donner et 
al., 1997) this compound was identified as cyanidin-3-(6"-malonylglucoside). 
Peak A6 (tR - 21.4 min) had a [M+H]
+ at m/z 697 which on MS
2 fragmented to 
produce ions at m/z 611 (M-86, cleavage of a malonyl unit) and m/z 287 (cyanidin, M-
410, loss of a m
2 alonyllaminaribioside unit). The MS  spectrum and its elution after 
alonylglucoside) indicate that A6 was cyanidin-3-(6"-
alonyllam et al., 1997). 
ylglucoside unit). On 
the bas
es the HPLC trace obtained at 365 nm 
 
in produced by three successive losses of 162 amu each of which 
cyanidin-3-(6"-m
m inaribioside), a known red onion anthocyanin (Donner 
Peak A7 (tR - 24.0 min) had a [M+H]
+ at m/z 549 and MS
2 produced two 
fragment ions, the first at m/z 463 (M-86, loss of malonic acid) and the second at m/z 
301 (peonidin, M-248 loss corresponding to cleavage of a malon
is of the mass spectral data and HPLC elution profile, A7 was identified as 
peonidin-3-malonylglucoside, the presence of which in red onions has been reported by 
(Donner et al., 1997). 
The quantities of the individual anthocyanins in the 270 g fried red onion meal 
consumed by the human volunteers are presented in Table 3-1. The total anthocyanin 
content of the meal was 77 ± 2 µmole. 
Flavonols: The flavonols in the red onion extract were analysed using the same gradient 
HPLC system as employed for anthocyanins but data dependent MS
2 used negative 
rather than positive ionisation. Figure 3-1 illustrat
and indicates the 10 peaks (F1–F10) for which MS
2 data were obtained. The 
identifications of these peaks, based on a combination of MS
2 spectra, co-
chromatography and the previous identification of flavonols in yellow onions by 
Tsushida & Suzuki (1995), are summarised in Table 3-2  
. 
Peak F1 (t  - 12.9 min) had a negatively charged molecular ion [M-H]
-
R  at m/z 
787 which yielded MS
2 fragments at m/z 625, 463 and 301. The m/z 301 ion is the
aglycone quercet
 
79 corr
 and 301.  
The
s at m/z 
477 and 285. The m/z 285 ion, produced by successive losses of 162 amu, 
corresponds to the aglycone k
 – 24.5 min) was a methylquercetin diglucoside yielding [M-H]
- 
and MS  fragments at m/z 639 and 477, 14 amu higher than the quercetin 
digl
ution after quercetin-3,4'-diglucoside (F3) and 
 spectrum ([M-H]
- at m/z 463 
and a MS
2 ion at m/z 301). Co-chromatography established the identity of F7 as 
quercetin-4'-glucoside. However, peak F7 also contained traces amounts of a 
methyl
esponds with the cleavage of a glucosyl unit. Peak F1 was, therefore a quercetin 
triglucoside and the production of three fragment ions each with a loss of 162 amu 
indicates that the three sugars are attached at different positions on the flavonol ring. 
Peaks F2 and F3 (tR –21.5 and 22.8 min) are both quercetin diglucosides 
with a [M-H]
- at m/z 625 which fragments to produced MS
2 ions at m/z 463
 larger peak, F3 (Figure 3-1), co-chromatographed with quercetin-3,4'-
diglucoside which is a major flavonol in onions.  The smaller F2 peak was probably 
quercetin-7,3'-diglucoside, a minor onion flavonol which when analysed by reversed 
phase HPLC elutes before quercetin-3,4'-diglucoside (Tsushida & Suzuki, 1995). 
Peak F4 (tR – 23.3 min) yielded a [M-H]
- at 609 and MS
2 fragment
aempferol. F4 was, therefore, a kaempferol diglucoside 
with the sugar moieties attached to kaempferol at different positions. Trace quantities 
of kaempferol-3,4'-diglucoside have been reported to occur in onions (Tsushida & 
Suzuki, 1995) 
Peak F5 (tR
2
ucoside, F2, because of the additional methyl group. This compound may be 
isorhamnetin-3,4'-diglucoside which has been identified as a minor onion flavonol 
(Tsushida & Suzuki, 1995). Its el
kaempferol-3,4'-diglucoside (F4), was in-keeping with this possibility. 
Peak F6 (t – 28.5 min) was a quercetin monoglucoside, having a [M-H]
-
R   at 
m/z 463 which with neutral loss of 162 yielded a MS
2 fragment corresponding to 
quercetin at m/z 301. On the basis of co-chromatography with a reference compound 
peak 7 was identified as quercein-3-glucoside. 
Peak F7 (t  – 33.4 min) was a major flavonol in the onion extract ( R Figure 
3-1) and produced a typical quercetin glucoside mass
quercetin glucoside which had a tR of 33.2 min and co-chromatographed with 
isorhamnetin-3-glucoside. Both compounds had a [M-H]
- 2  at m/z 477 and a MS  ion 
at m/z 315. 
 
80 - Peak F8 (t  – 34.7 min) produced a [M-H] R  at m/z 447 which with a loss of 
162 yielded a MS
2 at m/z 285. It was, therefore, a kaempferol glucoside, possibly 
kaempferol-4'-glucoside, which elutes after, quercetin-4'-glucoside (F7) and has 
previou
ich 
fragme
Ho
qu
µm  for 95% of the flavonol intake. 
3.3
ex
M h either urine 
or plasma. With the sample sizes analysed and the limit of detection at A515 nm, 
anthocyan
sly been identified in onion extracts by (Tsushida & Suzuki, 1995) 
Peak F9 (tR – 36.2 min) was identified as isorhamnetin-4'-glucoside on the 
basis of its mass spectrum [M-H]
- at m/z 477 and a MS
2 ion at m/z 315 and co-
chromatography with an authentic standard. 
Peak F10 (tR – 43.2 min) was identified as the aglycone quercetin on the 
basis of MS
2 and HPLC retention properties. It yielded a [M-H]
- at m/z 301 wh
nted to produced characteristic MS
2 ions at m/z 179 and 151 (Mullen et al., 
2003a). This identification was confirmed by co-chromatography with a standard. 
The total amount of flavonols in the 270 g onion meal was 275 ± 8.8 µmole. 
wever, the major components, quercetin-3,4'-diglucoside (107 ± 1.4 µmole), 
ercetin-4'-glucoside (143 ± 12 µmole) and isorhamnetin-4'-glucoside (11 ± 1.4 
ole), accounted
.2  Analysis of plasma and urine 
Plasma collected one hour after ingestion of the fried red onions, and urine 
creted 0-4 h after eating the meal, were also analysed by HPLC with diode array and 
S
2 detection.  No peaks were apparent in the 515 nm traces obtained wit
ins at levels > 0.1 % of the amounts ingested would have been detected. This 
ding is in keeping with other reports on the fate of dietary anthocyanins following 
sorption. The picture that has emerged is that a variety of anthocyanins appear in 
ne after supplementation with berries or berry 
fin
ab
uri extracts but at best in extremely low 
concentra
al.
pla
ba
ob m are illustrated in Figure 3-2 and the identifications based on MS  
spectra are summarised in.Table 3-3. 
tions, typically 0.1% or less of the ingested dose (Felgines et al., 2002; Wu et 
, 2002).  
In contrast to the anthocyanins, sizable quantities of flavonols were present in 
sma and urine, corresponding to ca. 2% of the intake, with a total of 23 quercetin-
sed compounds being detected in the plasma and urine samples. Typical HPLC traces 
tained at A365 n
2
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t
e 3-1. H nins in efer to HPLC trace in Figure 3-1
 
 time;   ion;  c n i
biose u ylglu de 
ted  
PLC-MS-MS identification of anthocya
 [M+H]
 fried red onions. Peak numbers r
yanidin; Peo – peo
unit. T - tentative 
R - retention
Lb, laminari
 
 
 
 
 
 
 
  
+ - positively charged molecular
nit; mal - malonyl unit; malGlc - malon
[M+H]
+    
idin; Glc - glucos
Amount inges
A-1 cyanidin-3- +H]
+- glucoside  449  287  [C]([M Glc)  9.3 ± 0.3 
A-2 cyanidin
A-3 cyanidin
A-4 cyanidin
A-5 cyanidin
A-6 cyanidin
A-7 peonidin
-3-lamina +H]
+-
-3-(3''-gl
+-ma 287 Gl
-3-(3''-ma
+-m
-3-(6''-ma
+-m
-3-(6''-ma
+-m
-3-malon
+-ma  [P
ribioside  611  287  [C]([M
ucosyl-6''-malonylglucoside) 697  449  ([M+H]
lonylglucoside)  535  449  ([M+H]
lonylglucoside)  535  449  ([M+H]
lonyllaminaribioside)  697  611  ([M+H]
ylglucoside  549  463  ([M+H]
Lb) 
lGlc), 
al), 287 [C]
al), 287 [C]
al), 287 [C]
l), 301
2.9 ± 0.1 
c) 0.1 ± 0.02 
0.4 ± 0.02 
48 ± 1.7 
14 ± 0.5 
1.3 ± 0.06 
 [C]([M+H]
+-malGlc-
([M+H]
+-malGlc) 
([M+H]
+-mal-Glc) 
([M+H]
+-mal-Lb) 
eo]( [M+H]
+-mal-Glc) 
  C –
cosi
de unit; 
82- Table 3-2. HPLC-MS-MS identification of flavonols in fried red onions. Peak numbers refer to HPLC trace in Figure 3-1
Peak   tR (min)  compound  [M-H]
– (m/z) MS
2 fragment ions (m/z) 
F1 12.9  quercetin  triglucoside  787  25  ([M-H]
–-Glc), 463 ([M-H]
–-Glc-Glc), 301 [Q]([M 6 -H]
–-Glc-Glc-Glc) 
F2 21.5  quercetin-7,3'-diglucoside   [Q]([M-H]
–-Glc-Glc) 
ucoside   [Q] [M-H]
–-Glc-Glc) 
oside
de 
–
625  463  ([M-H]
–-Glc), 301
F3 22.8  quercetin-3,4'-digl 625  463  ([M-H]
–-Glc), 301
F4 23.3  kaempferol-3,4'-diglucoside  609  447  ([M-H]
–-Glc), 285 [K]([M-H]
–-Glc-Glc) 
F5 24.5  isorhamnetin-3,4'-digluc 639  477  ([M-H]
–-Glc), 315 [Iso]([M-H]
–-Glc-Glc) 
F6 28.5  quercetin-3-glucoside  463  301  [Q]([M-H]
–-Glc) 
– F7 33.2  isorhamnetin-3-glucoside  477  315  [Iso]([M-H] -Glc) 
F7 33.4  quercetin-4'-glucosi 463  301  ([Q][M-H]
–-Glc) 
F8 34.7  kaempferol-4'-glucoside 447  285  [K]([M-H] -Glc) 
F9 36.2  isorhamnetin-4'-glucoside  477  315  [Iso]([M-H]
–-Glc) 
F10 43.2  quercetin  301  179,  151 
tR - retention time;  [M-H]
- - negatively charged molecular ion;   Glc - glucosyl unit;  Iso - isorhamnetin;  K – kaempferol; Q – quercetin. 
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ur -3. Traces m/z 477 trace from (A ine from onion feed, (B) Urine from onion 
  ( Urine from onion feed plus quercetin-7-
curonide 
 diff at w  detected can be summarised as follows: 
ercet que in monoglucuronides were detected, each 
ng g olecular ion [M-H]
- at m/z 477 which on 
2  v  a glucuronide unit to produce a quercetin 
m h ith reference compounds on the Synergi 
x  HPLC column facilitated the id fication of quercetin-4'-glucuronide, (peak 
18)  k ) (Figure 1-5). However, peak 10, a 
significant component in both plasma and urine, co-chromatographed with both 
quercetin-3-glucuronide, quercetin-7-glucuronide (Figure 1-5). A second HPLC system 
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84using a Synergi Polar-RP column was therefore used to resolve these components 
(Figure 3-3). Quercetin-7-glucuronide had a tR of 34.6 min and quercetin-3-glucuronide 
eluted later with a t R of 36.2 min. When plasma and urine were analysed using the 
Polar-RP column, peak 10 co-chromatographed with quercetin-3-glucuronide (Figure 
3-3 A and B) and there was no evidence of the presence of quercetin-7-glucuronide 
(Figure 3-3 C). This finding refutes claims by Spencer et al., (2003) that quercetin-7-
glucuronide is one of the major in vivo metabolites of quercetin in humans. 
Quercetin diglucuronides. Low levels of three quercetin diglucuronides, peaks 
1,6 and 9, were present in urine. Each had a [M-H]
- at m/z 653 which yielded MS
2 
fragments at m/z 477 (M-176) and m/z 301 (M-352, cleavage of two glucuronide units).  
This indicates that the two glucuronyl units are attached at different positions on the 
quercetin skeleton.  If they have been linked at the same position it is unlikely that a M-
176 fragment would have been produced at m/z 477 as it has been shown that 
anthocyanin disaccharide conjugates fragment with loss of the intact disaccharide 
moiety (Giusti et al., 1999).  
Methylquercetin monoglucuronides Two methylquercetin glucuronides were 
detected, peaks 17 and 20. Which were characterised by mass spectrum with fragment 
ions at m/z values 14 amu higher than obtained with quercetin glucuronides. Co-
chromatography with reference compounds established that peak 17 was 3'-
methylquercetin-3-glucuronide (isorhamnetin-3-glucuronide) and peak 20 was 3'-
methylquercetin-4'-glucuronide (isorhamnetin-4'-glucuronide) (Figure 1-5). 
Methylquercetin diglucuronides.  Peaks 2 and 4 were identified as 
methylquercetin diglucuronides on the basis of mass spectra with fragment ions at m/z 
values 14 amu higher than obtained with quercetin diglucuronides. 
Quercetin.  The plasma of one of the six volunteers contained traces of the 
aglycone, quercetin, which had a [M-H]
- at m/z 301 and MS
2 fragment ions at m/z 179 
and 151.  
Quercetin sulphates. Peaks 22 and 23 had a [M-H]
- at m/z 381 and MS
2 yielded 
a major ion at m/z 301 (M-80) which is in-keeping with the fragmentation of a quercetin 
sulphate. On the basis of co-chromatography with a reference, compound peak 22 was 
identified as quercetin-3'-sulphate (Figure 1-5), which was the major quercetin 
 
85 metabolite in plasma. However, the position of the sulphate group on the quercetin 
ulphate in peak 23 remains undetermined. 
Quercetin glucuronide sulphates. Peaks 13 and 14 both produced a [M-H]
- at 
m/z 381 and MS
2 yielded ions at m/z 477 (M-80, loss of SO3), m/z 463 (M-176, loss of a 
lucuronide unit) and m/z 301 (quercetin) indicating that both compound are quercetin 
lucuronide sulphates. Peak 14 was the main quercetin metabolite in the urine of all 
volunteers 
Quercetin glucosides.  The plasma of one volunteer contained traces of 
quercetin-3,4'-diglucoside as well as small amounts of quercetin-3-glucoside and its 
methylated derivative isorhamnetin-3-glucoside (Figure 1-5). The mass spectra of these 
compounds are summarised in Table 3-3 and in all three instances identity was 
stablished by co-chromatography with the appropriate standard. 
Quercetin glucoside glucuronides.  Peaks 3, 7 and 8 which were detected in 
urine had a [M-H]
- at m/z 639 which on MS
2 yielded ions at m/z 477 (M-162, loss of 
lucose), m/z 463 (M-176, loss of a glucuronide unit) and m/z 301 indicating that both 
ompound are quercetin glucoside glucuronides. 
Quercetin glucoside sulphates.  Peaks 12 and 15 were characterised by a [M-H]
- 
at m/z 543 which when fragmented produced MS
2 ions at m/z 463 (M-80, loss of SO3), 
/z 381 (M-162, loss of a glucoside unit) and m/z 301 demonstrating the presence of 
s
g
g
e
g
c
m
quercetin glucoside sulphates. 
 
 
 
86  
Table 3-3. H
 
 
 
 
 
 
 
 
 
 
87 
f 270 g of fried red onions by 
A and 3-2B 
PLC-M entifica uerceti  in plas ption o
si  volunt k num ion tim es. 3-2
S-MS id
x human
tion of q
eers. Pea
n metabolites detected
bers and HPLC retent
ma and urine after the consum
es refer to HPLC trace in Figur
MS  2   fragments ions (m/z) mpound    M-H]- (m/z) peak  tR [ Location  (min)   co
1 15.6 qu curo 301 [Q]([M  -  H]
--GlcUA -GlcUA) 653 477([M -H]
--GlcUA),  ercetin diglu nide urine
2
3
4
5
20.4 m n di 315
21.5 qu sid ([M
22.7 m n di 315
-  dig  [Q]
 [MQ]([M  -H]
--GlcUA -GlcUA)
-H] 
-  -  GlcUA), 301 [Q]([M -H]
--GlcUA -Glc)
 [MQ]([M  -H]
--GlcUA -GlcUA)
([M  -  H] 
-  -  Glc-Glc)
667 491([M -H]
--GlcUA), 
639 477([M -H]
--Glc), 463
667 491([M -H]
--GlcUA), 
625 463([M -H]
--Glc), 301
ethylquerceti
ercetin gluco
ethylquerceti
ercetin -  3,4' 
glucuronide
e glucuronide
glucuronide
lucoside*
urine
urine
urine
plasma
urine
urine
urine
urine, plasma
urine, plasma
22.8 qu
6
7
8
9
10
11
24.8 qu curo 301
26.2 qu sid ([M
27.0 qu osid ([M -H] 
-
27.4 qu curo  301 [Q]([
28.4 qu ucu A)
28.4 qu uco
 [Q]([M  -  H]
--GlcUA -GlcUA)
-H] 
-  -  GlcUA), 301 [Q]([M -H]
--GlcUA -Glc)
  -  GlcUA), 301 [Q]([M -H]
--Glc-GlcUA)
M  -  H]
--GlcUA -GlcUA)
653 477([M -H]
--GlcUA), 
639 477([M -H]
--Glc), 463
639 477([M -H]
--Glc), 463
653 477([M -H]
--GlcUA),
477 301 [Q]([M -H]
--GlcU
463 301 [Q]([M -H]
--Glc)
ercetin diglu
ercetin gluco
ercet in gluc
ercetin diglu
ercetin -  3  -  gl
ercetin -  3  -  gl
nide
e glucuronide
e glucuronide
nide
ronide
side* plasma
urine
urine
urine, plasma
urine
29.6 quer 1([M -  H] 
roni 1([M -  H] 
30.3 qu roni 1([M -  H] 
30.6 qu sid 1([M -  H] 
33.2 iso   3  -  g )
-  -  Glc), 301 [Q]([M -H]
--SO 3-Glc)
-  -  GlcUA) , 301 [Q]([M -H]
--SO 3-GlcUA)
-  -  GlcAU), 301 [Q]([M -H]
--SO 3-GlcUA)
-  -  Glc), 301 [Q]([M -H]
--SO 3-Glc)
543 463([M -H]
--SO 3), 38
557 477([M -H]
--SO 3), 38
557 477([M -H]
--SO 3), 38
543 463([M -H]
--SO 3), 38
477 315 [Iso]([M -H]
--Glc
12
13
14
15
16
cetin glucosid
ercetin glucu
ercetin glucu
ercetin gluco
rhamnetin  -
e sulfate
de sulfate
de sulfate
e sulfate
lucoside*
30.1 qu
plasma
urine, plasma
urine
urine, plasma
urine, plasma
34.1 iso   3  -  g cUA)   
34.4 qu lucu A)
36.3 qu lucu A)
37.2 iso   4  '  -  g cUA)   
43.2 Q
rhamnetin  -
ercetin -  4  '  -  g
ercetin -  3  '  -  g
rhamnetin  -
uercetin*   
491 315 [MQ]([M -H]
--Gl
477 301 [Q]([M -H]
--GlcU
477 301 [ Q]([M -H]
--GlcU
491 315 [MQ]([M -H]
--Gl
301 179, 151
17
18
19
20
21
lucuronide
ronide
ronide
lucuronide
plasma
urine, plasma 47.9 qu ulfa )
48.3      )
ercetin -  3'  -  s
quercetin sulfate
381 301 [Q]([M -H]
--SO 3
381 301 [Q]( [M-H]
--SO 3
te 22
23 plasma
t  R   - retention time;  [M  -  H] 
-     - negatively  rged molecular ion; Iso  cha - isorhamnetin;  K  – kaempferol;  MQ  – methylquercetin; 
cosyl u A    volunteers    Glc - glu nit;  GlcU –  l u etected  six glucurony nit; *indicates compounds d in the plasma of only one of the  
 
3.4 Discussion 
etabolites were also observed. However, the location and relative quantities 
of the m
ition, the rat did not 
produce any mono sulphate metabolites. A total of 19 quercetin metabolites were found 
in the p
The present study is the first to report on the use of HPLC with full scan MS
2 
and abs
 the SIM mode (Day et al., 2001). Both these studies 
identified the quercetin metabolites with MS in the positive ion mode. However, 
quantification was made separately using another HPLC system with electrochemical or 
absorbance detection systems respectively. Negative and positive ionisation with our 
MS instrumentation provides very similar limits of detection for a standard of quercetin-
3-glucoside. However, when a urine sample is spiked with quercetin-3-glucoside, 
analysis with negative ionisation is about 10 times more sensitive than positive 
ionisation because there is a much lower background and hence an enhanced signal-to-
noise ratio. 
During the development of this analytical system it became apparent that no 
single method for the identification and quantification of quercetin metabolites could be 
relied upon. It should also be borne in mind when developing a chromatographic system 
In the previous chapter a method was developed to determine the identity and 
quantity of flavonol metabolites after a feed of [2-
14C]quercetin-4'-glucoside. A total of 
19 metabolites were detected and 18 of these identified. In this study 10 of the 18 
identified m
etabolites was different. For example the main plasma peak in the rat study, a 
methyl quercetin glucuronide sulphate was not found in human plasma. Conversely, the 
main plasma peak in humans, the quercetin-3´-sulphate was found only in the intestine 
of the rats. One of the major differences between the rat and human metabolic profiles is 
the increased number and levels of methyl metabolites. In add
lasma and urine of all the volunteers. One volunteer had 4 compounds in plasma 
that were not detected in samples from any of the other volunteers. These were the 
aglycone quercetin and 3 of the origin sugar conjugates (Table 3-3). 
orbance detection to analyse flavonols appearing in human plasma and urine. It 
provides a much more detailed analysis than was achieved in earlier studies carried out 
after the ingestion of onions which utilised HPLC with either MS
2 in SRM mode 
(Wittig et al., 2001) or MS in
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analysi
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produce
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would 
positive re
ove
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evi
in t
nvestigate novel metabolites that there is sufficient separating capacity to cope with 
any potential problems as possible. In our system the earliest eluting major flavonol 
 the feed, quercetin-3,4′-diglucoside elutes after 22.8 minutes of a 60 minute 
omatogram. This is to prevent the more polar diglucur de tabolites and 
l triglucuronides eluting in the void volume peak. Studies presented here have 
ntified four peaks that elute earlier than quercetin-3,4′-digluco
The importance of having the right chromatographic conditions to adequately 
 peaks is vital when using only retention time data an absorbance, 
ence or electrochemical detection system. In fact the less spe e detection 
e importance that the chromatographic system ptimised to 
sate for the lack of specificity. However, when using a mass spectrometer its 
ing power should not be overestimated, even in full scan mode.  
As previously discussed the study by Wittig et al., (2001) investigating flavonol 
n human plasma after an 800 g onion feed, five quercetin glucuronides were 
d by SRM analysis. This monitored, in positive ion mode, the entation of 
+ ion at m/z 479 fragmenting to m/z 303, the aglycone er . Although 
e five possible points of glucuronidation of the aglycone glucuronide 
ormed in vitro by UDP-glucuronyl transferase. No sulphates were 
d in this study, which is contrary to the findings here (Day et al., 
n another in vitro study using human liver cell free extracts   al., (2000) 
d that the C-5 position did not appear to be a site for glucuronidation. Our 
s found only three such mono glucuronide metabolites. However, the major 
in diglucuronide (peak 9) and quercetin glucuronide sulphate (peak 14) both 
d strong m/z 477 fragment ions in negative ionisation full scan mode. In the 
 reaction monitoring method used by Wittig et al., (2001) these fragment ions 
have produced a positive response for a mono-glucuro ing a false 
sult.   
Although full scan MS
2 would seem to answer all the prob entification, 
r reliance on it can lead to mis-identification. A strong signal for a with an m/z 
77 and MS
2 predominant fragment ion at m/z 301 would, at first glance, seem strong 
dence a  cet on uc id w , th es  o  molecular ion 
he MS
2 scan and additional ions at m/z 459 and m/z 415 is not typical of the loss of a 
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glucuronide moiety (Figure 3-4). It is sometimes forgotten that the absence of ions in a 
spectra is as important as their presence. Again this compound would have shown up as 
 analysis. SIM would also have shown a false positive peak in 
this analysis, as discussed in the previous chapter. However, use of the absorbance 
detectio
a false positive in Wittig’s
n system to aid identification can provide vital evidence for potential 
misidentification. The absorbance spectrum provided further evidence of this compound 
not being a quercetin metabolite as there was no characteristic flavonol spectrum 
displaying a 365 nm maxima. The MS
3 analysis of this compound is shown in Figure 
2-6. 
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Figure 3-4. MS
2 of m/z 477 (A) quercetin-3-glucuronide and (B) unknown in plasma 
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The value of full scan data dependant MS
2 was seen in the analysis of the 
“exceptional” volunteer. Quercetin-3-glucoside and quercetin-3-glucuronide were found 
in the plasma of this volunteer (Figure 3-2). Both compounds eluted at 28.4 mins. and 
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their absorbance spectra cannot be used to differentiate them. In this case the MS
2 
capability of our system allowed the identification of both compounds. The relative 
areas of the molecular ions were used to calculate the concentration of the glucuronide 
reported. Although MS
2 can be used to get around such a problem, if the plasma of all 
subjects contained both compounds the system would have to be altered to obtain 
separation of these compounds. 
Full scan MS
2 also allowed the identification of a further four unexpected 
metabolites in the plasma of this volunteer, which, like all other metabolites were 
quantified by the absorbance detector. The use of two detection systems, one to identify 
and one to quantify the metabolites, in this study prevented possible misidentifications 
and allowed accurate determination of the quantities present. 
Post-column reaction with aluminium nitrate has a better limit of detection, ca. 3 
pg on-c
ode we were able to detect and quantify levels as low as 200 pg 
of quercetin-4′-glucoside. This was used to confirm that the 0 h sample contained levels 
that we
olumn (Hollman et al., 1996b) for a standard but 100 pg in an extract (Hollman 
et al., 1997b), than the absorbance system used in our study. However, it can detect 
only metabolites with a free three hydroxyl group. Therefore is of no use in studies 
involving intact metabolites. However, if this method was used along with absorbance 
detection a check on peak purity would be possible, as the ratio of absorbance peak to 
the fluorescence peak should also match that of a standard. Thus giving a method of 
detecting false positives for all but the smallest peaks. A serious practical disadvantage 
of the fluorescence system is coupling it to a mass spectrometer would be difficult and 
could prove damaging to the mass spectrometer if the aluminium nitrate was pumped 
into it. 
The absorbance detector used here had a limit of detection of 400 pg injected on 
column, which proved sufficient to allow measurement of the 18 metabolites of 
quercetin over the course of the experiment. Using the mass spectrometer in selected 
reaction monitoring m
re below these detection limits. Samples of 500 µL of plasma proved adequate to 
allow accurate measurement of metabolites by absorbance detection and full scan data 
dependant MS
2 had sufficient sensitivity to allow positive identification of these peaks. 
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3.5 Conclusion 
The data presented here demonstrates the value of gradient HPLC with 
absorption detection used in conjunction with data dependent full scan MS
2 for the 
analysis of trace levels of natural products in impure extracts. When reference 
compounds are available trace quantities of analyte can be identified. In the absence of 
standards, MS
2 can facilitate a degree of structural elucidation, such as that obtained 
with quercetin glucuronide sulphates, methylquercetin glucuronides and quercetin 
diglucuronides (Table 3-3), that would not be possible with traditional single stage MS.  
This has been discussed in some detail with specific reference to quercetin metabolites 
in earlier publications (Mullen et al., 2002a; 2003a). Further information on the position 
and orientation of substituent groups would require the use of NMR. However, this 
would involve not only extensive sample purification but also a requirement for several 
orders of magnitude more analyte than the low nanogram quantities required for HPLC-
MS
2. With many of the plasma and urinary quercetin metabolites detected in trace 
amounts in the present study, this would not be a practical proposition. The use of the 
absorbance detection system provided an accurate method to facilitate the selective 
quantification of these compounds. 
It would appear from the results of previous studies (Hollman et al., 1996a; 
Erlund et al., 1999; Day et al., 2001; Wittig et al., 2001), and experience gained in 
developing this method there is no single detection system that can be used to analyse 
the levels of intact flavonol metabolites in plasma. Although we could use HPLC-PDA-
MS
2 in our analysis, expecting that this level of analytical instrumentation is necessary 
for analysis would be an extreme request. However, some measures when using simpler 
system sks of potential errors being made.   s should be taken to reduce the ri
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Figure 3-5. Fluorescence analysis used for quercetin  (Hollman et al., 1996a) 
 
In the case of the analytical system employed by Hollman et al., (1996a; 1997) 
and Erlund 
which has the same retention time as methylquercetin. In brief, the less selective the 
detection method the greater the need for increased chromatographic separation. A 
et al. (1999) use of a gradient HPLC method would have reduced the risk of 
any co-elution with interfering compounds. The wish to have a fast isocratic analysis is 
always superficially attractive but it comes with risks. Furthermore, the post-column 
fluorescence method may be very selective for flavonols, with only those with a free 3 
hydroxyl group fluorescing, but as can be seen in Figure 3-5 there are a multitude of 
other compounds that also fluoresce when using this method. Hollman states that 
methylquercetin cannot be measured in this method but this is not due to its inability to 
react with the aluminium nitrate but due to the large peak that elutes after quercetin, and 
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second detection system can provide additional information that can indicate potential 
co-elution of compounds. This concept will be discussed in more detail in Chapter 4. 
In this chapter a method that can both identify and quantify intact metabolites of 
quercetin was used to measure these compounds in plasma and urine. In the following 
chapter this method will be used to generate pharmacokinetic data from plasma 
collected over 24 h from the same onion feed used in this chapter. Bioavailability and 
metabolism data will also be discussed. 
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Chapter 4  Absorption, excretion and metabolite 
profiling of methyl-, glucuronyl-, glucosyl and sulpho-
conjugates of quercetin in human plasma and urine 
after ingestion of onions  
4.1 Introduction 
The previous two chapters have described the use of HPLC-PDA-MS
2, with and 
without a radiolabelled standard, to detect metabolites formed in feeds with quercetin-
4′-glucoside to rats and humans. Flavonols, like quercetin-4′-glucoside, have had 
several potential nutritional and health promoting roles in the human body attributed to 
them (Duthie et al., 2000), but there is still much to be learnt about their bioavailability 
and, in particular, which metabolites appear in plasma and in what amounts. This 
information is essential to understanding the potential role of these compounds in 
reducing coronary heart disease, strokes and possibly cancer, as it is likely that the 
metabolites do not have the same bioactivity as the parent compound. To gain a full 
picture of the absorption and metabolism of flavonols it is essential to be able to detect 
and quantify all the major metabolites in plasma and urine and this requires the use of 
appropriate analytical methodology such as described in the previous chapters. 
Quercetin is the major flavonol in many foods including onions which consistently 
contain high levels of this flavonol (Crozier et al. 1998). It is now believed that 
absorption of quercetin glucosides from the gastrointestinal tract involves 
deglycosylation by luminal lactase phloridzin hydrolase and/or cleavage within the 
enterocyte by cytosolic β-glucosidase (Day et al. 2003a).  
  In Chapter 3 the results from the qualitative analysis of a feed Mullen et al., 
(2004) of 270 g of lightly fried onions to human volunteers was reported. Using HPLC 
with photodiode array (PDA) and MS
2 detection, 23 quercetin-based compounds were 
identified in plasma and urine collected 1 h and 0-4 h, respectively, after ingestion.  
  This chapter describes an extension of this study with the quantitative analysis of 
metabolites in plasma and urine collected over a 24 h post ingestion period. The data are 
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discussed with regard to the potential metabolic pathways that operate within the body 
following the ingestion of a quercetin glucoside rich meal. 
 
  Six volunteers (4 males and 2 females), who were healthy, non-smokers and not 
on any medication, participated in this study and gave their written consent. They were 
aged between 23 and 45 years and had a mean body mass index of 23.7 (range 20.9-
27.6). Subjects were required to follow a low flavonoid diet for two days and to fast 
overnight prior to supplementation. This diet excluded most fruits, vegetables and 
beverages including tea, coffee, fruit juices, and wine.  On the morning of the study 
onions (Allium cepa) were skinned, chopped into small slices, and fried for 4 min in 
margarine. Aliquots of the fried onions were taken for qualitative and quantitative 
analysis of their flavonol content.  
All subjects consumed 270 g of fried onions. Venous blood samples were taken 
before (0 h) and 0.5, 1, 2, 3, 6 and 24 h post-ingestion. Twelve ml of blood was 
collected in heparinised tubes at each time point and immediately centrifuged at 4000 g 
for 10 min at 4°C. The plasma was separated from the red blood cells and 500 µL 
aliquots were acidified to pH 3 with 15 µL of 50% aqueous formic acid and 50 µL of 
ascorbic acid (10 mmole/L) added to prevent oxidation. The plasma samples were then 
stored at -80°C prior to analysis. Urine was collected before and over 0-4, 4-8 and 8-24 
h periods after the consumption of the fried onion supplement.  The volume of each 
sample was recorded prior to acidification to pH 3.0 and the storage of aliquots at –80 
°C. The study protocol was approved by the Glasgow Royal Infirmary Local Research 
Ethics Committee. 
 
4.2.2  Materials and Methods 
All details were as described in Chapter 3. 
4.2 Methods 
4.2.1 Study  design 
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4.2 ine
  s 
def s 
the time in hours at which 
metabolites in hours was a t1/2 = 0.693/Ke where 
Ke is the slope of the linear regression of the log of 0-6 h plasma metabolite 
4.3.2
unds being detected.  Typical 
HPLC traces obtained at A nm are illustrated in Figure 3-2 and the identifications 
.3  Pharmacok tic analysis of plasma metabolites 
Maximum post-ingestion plasma concentration of quercetin metabolites wa
ined as C . The time to reach maximum plasma concentration (tmax) was defined a
C
max 
max  was reached.  The elimination half-life for the 
 computed by using the following formul
concentrations. 
4.3 Results 
4.3.1  Analysis of fried onions 
  Gradient reverse phase HPLC with absorbance detection and full scan data 
dependent MS
2 was used to identify and quantify the flavonol and anthocyanin content 
of the fried red onion meals.  Absorbance at 365 nm and negative ionisation MS
2 were 
used for flavonol analysis. The total amount of flavonols in the 270 g onion meal was 
275 ± 8.8 µmole.  In keeping with the data of Tsushida & Suzuki, (1995), the major 
components were quercetin-3,4'-diglucoside, (107 ± 1.4 µmole), quercetin-4'-glucoside  
(143 ± 12 µmole) and isorhamnetin-4'-glucoside  (11 ± 1.4 µmole) (Figure 1-5) which 
accounted for 95% of the 275 ± 8.8 µmole flavonol intake. 
  Qualitative analysis of plasma and urine 
  Plasma and urine samples were analysed by HPLC with PDA and MS
2 
detection.  Flavonol metabolites were present in plasma and urine, corresponding to ca. 
4% of the intake, with a total of 23 quercetin-based compo
365 
based on MS
2 spectra and tR data are summarised in Table 3-3. The use of HPLC-MS
2 
to identify these quercetin metabolites has been discussed in detail in Chapter 3 and by 
(Mullen et al., 2004).  
4.3.3  Quantitative analysis of flavonol metabolites in plasma 
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Eleven quercetin metabolites were detected in plasma in quantities that 
facilitated either their full or partial identification as outlined in Chapter 3 (Table 3-3). 
hose present in sufficient quantities to enable pharmacokinetic profiles to be obtained 
were a quercetin diglucuronide (peak 9), a quercetin glucuronide sulphate (peak 14), 
, isorhamnetin-3-glucuronide and quercetin-3'-sulphate (Figure 
1-5). Quercetin-3'-glucuronide and isorhamnetin-4'-glucuronide was present in the 
s in low, non-quantifiable, amounts while other flavonol 
derivatives, quercetin-3,4'-diglucoside, quercetin-3-glucoside, isorhamnetin-3-glucoside 
pounds had a Cmax of 665 ± 82 
nmole/
 ± 0.22 h was delayed compared to that of the other metabolites and 
e  T1/2 (4.54 h) was much slower than that observed with quercetin-3'-sulphate, 
quercetin-3-glucuronide and the quercetin diglucuronide (Table 4-1).  
T
quercetin-3-glucuronide
plasma of all volunteer
and the aglycone quercetin were detected, albeit in very small quantities, only in the 
plasma of volunteer 6 (Table 3-3).  
The 0-6 h pharmacokinetic profiles of the five major plasma flavonol 
metabolites are illustrated in Figure 4-1. No quercetin metabolites were present in 
plasma samples collected at either prior (0 h) or 24 h after supplementation. This was 
confirmed using the enhanced sensitivity and selectivity of MS
2 in the selected reaction 
monitoring mode. Pharmacokinetic analyses of the 0-24 h data points are summarised in 
Table 4-1. The two main metabolites which accumulated in plasma were quercetin-3'-
sulphate and quercetin-3-glucuronide. These com
L and 351 ± 27 nmole/L, respectively. In both instances Tmax was less than 1 h 
after the ingestion of the onion supplement (Table 4-1). A quercetin diglucuronide (peak 
9) had a similar Tmax (0.80 ± 0.12 h) but a lower Cmax (62 ± 12 nmole/L) than the two 
main metabolites. The levels of all three metabolites declined after reaching Cmax and 
they had a similar T1/2 with values of 1.71-2.33 h (Table 4-1). The pharmacokinetic 
profiles of isorhamnetin-3-glucuronide (peak 17) and quercetin glucuronide sulphate 
(peak 14) were different to those of the other metabolites illustrated in (Figure 4-1). 
Isorhamnetin-3-glucuronide had a Cmax of 112 ± 18 nmole/L and a Tmax of 0.60 h and 
there was a slow rate of decline after C which is reflected in a T max  1/2 of 5.34 h (Table 
4-1). The Cmax of the quercetin glucuronide sulphate (peak 14) was 123 ± 26 nmole/L 
while its Tmax at 2.5
th
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Figure 4-1. concentration of (A) quercetin-3'-sulphate, quercetin-3-glucuronide (B) a 
quercetin glucuronide sulphate, isorhamnetin-3-glucuronide and a quercetin 
diglucuronide in plasma from six human volunteers collected 0-6 h after the ingestion of 
onions.  Data expressed as mean values in nmole/L ± standard error (n = 6). 
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Table 4-1. Pharmacokinetic parameters of quercetin metabolites in the plasma of human 
volunteers after the consumption of onions.   
 
Metabolite (peak number)  C T T max max 1/2
Quercetin-3'-sulphate (22)  665 ± 82  0.75 ± 0.12  1.71 
Quercetin-3-glucuronide (10)  351 ± 27  0.60 ± 0.10  2.33 
Isorhamnetin-3-glucuronide (17)  112 ± 18  0.60 ± 0.10  5.34  
Quercetin diglucuronide (9)    62 ± 12  0.80 ± 0.12  1.76  
Quercetin glucuronide sulphate (14)  123 ± 26  2.5 ± 0.22  4.54  
 
C – maximum concentration in plasma expressed in nmole/L. T  – time to reach C max  max max 
expressed in h.  T  – the elimination half-life of metabolites in h. Data presented as mean values ± 
standard error (n = 6).  Peak numbers as in 
1/2
Figure 3-3
4.3.4  Quantitative analysis of flavonol metabolite excretion in urine 
Eighteen flavonol metabolites were detected in urine samples collected 0-4, 4-8 and 8-
24 h after the ingestion of red onions (Table 3-3)
ion of the onion 
supplement. Substantial amounts of quercetin-3'-glucuronide (1845 ± 193 nmole), 
isorhamnetin-3-glucuronde (1789 ± 27 nmole) and two quercetin glucuronide sulphates 
(peak 13, 1384 ± 163 nmole; peak 14, 1229 ± 190 nmole) were also detected. 
. Six of these compounds, two 
quercetin diglucuronides (peaks 1 and 6), two quercetin glucoside sulphates (peaks 7 
and 8), quercetin-4'-glucuronide and quercetin-3'-sulphate (Figure 1-5), were present in 
quantities insufficient for routine quantification.   
Twelve urinary metabolites were detected in amounts that facilitated quantitative 
analysis (Table 4-2). These metabolites consisted of quercetin-3-glucuronide, quercetin-
3'-glucuronide a quercetin diglucuronide, a quercetin glucuronide glucoside, two 
quercetin glucuronide sulphates, two quercetin glucoside sulphates, isorhamnetin-3-
glucuronide, isorhamnetin-4'-glucuronide and two methylquercetin diglucuronides. The 
main urinary metabolite present was a quercetin diglucuronide  (peak 9) with 2223 ± 
417 nmole being excreted over the 24 h period following ingest
100  
 
Table 4-2. Concentration of quercetin metabolites in the urine of human subjects 0-24 h 
after the consumption of an onion supplement.  
Metabolites (peak number)  0 - 4 h 4 -8 h  8 -24 h  0-24 h    
Quercetin-3-glucuronide (10)   512 ± 101  400 ± 113  n.d.    912 ± 149 
Quercetin-3'-glucuronide (19)  979 ± 2   804 ± 194    62 ± 30  1845 ± 193 
Quercetin diglucuronide (9)  1007 ± 253  942 ± 273  274 ± 98  2223 ± 417 
Quercetin glucuronide glucoside (3)     99 ±        64 ±   16  n.d.   163 ±  23 
Quercetin glucuronide sulphate (13)  608 ± 1   566 ± 143  210 ± 73  1384 ± 163 
Quercetin glucuronide sulphate (14)  743 ± 170  418 ±   98    68 ± 50   1229 ± 190 
Quercetin glucoside sulphate (12)  226 ±  73  130 ±   34    35 ± 26   392 ±  60 
Quercetin glucoside sulphate (15)  538 ± 1   257 ±   98    26 ± 11   821 ± 156 
Isorhamnetin-3-glucuronide (17)  767 ±     861 ±   10  161 ± 10  1789 ± 239 
Isorhamnetin-4'-glucuronide (20)  451 ±  1   249 ±    2  n.d.   700 ± 114 
Methylquercetin diglucuronide (2)  439 ± 132  475 ±   67     89 ± 69  1003 ± 156 
Methylquercetin diglucuronide (4)  189 ±     163 ±   41     74 ± 36    426 ±  99 
Total  6558 ± 1 3  5329 ± 1018  999 ± 267  12886 ± 1038 
20
21
24
27
18
1
49
32
Mean values expressed as nmole ± standard error (n = 6). Peak numbers as in Table 3-3. 
n.d. – not detected. 
 
4.4 Discussion 
Th e 
concen tin in 
t  
pharma f the 
bioactivity and role of dietary flavonols in disease prevention. Furthermore the data 
obtained here provides a better insight into the pathways involved with A.D.M.E. of 
quercetin and provides a platform from which theories on the A.D.M.E. of other 
flavonoids can be launched. 
4.4.1  Quantitative analysis of flavonol absorption 
e results of this study have provided, for the first time, detailed quantitativ
trations of metabolites of methyl, glucuronyl and sulfo-conjugates of querce
he plasma and urine of human volunteers after ingestion of onions. The
cokinetics presented should allow better and more relevant studies o
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The two major metabolites, quercetin-3'-sulphate and quercetin-3-glucuronide appeared 
in plasma within 30 min of the ingestion of onions, both had T  values of under 1 h 
diglucuronide (peak 9) with a lower Cmax and similar Tmax and T1/2 values was also 
etected. The pharmacokinetic profiles of isorhamnetin-3-glucuronide and a quercetin 
glucu  were somewh different in at both had  much longer 
T1/2 and the glucuronide sulphate also had a much delayed 
contribution of these two com inimal, 
having no effect on the T and only extending the T to 2.61 h. This T  is much 
shorte ies carr an  (1996a; 
2000a nsequence  han y of tical data 
obtain
 The  longer  T1/2 values obtained in these earlier studies are also accompanied by 
pre-f  or 
non-specific detection system, as can be seen in (Figure 3-5). Erlund et al., (1999) tried 
om 
quercetin and being unable to do so concluded, with some justification, that the peak 
be seen from Figure 4-2 the level of 
querc
max
and T values of 1.71 and 2.33 h respectively. (Figure 4-1, Table 4-1). A quercetin  1/2 
d
ronide sulphate (peak 14) at   th  a
Tmax. However, the total 
pounds to the overall absorption profile was m
max  1/2  1/2
et at.,  r than similar absorption stud ied out previously Hollm
) which, arguably, is a co of the en ced accurac  analy
ed by HPLC-MS
2.  
eed plasma that contains conjugated quercetin. This was found after either acid
enzyme hydrolysis. Both of these systems employ a short isocratic HPLC analysis and a 
a variety of different columns in an attempt to separate the background peak fr
was, therefore, quercetin. In all our studies we have never encountered such a result. It 
cannot be due to a lack of sensitivity of our detection system as the level of the 
background peak is between 20 and 80 ng/mL (Hollman et al., 1996a). Some other 
factors that give backing to my results come from previously published results Hollman 
et al., (1996a; 2000); Jin et al., (2004a). As can 
etin present in the pre-feed plasma of Hollman was between 20 and 80 ng/mL. 
This was after five days on a flavonol free diet. After a meal containing 62 mg of 
quercetin, plasma levels were back below the starting level within 12 hours with one 
subject. It is somewhat paradoxical that after five days without flavonols the 
background levels of quercetin present in plasma would be higher than that found 12 h 
after a high dose of quercetin. 
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harmacokinetic plot of quercetin levels in plasm g 
Hollman et al  (1996). ontal lines 
T=0 samples. 
 
Figure 4-3. Example of pre and post-meal hydrolysed plasma ch
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Figure 4-4. Example of  (A) pre and (B) post-meal plasma extract by Jin et al  (2004) peak 
1 is quercetin 
ight to my explanation was carried out by Moon et al., 
(2000). Again this was an onion feed to human volunteers and the level of quercetin, 
after enzyme hydrolysis, was measured by HPLC with electrochemical detection. 
However, the level of quercetin was also measured before and after the study prior to 
enzyme hydrolysis. In both pre hydrolysis samples small peaks can be seen at the 
 
The method used by Erlund et al., (1999) is technically more elaborate than that of 
Hollman et al., (1996b), in that there was a sample purification stage by C18 solid phase 
extraction and partitioning against a dichloromethane/toluene mixture, which was 
needed to remove a co-eluting peak from the enzyme preparation. The resultant 
chromatogram (Figure 4-3) is much cleaner than that seen in Figure 3-5 and it seemed 
the only way to further investigate this work was to try and recreate it and include it into 
the mass spectrometric method developed in Glasgow. However, Jin et al., (2004b) 
carried out a similar investigation into flavonols from tea and used HPLC with 
electrochemical detection. In this method a 40 min gradient was needed to allow 
separation of quercetin from interfering peaks (Figure 4-4). Furthermore, there was only 
a 12 h period prior to the feed when quercetin containing drinks were not allowed to be 
consumed. No conjugated quercetin was found in the pre-feed plasma and although 
sampling did not occur after 6 h, the quercetin content had fallen to a level comparable 
to those in the current study (Figure 4-1). 
Another study, which adds we
104  
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tention time of quercetin. In view of our data and that of Jin et al., (2004c) there 
appears to be no argument with regard to the fact that no free quercetin is found in 
a. Therefore, these interfering peaks could explain the high background seen in 
ther studies. 
 
 Moon et al.,  
(2000). (A). extract of plasma before the trial. (B). extract of plasma after the trial. (C). 
re
plasm
o
Figure 4-5. HPLC chromatograms of extracts of human plasma taken from
extract of plasma after the trial and after enzyme hydrolysis.   
 
metabolites excreted in the urine of six human subjects 
0-4, 4-8 and 8-24 h after the consumption of an onion supplement.  
ption by humans reported by Graefe et al. 
(2001). 
olite (peak numbers)  0 - 4 h  4 -8 h  8 -24 h  0-24 h  
Table 4-3 Mean levels of quercetin 
Metab
Methylquercetin diglucuronides (2,4)  638 ± 159  648 ± 109  163 ± 79  1449 ± 240 
  (43%) (45%) (12%)   
rcetin glucoside glucuronide (3)  99 ± 21  64 ± 16  n.d.  163 ± 23 
  (61%) (39%)  (0%)   
rcetin diglucuronide (9)  1008 ± 253  942 ± 274  274 ± 98  2223 ± 417 
  (56%) (42%) (12%)   
  44%)  (1%)   
rcetin glucoside sulphates (12,15)  735 ± 179  490 ± 112  206 ± 167  1431 ± 232 
Que
Que
Quercetin-3- and 3'-glucuronides  1491 ± 316  1204 ± 301  62 ± 30  2757 ± 322 
(55%) (
Que
  (52%) (34%) (14%)   
Quercetin glucuronide sulphates (13,14)  1366 ± 266  984 ± 225  279 ± 105  2629 ± 282 
  (52%) (37%) (11%)   
Isorhamnetin-3- and 4'-glucuronides   1218  ± 310  1060 ± 277  163 ± 53  2490 ± 318 
  (49%) (43%)  (8%)   
For each time period data expressed as nmole ± standard error (n = 6) and in italicized 
parentheses as a percent of the total amount excreted over 24 h. Peak numbers as in Table 3-3. n.d. 
– not detected. 
In keeping with the short T values presented in Table 4-1 1/2  , 92% of the urinary 
flavonol metabolites were excreted within the first eight hours after ingestion of onions 
Table 4-3. Total 0-24 h flavonol metabolite excretion in urine for the individual 
volunteers were 13.9, 13.7, 10.1, 16.4, 9.6 and 14.0 µmole and the mean value of 12.9 ± 
1.1 µmole corresponds to 4.7% of intake. This is in agreement with the level excretion 
of flavonols in urine after onion consum
  One alternative explanation for the presence of actual quercetin conjugates in the 
T=0 samples in the aforementioned studies is the foods the volunteers were allowed to 
eat during the study. In the study by (Hollman et al., 1996b) the volunteers were given a 
list of food and drinks to avoid based on the finding of a study of the levels of these 
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compounds (Hertog et al., 1992a). As discussed in Chapter 1.4 seasonal and varietal 
variations can account for significant changes in the levels of flavonols in foods. The 
volunteers may have unwittingly been consuming foods that contained much higher 
flavonol levels than they thought. As the only measure of flavonol content was by 
reference to (Hertog et al., 1992a) the actual amount consumed is unknown. In the 
studies carried out here all flavonol containing foods were, so to speak, off the menu.  
 
4.5  Qualitative analysis of flavonol absorption 
The number and varieties of metabolites formed from the two main onion flavonols, 
quercetin-4´-glucoside and quercetin-3,4´-diglucoside are shown in Table 3-3. The 
present study cannot provide direct information on the mechanisms involved or the 
efficiency with which these compounds are hydrolysed and/or enter the enteroctye. It 
does provide information well beyond that obtained with the classical hydrolysis 
methods. However, it is evident that following release of the aglycone, quercetin is 
subjected to glucuronidation, sulphation and/or methylation. The enzymes involved in 
the production of these metabolites from quercetin, glucuronosyltransferase, 
sulpharyltransferase and O-methyltransferase, have been found in human intestine 
(Radominska-Pandya et al., 1998; De Santi et al., 2000; Chen et al., 2003; Murota & 
Terao, 2003). It is, therefore, feasible that after the initial deglycosylation of the onion 
quercetin glucosides, all the quercetin metabolites that appear in plasma are the result of 
conversions occurring in the lumen of the small intestine.  The reason for the individual 
metabolites displaying different pharmacokinetic profiles could be due to differing 
enzyme specificities and/or varying rates of efflux from the enterocyte into the 
bloodstream although deposition in body tissues and a slow release in the bloodstream 
could also be factors of influence. Another possibility is that the major plasma 
metabolites, quercetin-3'-sulphate and quercetin-3-glucuronide, are produced in the 
mall intestine, pass into the portal vein and are further converted to the more minor 
c
is . 
Human hepato s well as β-
glucuronidase activity (Boersma et al. 2002; O’Leary et al. 2003). Ex vivo incubation of 
s
omponents, the quercetin glucuronide sulphate, the quercetin diglucuronide and 
orhamnetin-3-glucuronide in the liver as illustrated in Figure 4-6 and Figure 4-7
cytes contain glucuronyl-, sulpho- and methyltransferases a
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quercetin-3-glucuronide with human hepG2 hepatonoma cells results in cleavage of the 
glucuronide moiety and the formation of quercetin-3'-sulphate (O’Leary et al. 2003). 
Further investigation is required to 
which the sulphate, the main quercetin plasma metabolite, is synthesized in vivo.  A 
single step sulphation of the aglycone  nterocy s illustrated in Figure 4-6, 
w t for not  y ex rou
 
,4'-diglucoside as they pass from the lumen of the small intestine into the 
bloodstream via the liver.  
Q – que
determine if this two step pathway is the way in 
in the e te, a
ould appear to be a more straigh ward, but  necessaril clusive,  te. 
Figure 4-6. Schematic of the proposed metabolic fate of quercetin-4'-glucoside and 
quercetin-3
rcetin; glc – glucoside; diglc - diglucoside; glcUA - glucuronide; S - sulphate; LPH – lactase 
phlorizen hydrolase; C-β-G – cytosolic β-glucosidase; UGT – glucuronyltransferase; ST – 
sulphotransferase. 
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Figu e 4-7. Schematic of the proposed metabolic fate of quercetin-3-glucuronide and quercetin-3'-sulp
intestine to the liver where they are further metabolised before returning to the bloodstream and 
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Some tentative evidence of the initial stages of metabolism is discussed with 
regard to results seen in feeds of flavonol meals to ileostomy volunteers. Studies 
involving volunteers who have undergone an ileostomy can give an insight into the 
metabolism of quercetin glucosides. In two publications, (Hollman et al., 1995b; 1997c) 
on the same study, it was claimed that the level of quercetin glucosides absorbed was 
52, 17 and 24% after quercetin-rich meals of onions, tea and the quercetin aglycone 
respectively. Absorption was defined as oral intake minus ileal excretion. However, all 
measurements were made on hydrolysed samples therefore no information as to the 
metabolism of the glucosides could be made. In a similar study by Walle et al., (2000) 
analysis of the ileal fluid prior to enzyme hydrolysis showed that all of the quercetin 
glucosides from an onion feed, had been hydrolysed. This was using HPLC analysis 
with absorbance detection. Walle’s conclusion differs from that of Hollman not in the 
level of quercetin thought to be absorbed but in the fact that glucosides must be 
hydrolysed to the aglycone prior to absorption from the small intestine. Although 
positive identification could not be made, two peaks that matched the retention time of 
quercetin glucuronides, from liver microsome incubations, were seen in Walle’s 
chromatograms.  
Both studies produced roughly the same results, in terms of what percentage of 
the dose was recovered in the ileal fluid, but differ in the conclusions that were drawn. 
Hol ily 
abs re 
hydrolysed prior to absorption. fined the amount absorbed in 
of a n it 
has been absorbed. It is quite possible that the parent compound has been metabolised to 
a form that can no longer be recognised by its original properties that is, in Walle’s 
system no longer having an absorbance maxima at 365 nm or in Hollman’s no longer 
forming a fluorescent complex with aluminium nitrate. 
A study on four ileal volunteers who consumed a flavonol-rich meal of onion 
soup was undertaken in Glasgow to obtain more information on what was occurring in 
the small intestine. No amount of persuasion or bribes could convince the ileal 
volunteers to try the meal of lightly fried onions. Unfortunately due to lack of funding 
lman et al., (1995b; 1997c) claimed that quercetin glycosides were more read
orbed, whereas Walle et al., (2000) stated that all glycoside conjugates we
 However, both studies de
the same manner, oral intake less ileal recovery, which is not necessarily a true measure 
bsorption. Not being able to detect a quercetin-based compound does not mea
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and ileal volunteers this work could not be completed to a le suita for publication 
or to be presented in this thesis. However, the small amou f ation available 
allows for some interesting insights as to what may be occu   all intestine 
and by extrapolation what could be occurring during and post absorption. 
The ileal fluid collected over 24 h following con n  the soup was 
analysed by HPLC-PDA-MS for the level of quercetin conta
in broad agreement with those of Walle et al., (2000) and Ho t  (1995b) in that 
25% of the flavonol dose was recovered. However, it was also possible to identify the 
quercetin-based compounds found in the ileal fluid. The t   tabolites peaks 
were quercetin-3´-glucuronide and quercetin-3´-sulphate, with the quercetin aglycone 
making up the third largest peak. 
This information is of some value to the proble o nd where the 
metabolites are formed and absorbed. It would seem from  ndings the sulphate 
metabolite is formed in the small intestine and is then transported through the enterocyte 
into the portal blood stream. The proposed route shown in Figure 4-6 would also require 
efflux of large quantities of the sulphate out of the enteroc i en and 
hence its presence in ileal fluid. The other main metabolite seen in the ileal fluid is 
quercetin-3´-glucuronide. This is not one of the metabolites found in quantifiable 
amount in plasma, though present as a major metabolite in urine. Based on these 
finding, (Figure 4-6) could be interpreted in a different way as seen in  ure 4-8. 
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Figure 4-8. Modified schematic of proposed quercetin glucoside absorption and 
t have the 3′,4′ arrangement did 
not undergo such dramatic metabolism, and were better absorbed, this would give 
further
that the 3 glucuronide was the main compound circulating in plasma, with the aglycone 
metabolism seen in Figure 4-6, based on identity of metabolites in ileal fluid. 
The metabolic profile seen in ileal fluid indicates that the two main compounds 
formed from onions are both 3′ metabolites. It could be that after deglycosylation the 
first reaction the aglycone undergoes is to conjugate the 3′ hydroxyl group. It is 
speculation, but it may be that having an ortho 3′ and 4′ hydroxyl groups on the B ring, 
which makes quercetin a powerful antioxidant in vitro, (RiceEvans et al., 1997) is 
something that the body views as being potentially harmful and therefore combats it by 
conjugation. Support of this speculation would come if other flavonoids which have this 
3′,4′ arrangement, were treated similarly. Work by Boersma et al.,  (2002) demonstrated 
the human UGT are especially effective in conjugating the 3′,4′ catechol unit of 
quercetin and luteolin. If other flavonoids which did no
 support to this theory. 
Although very little is known about the metabolism of flavonoids, other than 
quercetin, a study into the bioavailability of kaempferol, a 4′ hydroxyl flavonol, found 
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being present too. Urinary excretion also showed the 3 glucuronide to be the main 
metabolite with putative sulphate and disulphate metabolites. Absorption levels in this 
study were reported to be 2% from a very low level dose of only 9 mg (Dupont et al., 
2004) 
Another pair of compounds that could have been used for comparison are the 
flavones apigenin and luteolin, having the 4´-and 3´,4´-hydroxyl groups, respectively. 
Unfortunately, as their dietary intake is rather low, few studies have been made into 
their absorption. In vitro studies with rats by Gradolatto et al., (2004) produced some 
interesting data. Phase II in vitro metabolism of apigenin showed three 
monoglucuronide and one mono sulphate conjugate while luteolin produced four 
monoglucuronide, two mono sulphate conjugates and a methyl metabolite. No 
information on human metabolites or levels of absorption is currently available. Support 
of the m
onide 
metabolite is the major compound found in both urine and plasma (Mullen et al., 
ith cyanidin-3-glucoside multiple metabolites have been reported to occur in 
oth urine and plasma. (Kay et al., 2005a). Levels of absorption for pelargonidin-3-
glucoside range from 1% in the aforementioned study to 1.8% (Felgines et al., 2003), 
hile that of cyanidin-3-glucoside is low at 0.1% intake (Kay et al., 2005b). 
The flavanones have two compounds that can be used for comparison. They are 
esperetin and naringenin. It is slightly different in this case as hesperetin has a 3´ 
hydroxyl and a 4´ methoxy group on the B ring whereas naringenin has only a 4´ 
ydroxyl group. Eriodictyol would have been the ideal compound to compare with 
naringenin having a 3′,4′ dihydroxyl structure however, no comparable studies could be 
found. In a study by (Mullen et al., 2008a) a feed of orange juice fortified with 130 
µmole of hesperetin-3-rutinoside produced six urinary hesperetin metabolites. The 
etabolism of luteolin is provided by Spencer et al., (1999) who reported six 
glucuronyl metabolites of luteolin from the jejunum and ileum of rats. Boersma et al., 
(2002) speculated, from their work, that some of these glucuronyl metabolites may have 
also undergone methylation. 
Further evidence for the 3′,4′-dihydroxyl group undergoing increased metabolic 
transformation can be seen when comparing the metabolites of the anthocyanins 
pelargonidin-3-glucoside and cyanidin-3-glucoside, which have 4′-and 3´,4′-hydroxyl 
groups, respectively. In the case of pelargonidin-3-glucoside a single glucur
2008b). W
b
w
h
h
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much lower intake of narigenin-3-rutinoside produced only three metabolites. However, 
excretion of naringenin was 12% of the intake while that of hesperetin was only 5% for 
a 10 fold larger dose. This could be due to the dose effect but as other studies agree it 
suggest that naringenin-3-rutinoside is more bioavailable than hesperetin-3-rutinoside 
(Erlund et al., 2001; Manach et al., 2005) 
Studies involving (-)-epicatechin have shown that it too undergoes substantial 
metabolism with multiple sulphate, glucuronide and methyl derivatives being found in 
both plasma and urine (Li et al., 2001; Roura et al., 2005). However, there are no 
metabolism or bioavailability studies on a mono-hydroxylated flavan-3-ol (epiafzelchin) 
that can be compared with it.  
Of course an alternative view could be that having more hydroxyl groups on the 
B ring just means there are more sites for conjugation, therefore, more metabolites can 
be formed. However, unless more studies look at the metabolites formed rather than 
simply measuring the levels of the aglycone little progress will be made. 
Returning to the metabolites in ileal fluid, the quercetin-3´-glucuronide formed 
in the t be 
absorbed o  
sulphat
idneys. We assume that most of the observed metabolism 
occurs in the liver, which contains all the prerequisite enzymes, prior to transport to the 
kidney
 small intestine, does not appear in the plasma. It must, therefore, either no
r be the first step in the formation of the diglucuronide or the glucuronide
e metabolites, which are both found in plasma. Information on the position of the 
glucuronide moiety on these two metabolites could help to answer this question.  
The Cmax values and 24 h urinary excretion of the flavonol metabolites (Table 
4-2) detected after consumption of onions presents clear evidence of substantial phase II 
metabolism with many of the major urinary metabolites either not being detected in 
plasma or being present in low concentrations. For instance, quercetin-3'-sulphate, the 
main plasma metabolite, was present in urine in only trace quantities while several 
quercetin glucoside glucuronides and quercetin glucoside sulphates, absent in plasma, 
were excreted in substantial amounts. The virtual absence of many of these urinary 
metabolites in plasma indicates that once released into the bloodstream they are rapidly 
removed by excretion via the k
s. The possible exception, as illustrated in Figure 4-7, may be the formation of 
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the glucoside conjugates in the kidneys, which are known to possess β-
glucosyltransferase activity (Matern & Matern 1987).  
Table 4-4. Quercetin metabolites detected in plasma and urine after the consumption of 
270 g of fried onions by six human volunteers. Estimates of levels in plasma expressed as 
nmole/L ± S.E. (n = 6) at peak plasma concentration. Amounts in urine expressed as total 
amount excreted in nmole ± S.E. over a 24 h period post-ingestion of onions   
Metabolite (peak number) Plasma  Urine 
Quercetin diglucuronide (1)   n.d.  trace 
Methylquercetin diglucuronide (2)  n.d.  1003 ± 156 
Quercetin glucoside glucuronide (3)  n.d.   163 ±   23 
Methylquercetin diglucuronide (4)  n.d.   426 ±   99 
Quercetin diglucuronide (6)  n.d. trace 
Quercetin glucoside glucuronide (7)  n.d. trace 
Quercetin glucoside glucuronide (8)  n.d. trace 
Quercetin diglucuronide (9)    51 ± 13  2223 ± 417 
Quercetin-3-glucuronide (10)  306 ± 42    912 ±  149 
Quercetin glucoside sulphate (12)  n.d.    393 ±   60 
Quercetin glucuronide sulphate (13)  n.d.  1384 ± 163 
Quercetin glucuronide sulphate (14)  117 ± 12  1229 ± 190 
Quercetin glucoside sulphate (15)  n.d.    821 ± 156 
Isorhamnetin-3-glucuronide (17)    98 ± 17  1789 ±   27 
Quercetin-4'-glucuronide (18)  n.d. trace 
Quercetin-3'-glucuronide (19)  trace  1845 ± 193 
Isorhamnetin-4'-glucuronide (20)  trace    700 ±   11 
Quercetin-3'-sulphate (22)  539 ± 46  trace 
Peak numbers refer to HPLC traces in Figure 3-2 and Table 3-3.   n.d. -  not detected.  Trace - compound 
detected but not in sufficient amounts for routine quantification.  Information on trace levels of 
metabolites detected exclusively in the plasma of volunteer 6 Table 3-3 are not presented. 
The 4.7 % recovery of the ingested flavonol glucosides as metabolites in urine in 
this study leaves a large amount of the ingested dosed unaccounted for. The most likely 
fate of these compounds is that they are converted to low molecular weight phenolic 
acids (Gonthier et al., 2003) most probably 3-hydroxyphenylpropionic acid, 3,4-
dihydroxyphenylpropionic acid and 3-methoxy-4-hydroxyphenylpropionic acid (Olthof 
et al. 2003). These compounds were not analysed in the current study. They have a low 
extinction coefficient and a λ  below 250 nm and as a result are not readily detected  max
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with a PDA detector and, in addition, they do not ionize readily when subjected to MS 
with an electrospray interface.   
The data obtained in this study reveal that extensive modification of quercetin 
glucosides occurs following ingestion of onions and the appearance of metabolites in 
the bloodstream and urine. The metabolic conversions involve a complex combination 
of de
7 and Figure 4-8 are a first step in this process.  
he true in vivo 
systems where the passage of metabolites into and out of cells and organs is likely to be 
subjected to
 
involve
glycosylation, glucuronidation, sulphation, methylation and possibly 
deglucuronidation and glycosylation steps. Where in the body these events take place 
and the sequence in which they occur after the initial deglycosylation, is a matter of 
speculation and a topic that requires further investigation. However, the schematics 
shown in Figure 4-6, Figure 4-
While experimentation with human subjects is useful it has it limitations as the 
analysis of deposition of flavonol metabolites in body tissues such as the liver, kidneys 
and brain, is not possible for obvious reasons. ex-vivo studies with cultured cells and 
tissues have their place but it is open to doubt as to whether they reflect t
 refined controls. Animal test systems are, therefore, the only direct way in 
which the true bioavailability of flavonols and other dietary flavonoids and phenolics 
can be investigated. As demonstrated in recent studies with rats, this is best achieved 
using radiolabelled substrates as the accumulation of radioactivity in body fluids and 
tissues can be easily monitored by liquid scintillation counting and the compounds
n d identified and quantified using HPLC-MS  in combination with an on-line 
radioactivity monitor (Mullen et al., 2002a; 2003a).  
The work in the following chapter will investigate the fate of [2-
14C]quercetin-
4'-glucoside over a 72 h period to try and determine the fate of this compound in rats. 
The methodology developed in Chapter 2 will again be used and the animals will be 
housed in metabolism cages, for the duration of the experiment, to allow separate 
collection of urine and faeces. The aim is to be able to account for 100% of the given 
dose by analysis of excretory products and tissues. 
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14 Chapter 5  The fate of [2- C] quercetin-4′-glucoside 
in rats by HPLC radio-counting and tandem mass 
5.1 
In thods we veloped t sure the levels and 
forms of tio onions or ´-glucoside in 
man and  tigations showed the large number and types 
of intact  gestion. H ver, these
informati com nds cease isplay the properties 
used to d r a ts to answ s question.  
P -glucoside was used in  eeding studies 
with rats ed up to 5h afte (Mullen et al., 
2002a; G e   radi vonols during 
their pass ent   be run fo nger period of 
time. To allow for comparison with the origina  1 h s included in the 
sampling 8 h and  , which w osen for this study.  
Housing the rats in m r this period of time allowed f r the collection 
of all excreted products except exhaled CO2 as be ported, in an earlier 
hum
14
of q g it 
could   used 
in this 
The experimental time points for analysis were 1, 6, 12, 24, 48 and 72 h. At each time 
point three male Sprague-Dawley rats (Iffa Credo, L'Arbresle, France) weighing 250 g 
spectrometry 
Introduction 
 the previous chapters me re de o mea
 quercetin metabolites after inges n of   quercetin-4
in rats. The results of these inves
metabolites formed post in owe  studies could provide no 
on on what happened once these  pou d to d
etect them. The work in this chapte ttemp er thi
14 reviously [2- C]quercetin-4' short term f
 to determine the metabolites form r ingestion 
raf et al., 2005). To investigate th fate of the olabelled fla
age through the rat, the experim must r a much lo
l study, a ample was 
 times of 6 h, 12 h, 24 h, 4 72 h ere ch
etabolism cages fo o
, which h en re
an  C labelled quercetin study by Walle et al., (2001a), to be the major metabolite 
uercetin. However, as the quercetin was labelled at the 4 position in the C rin
not be used to follow the fate of the A or B ring metabolites. The compound
study is labelled at the 2 position of the C ring and so will be able to follow the 
fate of the B ring metabolites (see Chapter 2).  
5.2  Materials and methods 
5.2.1  Animals and sample preparation 
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were used (range 242-256 g,). They were housed individually in stainless steel 
metabolic cages and had free access to deionised water (Figure 5-1). They were kept 
under light from 0700 to 1900 h, and the room temperature was 23 ± 1 °C, with constant 
humidi
 with 
chilled
ty. They were deprived of food for 16 h before being force-fed by gavage at the 
beginning of the experiment with a solution of [2-
14C]quercetin-4′-glucoside in 
water/ethanol (92/8) v/v. Rats were handled according to the guidelines of the 
Committee on Animal Care at the University of Montpellier and NIH guidelines (1). 
They were anaesthetized with pentobarbital (60 g/L pentobarbital , 60 mg/kg body). 
Blood was drawn by cardiac puncture with heparin-moistened syringes and plasma and 
erythrocytes were separated by centrifugation at 2300 g for 10 min at room temperature 
then stored at -80°C until analysis. The whole body tissues were perfused in situ
 0.15 M NaCl to remove residual blood. Brain, heart, lungs, kidneys, liver, testis, 
muscle and spleen, were removed and rinsed in saline, blotted dry and immediately 
frozen in liquid nitrogen and stored at –80 °C until analysis. The gastrointestinal tract 
was removed intact along with its contents, then separated into stomach, duodenum, 
small intestine (jejunum and ileum), caecum and colon, immediately frozen in liquid 
nitrogen then stored at –80 °C until analysis. All tissues were weighed. Faeces and urine 
were collected from each rat during the time period starting from the force-feeding of 
labelled compounds to the sacrifice, then stored at –80 °C prior to analysis. 
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Figure 5-1. Metabolism cage with faecal collection tray and urine collection beaker. 
 
 
(1) National Research Council (1985) Guide for the Care and the Use of Laboratory 
Animals. Publication no. 85-23(rev.). National Institutes of Health, Bethesda, 
MD.   
 
5.2.2 Materials 
Methanol and acetonitrile were from Rathburn Chemicals (Walkerburn, 
d was purchased from Riedel-DeHaen 
(Seeize, Germany). Acetic acid was from BDH (Poole, England). L (+)-ascorbic acid 
Scotland) and were both HPLC grade. Formic aci
and quercetin were purchased from Extrasynthese (Genay, France). Quercetin-3,4′-
diglucoside and quercetin-4′-glucoside were from AASC Ltd (Southampton, England). 
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Hippuric acid, 2, 3 and 4-hydroxyphenylacetic acid, benzoic acid, 3,4-
dihydroxyphenylacetic acid, 3,4-dihydroxybenzoic acid, 3-methoxy, 4-
hydroxyphenylacetic acid, 3-methoxy, 4-hydroxybenzoic acid, 3,5-dihydroxy, 3-
methoxybenzoic acid, 3-hydroxyphenylpropionic acid, 3,4-dihydroxyphenylpropionic 
acid and 3-methoxy-4-hydroxyphenylpropionic acid were from Sigma 
5.2.3  HPLC with diode array, radioactivity and MS
2 detection 
Samples were analysed on a Surveyor HPLC system comprising of a HPLC 
pump, diode array absorbance detector, scanning from 250 to 700 nm and an 
autosampler cooled to 4 °C. (Thermo Finnigan, San Jose, USA). Separation of 
quercetin metabolites was carried out using a 250 x 4.6 mm i.d. 4 μm Synergi RP-Max 
column (Phenomenex, Macclesfield, UK) eluted with a gradient over 60 min of 5-40% 
acetonitrile in 1% formic acid at a flow rate of 1 mL/min and maintained at 40 °C. 
After passing through the flow cell of the absorbance monitor, the column eluate was 
directed to a radioactivity monitor (Reeve Analytical Model 9701, Lab Logic, 
Sheffield, UK) fitted with a 500uL heterogeneous flow cell packed with cerium-
activated lithium glass scintillant, after which it was split and 0.3 mL/min was directed 
to a LCQ DecaXP ion trap mass spectrometer. Analysis with an electrospray interface 
(ESI) in negative ion mode provided the best limits of detection for quercetin based 
metabolites.  This was carried out using full scan, data dependant MS
2 scanning from 
/z 100 to 1000. Capillary temperature was 350 °C, sheath gas and auxiliary gas were 
60 and 10 units respectively, source voltage was 4kV.   
Separation of quercetin catabolites was also carried out using the same 
instrumentation however, separation was achieved using a 250 x 4.6 mm i.d. 4 μm 
Synergi Polar-RP column (Phenomenex, Macclesfield, UK) eluted with a gradient 
over 60 min of 5-45% methanol in 0.1% acetic acid at a flow rate of 1 mL/min and 
maintained at 40 °C. A second chromatographic system using a phenyl based column 
250 x 4.6 mm i.d. 4 μm Gemini (Phenomenex, Macclesfield, UK) eluting with the 
same solvent as the Polar column but running a 12 –20% gradient over 60 minutes was 
also used to confirm catabolite identification. After passing through the flow cell of 
the absorbance monitor, the column eluate was directed to a radioactivity monitor 
(Reeve Analytical Model 9701, Lab Logic, Sheffield, UK) fitted with a 500µL 
heterogeneous flow cell packed with cerium-activated lithium glass scintillant, after 
m
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which it was split and 0.3 mL/min directed to a LCQ DecaXP ion trap mass 
spectrometer. Analysis using an atmospheric chemical ionisation interface (APCI) in 
negative ion mode provided the best limits of detection for quercetin 
catabolites/phenolic acids. This was carried out using full scan, data dependant MS
2 
scanning from m/z 100 to 500. APCI vaporizer temperature was 350 °C, capillary 
temperature was 140 °C, sheath gas and auxiliary gas were 80 and 40 units 
respectively, source voltage was 5kV. 
 
5.2.4  Measurement of radioactivity in tissues 
Ten-mg aliquots of powdered freeze-dried tissue and 100 µL plasma were 
treated with 0.5 mL tissue solubilizer (National Diagnostics, Hull, UK) for 3 h at 50 
oC 
in a shaking water bath. Pigmented samples were bleached using 1.75 mL of a 25% 
solution of sodium hypochlorite. The solublization treatment produced clear solutions 
and 150 µL aliquots were taken and added to 5 mL scintillation cocktail (Optiflow Safe 
One, Fisons, Loughborough, UK) before determination of radioactivity using a Wallac 
1409 liquid scintillation counter (Pharmacia, Uppsala, Sweden).   
 
5.2
The level of radioactivity found in the tissue measurement experiment 
det
sample
radioactivity was found in the tissue no extraction procedure was carried out. 
Extraction was by addition of 50% aqueous methanol and continuous shaking. 
mixture was centrifuged at 2000 g for 20 minutes. The methanolic 
supernatant was decanted and the pellet re-extracted a second time. The extract was 
reduced to dryness 
.5  Extraction of samples 
ermined the size of aliquot used for extraction. This ranged from 10mg for stomach 
s taken from 1 h time points to 100 mg for 6 h stomach samples. If no 
After 30 minutes the 
in vacuo and by lyophilization. The residue was re-suspended in the 
HPLC mobile phase (starting composition) and up to 200 µL injected into the HPLC 
system.  
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5.3 Results 
5.3.1  Distribution of radioactivity in rat tissues and extracts 
cetin 4'-
glucoside, (specific activity 3.75 mCi/mmole). The purity of the dose was checked 
prior t
act 
Each rat was dosed with 1.84 x 10
7 5 14  dpm ± 3.14 x 10  of [2- C]quer
o feeding by HPLC-RC-MS
2 which proved that the [2-
14C]quercetin-4'-
glucoside was radiochemically pure. This was the same procedure used in Figure 2-1
At the specified time points the rats were sacrificed and the distribution of 
radioactivity determined. The data obtained are presented in Table 5-1. Recovery of 
radioactivity was between 80 ± 6% for 1 and 6 h samples and 98 ± 16% SD for 72 h 
samples.The only areas where substantial levels of radioactivity were detected were 
the GI tract, urine and faeces. Muscle tissue contained the highest amount out with 
these samples but this still only amounted for no more than 1% of the dose. When 
expressed as a dpm per gram the concentration is less than that of any of the major 
organs e.g. liver, kidney, heart and lungs. These organs only contained trace amounts 
of the radioactive dose 
The majority of radioactivity was found in the GI tract in the 1 and 6 h samples and 
from 12 h to 72 h in the urine. 
 
5.3.2  Distribution of radioactivity in the GI tr
Table 5-1 shows the total activity recovered from the whole of the GI tract. However, 
the GI tract was split into five segments, stomach, duodenum, ileum/jejunum, caecum 
and colon, that were individually analysed. The distribution of the radioactivity 
contained in these segments is shown in Figure 5-2
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Table 5-1.  ctivi  data sh as percentag e. Data i enthese Distribution of radioa ty in samples, own  e of administered dos
dose 
n par s are percentage of recovered 
Sample  1 hr  6 hr  12 hr  24 hr  48 hr  72 hr 
Urine  %)  ,399 ± 2 3 ± 913  47 ±  20 (0.3%)  460 ±144 (2.5   9 272 (52%)  11687 ±2236 (64%)  11,43 (63%)  12,641 ± 3,181 (69.%) 
Cagewash  %)  ,254 ± 1 2 ± 877 (1 69 ± 17 (0.4%)     776 ± 84(4.3  2 401 (12%)   1,982 ± 1106 (11%)  ,231  2.2%)  1,684 ± 461 (9.2%) 
Faeces  %)  ,715 ± 1 ±984 (1 111 ± 96 (0.9%)     0.0 ± 0.0 (0.0 1 11 (9.4%)  2,077 ± 825 (11.%)  2,906  3.7%)    3,349 ± 249 (18%) 
Liver  %)  87  94 ±14 ( 80 ±19 (0.4%)     95 ± 32 (0.5 ± 5 (0.5%)  95 ± 4 (0.5%)  0.5%)   81 ±11 (0.4%) 
Kidney  %)  116  51 ±20 ( 54 ± 17 (0.3%)     98 ± 24 (0.5 ± 4 (0.6%)  41 ± 6 (0.2%)  0.3%)   27 ± 5 (0.2%) 
Brain  %)  4   2 ±0 ( 2 ± 2 (0.0%)     2 ±1 (0.0 ± 3 (0.0%)   4 ± 3 (0.0%)  0.0%)    2 ± 2 (0.0%) 
Testes  %)  4    1 ± 0 (0.0% 2 ± 1.(0.0%)     7 ±1 (0.0 ± 1 (0.0%)   2 ± 0 (0.0%)  )    1 ± 0 (0.0%) 
GI tract  %)     3462 ± 107 5 ± 53 (0.4% 13,683 ± 767 (74.0%)  13,106 ±125 (72.2 0 (19.0%)  620 ± 159 (3.5%)  7 )   51 ± 1 (0.3%) 
Plasma  %)  40 ± 14 ± 5 (0.1%) 83 ± 43 (0.5%)  74 ±10 (0.4  15.(0.2%)  19 ± 7 (0.1%)      0 ± 0 (0.0%) 
Lungs  %)  1    1 ± 0 (0.0% 3 ± 1 (0.0%)  5 ± 3 (0.0 ± 0 (0.0%)   1 ± 0 (0.0%)  )    0 ± 0 (0.0%) 
Heart  %)  6    2 ± 1 (0.0% 7 ± 4 (0.0%)  8 ± 1 (0.0 ± 2 (0.0%)   3 ± 1 (0.0%)  )    1 ± 0 (0.0%) 
Muscle  %)  335 ± 1   156 ± 40 (0.4% 427 ± 249 (2.3%)  408 ± 101 (1.0 05 (0.8%)  204 ± 64 (0.5%) )  100 ±40 (0.2%) 
Total           16,869 ±
(92 ± 11%) 
16,949± 1,095     
(91 ± 6%) 
14,566 ± 1,029       
(80 ± 6%) 
1,5037 ± 258   
(82 ± 14%) 
 1,977          16,735 ± 1,638       
(92 ± 9%) 
    17,938 ± 2,988          
(98 ± 16%) 
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5.3.2.1 Analysis of the 1 h GI tract samples 
As it was not possible to identify the flavonols and phenolic acid metabolites in 
alyses were 
carried out. Firstly to identify any flavonol metabolites present. Secondly to identify the 
potenti e 
ity 
in the s
 
 
 
 
 
with a smaller fragment at m/z 299 a further loss of 32. This 
 
 reacted with methanol during the extraction process as 
escribed by (Dangles et al., 1999). A similar fragmentation pattern was seen by 
 with the peroxyl radical 
generator 2,2′-azobis-isobutyronitrile. 
ined 11 peaks, 9 of which were 
identified (Table 5-2).  
the same analytical conditions, with the exception of hippuric acid, two an
al phenolic acid compounds. Under both conditions it was possible to determin
the relative level of radioactivity from each peak. 
As can be seen in Figure 5-2, the GI tract from the 1 h rat only contained radioactiv
tomach, duodenum and ileum/jejunum. This accounted for 74.0 % ± 4.3 of the 
dose. Analysis of the radioactivity in the stomach samples by HPLC-RA-MS
2 ( 
Figure 5-3) showed the presence of 5 peaks. Only two of the peaks, which made up over
84% of the dose could be identified. These were the parent compound quercetin-4´-
glucoside, 41% ± 6.9 and quercetin 43% ± 5.7, (Table 5-2. Compounds detected in the 1
and 6 h G.I. tract, data reported as K dpm and, in parentheses as percentage of the given
dose.). One of the 4 unidentified peaks could be an “oxidised” quercetin compound. It
had a [M-H]  molecular ion at m/z 349, which on fragmentation produced a base ion at
m/z 331, a loss of 18, 
-
fragmentation pattern could be explained by the presence of a hemiacetal hydrate
derivative of quercetin that has
d
Krishnamachari et al., (2002b) when they reacted quercetin
 
Analysis of the radioactivity found in the duodenum revealed 8 peaks all of 
which were identified. The ileum/jejunum conta
124-  
Average level of radioactivity in GI tract
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2. Level of radioactivity found in G.I. tract segment as percentage of the original dose 
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5.3.2.2 Analysis of the 6 h GI tract samples 
Analysis of the 6 h rat GI tract showed the bulk of the radioactivity had left the stomach 
and duodenum and was distributed through the ileum/jejunum, caecum and colon  ( 
Figure 5-3 and Table 5-2), although trace levels of quercetin was detected in the 
stomach of one of the rats. 
The 6 h ileum/jejunum contained 19 metabolites of which 14 were positively 
identified (Table 5-2). The pattern of metabolites changed dramatically in the caecum 
with the occurrence of only six radioactive peaks. The same metabolic profile detected 
in the colon, except for the absence of peak 1 (Table 5-2). Peaks 1, 13 and 28 were not 
identified. However, the other metabolites were 3,4 dihydroxybenzoic acid (peak 4), 
3,4-dihydroxyphenylacetic acid (peak 5) and 3-hydroxyphenylacetic acid (peak 8). 
Their percentage of the administered dose found in the colon was 6.0%, 31.8% and 
31.9% respectively.  
 
What can be clearly seen from the results shown in Table 5-2 is that m - and 
di-glucuronidation occurs prior to the compounds being methylated. The two major 
metabolites in the duodenum of the 1 h sample are both quercetin monoglucuronides, 
most likely the 3′ and 4′ isomers, from their retention time properties, accounting for 
almost 50% of the radioactivity. This is also the case in the ileum/jejunum ple. 
However, in the 6 h sample of the ileum/jejunum the number of me lated 
metabolites has increased from one in the 1 h sample to six and now accounts for 30% 
of the radioactivity. 
 
5.3.2.3 Analysis of the 12 h GI tract samples 
The 12 h GI tract samples contained lower levels of radioactivity than the 1 
and 6 h samples, which made MS identification more difficult. Analysis of the 
ileum/jejunum showed that hippuric acid was the main compound present along with a 
ono
 sam
thy
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much lower level of 3-hydroxypheny acetic acid. The caecum and colon contained 
only 3-hydroxyphenyacetic acid.
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Table 5-2. Co ata ses as  e  en d mpounds detected in the 1 and 6 h G.I. tract, d  reported as K dpm and, in parenthe percentag of the giv ose. 
    1 h rat GI tract segments 6 h rat GI tract segments
Pno.  Rt  Compound  Stomach Duodenum Ileum/jejnum  Ileum/jejunum Caecum Colon
1 5.5  Unknown     316  (6.0%)
2 6.7  Unknown      789  (17.1%)  
3  10.2  Unknown   245   (3.3%)   527 (12.5%)  
4 10.5  3,4 dihydroxy benzoic acid    151 (3.3%)  255 (4.8%)  149 (6.0%)
5 11.6  3,4 dihydroxy phenyl acetic acid  1348  (25.4%)  793 (31.8%)
6 18.3  Hippuric acid   
7 18.8  Quercetin diglucuronide    269   (5.9%)    39 (0.9)
8 19.6  3  hydroxy phenyl acetic acid  1631  (30.7%)  796 (31.9%)
9  21.6  Unknown   337   (4.5%)  
10 22.1  Methyl que di rcetin  glucuronide   73 (1.6%)
11 23.5  Methyl que di rcetin  glucuronide   71 (1.5%)
12 25.4  Quercetin diglucuronide    29 (0.6%)
13 26.5  Unknown     424  (8.0%)  241   (9.7%)
14 27.2  Unknown  “oxidised  quercetin”  651   (8.7%)  
15 27.8  Methyl que di rcetin  glucuronide   303 (6.5%)
16 28.0  Quercetin diglucuronide   38     (2.4%)   144   (3.1%)  
17 29.1  Quercetin diglucuronide    202 (4.4)
18 29.8  Quercetin diglucuronide   10     (0.6%)   173   (3.8%)  
19 31.2  Quercetin glucuronide 471      (28.9%) 1,072 (23.3%)    398 (8.6%)
20 32.2  Quercetin glucuronide 195      (12.0%)  504  (11.0%)    350 (7.6%)
21 34.4  Benzoic  aicd   
22 36.6  Quercetin-4´-glucoside 4,356 (41%) 534   (32.8%)  352   (7.7%)  
23 37.5  Methyl quercetin glucuronide   47 (1.0%)
24 38.3  Methyl quercetin glucuronide  31     (1.9%)  147   (3.2%)    311 (6.7%)
25 39.4  Methyl quercetin glucuronide 188   (11.6%)  321   (7.0%)    159 (3.4%)
26 43.5  Methyl quercetin sulphate glucuronide   307 (6.6%)
27 44.3  Unknown    252  (5.4%)
28 44.3  Quercetin   3,201 (43%) 161     (9.9%)  255   (5.6%)  
29 45.2  Unknown    816 (16.8) 1330 (25.1%)  514  (20.6%)
30 49.0  Unknown      97 (1.9%)
31 50.0  Unknown    255 (6.5%)
32 50.3  Quercetin sulphate    765 (16.5%)
33 54.3  unknown  125 (2.7%)
 
  
5.3.2.4 Analysis of the 24 h GI tract samples 
Trace levels of radioactivity were found in the stomach and duodenum in these 
samples (Figure 5-2). Analysis of the ileum/jejunum showed the presence of three 
radioactive peaks. Only hippuric acid could be identified. One of the other radioactive 
peaks eluted at the same retention time as 3-hydroxphenylacetic acid but could not be 
identified as it did not ionise. The third peak also had no identifiable ions and eluted at 
a retention time matching 3,4-dihydroxyphenylacetic acid. The GI tract samples from 
the later timepoints did not contain sufficient radioactivity to allow identification of 
the trace quantities of metabolites and catabolites that were present.  
 
5.3.3 Urine  analysis 
As can be seen from the results in Table 5-1 a small amount of radioactivity is 
excreted in the urine within one hour. By six hours it has increase to 2.5% of the dose 
and to 52% after 12 hours. The 24 h sample shows an increase in the level excreted 
(64%) with no apparent increase by 48 hours. The best picture on excretion rate can be 
seen in the 72 hour samples. Here urine was collected from these rats at 0-24 h, 24-48 h 
and 48-72 h thereby giving a complete record from one set of rats. (see Figure 5-4). 
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Cumulative urinary
Figure 5-4. a ge na tio s 72  s =3). 
 
5.3.3.1  s of  ne by HPLC
s urine contained both flavonol  i tabolites analysis had to 
b r ut with two analytical method a u  
5 3
U e w analysed g HPLC-RA-MS
2 as previously described. A total of 20 
m bolites were identified (Table 5-3). None of the flavonol metabolites were present 
in concentrations to allow quantification by radioactivity or absorbance detection. 
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Analysis of the 24-48 h and 48-72 h urine did not find the presence of any flavonol 
metabolites 
Table 5-3. Flavonol metabolites found in urine and referenced to Table 5-2GI tract 
metabolites. 
Peak No  Rt.  Compound Table 2 peak No..
1 15.8  Quercetin triglucuronide nd
2 17.5  Hippuric acid 6
3 19.0  Quercetin triglucuronide nd
4 20.3  Quercetin diglucuronide nd
5 21.2  Methyl quercetin diglucuronide 10
6 22.6  Quercetin diglucuronide nd
7 23.5  Methyl quercetin glucoside glucuronide nd
8 24.1  Methyl quercetin diglucuronide nd
9 25.2  Methyl quercetin diglucuronide nd
10 25.7  Quercetin diglucuronide nd
11 26.1  Methyl quercetin diglucuronide nd
lucuronide 17 12 28.0  Quercetin dig
13 28.4  Methyl quercetin sulphate nd
14 30.1  Methyl quercetin glucuronide nd
15 30.5  Methyl quercetin sulphate nd
16 30.9  Methyl quercetin glucuronide nd
17 33.3  Methyl quercetin sulphate nd
18 34.6  Methyl quercetin glucuronide nd
19 39.5  Quercetin sulphate nd
20 48.8  Quercetin sulphate 31
21 53.0  Methyl quercetin nd
 
5.3.3.3 Urine phenolic acid data 
Analysis of the 1 h and 6 h rat urine samples showed the presence of measurable levels 
of radioactivity that did not correspond to any flavonol metabolites. However, due to the 
low levels no positive identity could be made on these compounds. The 12 h, 24 h, 24-
48h and 48-72h samples all produced good radioactivity chromatogram and 3 peaks 
were identified by both mass spectrometric data and co-elution with authentic standards 
under three different chromatographic methods (RP-Max, Polar and Gemini). The data 
from the analyses are shown in Figure 5-6 and the quantitative estimates are shown in 
Table 5-4. 
 
132  
Table 5-4. Identification and quantification of radioactive compounds excreted in urine 
from the 72 h rats. Values reported are as a percentage of the dose, total ± SD 
Sample  Peak 1  Peak 2  Peak 3  Peak 4 
Hippuric acid 
Peak 5 3-
HydroxyPAA 
Peak 6 
Benzoic acid 
0-24h 0.0  2.2  1.2 32.0  11.1  1.2 
24-48h 0.4  0.6 0.9  0.1  4.7  6.1 
48-72 0.0  0.3  0.7 0.0  5.5  2.1 
Total   0.4 ± 0.3  3.1 ± 1.3  2.8 ± 1.0  32.1 ± 8.3  21.3 ± 7.6  9.4 ± 3.7 
 
Using the data from the 72 h rats, hippuric acid is the largest metabolite with 
32.1% of the administered dose being excreted as this. However, it was only excreted 
during the first 48 h period, only 0.1% was excreted in the later samples. 3-
hydroxphenylacetic acid was the next major metabolite contributing 21.3% of the 
adm  up 
the third largest contributor with 9.4% of the dose. There was very little benzoic acid 
xcreted in the first 24 h period with the bulk appearing in the 24-48 h sample then 
 
inistered dose. This compound was excreted in all samples. Benzoic acid made
e
reducing again in the 48-72 h sample. 
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Figure 5-5. HPLC M of 6 h rat  able    S –PDA-radioactivity analysis  urine using the RP-Max method. Peak numbers as used inT 5-2. 
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Figure 5-6. HPLC radioactivity chromatograms of compounds in urine using th m 5-4.  e Polar column method. Peak nu bers as used in Table 
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5.3.4 Faecal  analysis 
No radioactivity was found in the 1 and 6 h samples. The 12, 24, 48 and 72 h 
samples all contained significant levels of radioactivity, between 9.4% of the dose in the 
12 h sample to 18.4% in the 72 h sample. 
 
The most accurate picture of the rate of faecal excretion of the dose ca  seen 
from the 72 h samples. (see Figure 5-7). The majority of the radioactivity (13%) is 
excreted in the first 24 hours with a further 4% in the next 24 h period and just over 1 % 
in the final 24 h period. 
 
Figure 5-7. Cumulative faecal levels of radioactivity from 72 h rats. ± SD (n=3) 
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Analysis of the faecal samples by HPLC-RA-MS
2 revealed the presence of a 
number of compounds. Only two peaks were seen in the 12 h sample. The main peak 
was 3-hydroxyphenylacetic acid, which accounted for 93.7% of the radioac y 
present. The other peak was hippuric d. Again using the 72 h rat, in the 0-24 h 
sam  only 3-hy yphenylacetic   was seen. In the 24-48 h samples 3-
hydroxyphenylacetic acid was also the  r peak with e hippuric acid in one of the 
three rats, making up 3.9% of the radio ity present.  ilar picture was seen in the 
48-72 h samples with two of the three rats having hippuric acid and one  own k 
present making up 9.6 and 2.2% of the radioactivity present respectively, (see Table 
5-5). Peak number as used in Table 5-4
 
Table 5-5 Radioactive compounds excreted in faeces as a percentage of faeca
radioactivity ± SD (n=3) 
 
tivit
 pea
l 
 aci
acid
majo
activ
ples drox
 som
A sim
unkn
 the 
  Peak 1  Peak 2  Peak 3  Peak 4 
Hippuric acid 
Peak 5           
3 Hydroxy PAA 
Peak 6 
Benzoic acid 
0-12h  0.0  0.0  0.0  6.3 ± 10.9  93.7 ± 10.9  0.0 
0-24h 0.0  0.0  0.0  0.0  100  0.0 
24 h  0.0  0.0  0.0  3.9 ± 2.3  96.1 ± 2.3  0.0 -48  
48-72  2.2 ± 3.9  0.0  0.0    9.6 ±16.6  88.2 ± 20.4  0.0 
 
 
 
5.3.5  Analysis of plasma 
Radioactivity was rapidly absorbed into the plasma, accounting for 0.45% of the 
dose in the 1 h sample. The level fell to below half of this by 12 h and was below the 
limits of detection in the 72 h sam  
Only phenolic acid analysis was carried out on plasma as levels of activity and 
sample size did not allow lyses. 
ple. 
 for multiple ana
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Although hippuric acid was found in all plasma samples a radioactive peak co-eluting 
seen in the 6 h and 12 h samples. 
 
 
The level of radioactivity peaked in the kidney at 0.64% of dose in the 12 h 
sample falling to 0.22% in the 24 h sample. Previous analysis of kidney taken at 1 h had 
revealed a range of flavonols present. However, our findings here for the 6 h and 12 h 
kidney show that hippuric acid was the only measurable radioactive compound present 
in the  was 
ain peak followed by 3-hydroxyphenylacetic acid and one unknown early eluting 
atched the retention time of one of the unknown peaks, peak 2 in the urine 
samples. 
with hippuric acid was only 
Radioactivity in p
Figure 5-8. level of radioactivity in plasma, ± SD (n=3) 
 
5.3.6 Analysis  of  kidney 
 6 h sample. The 12 h sample contained three radioactive peaks, hippuric acid
the m
peak which m
lasma
0.0 
0.1 
0.2 
0.3 
.4 
0.7 
.8 
1 6 12 24 48 72 
p
e
r
c
e
n
t
a
g
e
 
o
f
 
d
o
s
e
 
0
0.5 
0.6 
0
138  
 
5.3.7  Analysis of liver 
The level of radioactivity in the liver stayed at a constant level of around 0.5% 
throughout the experiment. However, analysis of the sample for phenolic acids did not 
reveal the presence of any of these compounds. The low level of activity did not allow 
for analysis for flavonols as well as phenolic acids. The liver was the largest organ in 
the rat and in terms of radioactivity per gram it was lower than that found in the early 
kidney samples. 
 
No significant levels of radioactivity were found in any other organ or tissue. 
Muscle did account for 1% of the dose at the 1 h sample but this is more likely due to 
resid  rat 
can be the source of error when only sm  solubilized for 
stimation of radioactive content. This is possibly the case to a lesser extent for the liver 
samples too. 
 
5.4 Discussion 
e da resente re pro s the  plete  e pictur  the 
fate of [2-
14C]quercetin-4´-glucoside when fed to rats. At least 70% of the dose was 
absorbed and excreted via the urine while 19% was excreted in faeces. The remainder of 
e dose was found in the radioactivity washed from the metabolism cages, which could 
ave come from either or a mixture of the urine and faecal material. 
tain data like this by use of a radiolabelled compound 
have not been fully successful due to various reasons. Two studies were carried out 
using r
f the carbon label. During ring fission by colonic 
bacteri
 fate of the carbonyl moiety. The study 
ual blood. The fact that muscle mass accounts for 25% of the body mass of the
all (10 mg) samples can be
e
Th ta p d he vide first com quantitativ e of
th
h
 
Previous attempts to ob
adioactively labelled quercetin (aglycone) with the carbon label at the 4 position 
in the C ring (Walle et al., 2001b; Abrahamse et al., 2005). These studies were limited 
in their success due to the positioning o
a the C ring is opened and the carbon at position 4 is separated from the A and B 
rings and can therefore only be used to follow the
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by Abrahamse et al., (2005) also reported on the fate of 
3H-labelled (-)-epicatechin in 
rats. Again this experiment had limited success, as there appears to have been exchange 
f the tritium label into water during the study. A similar study using both 
3H-labelled (-
epicatechin and (+)-catechin also reported exchange of the tritium with water in the 
oral but not the intravenous dose (Catterall et al., 2003). This had occurred in the oral 
dose within three hours and, as the label was in the 3 position, was believed to be due to 
bacterial degradation. Unlike the study here very little of the dose was excreted via the 
urine (2.5%), with the majority being excreted via the faeces within 24 h (84%). A 
further 5.8% was excreted in faeces between 24-48 h and then trace amounts (0.3% and 
0.2%) between 48-72 and 72-96 h. The compounds making up the radioactivity were 
not investigated. The researchers in this study were aware of the need to administer a 
nutritionally relevant dose and suggest that high doses may cause presystemic 
metabolism to become saturated thereby allowing more of the parent compound to pass 
into the circulatory system. 
 
The fate of (-)-[4-
3H]epigallocatechin gallate, EGCg was also investigated 
(Kohri et al., 2001). The investigators reported no tritiated water in urine of the rats and 
they found the excretion ratio of bile to urine to be 97:3. The major metabolite, after 
deconjugation wa
 
14C]-quercetin was carried out by (Ueno et al., 1983). 
 same problem as the studies by Walle et al., (2001b; 
2005) the samples collected after 1 and 6 h did contain information that has been an 
important addition to work reported 
 of quercetin, at best contain these compounds at 
approximately 0.5% w/w one can judge the level of the dose given to rats. In this study 
they found evidence of quercetin in many organs, especially those that were highly 
vascularised e.g. lungs followed by the liver and kidney. This could be explained by the 
o
)-
s 4′,4′′-di-O-methyl EGCg representing almost 15%. 
One other study using [4-
Although this suffered from the
here, and will be discussed later. 
 
A study into the fate and distribution of the aglycone quercetin in pigs and rats 
was carried out by (De Boer et al., 2005). They fed non labelled quercetin to rats at 
doses of 0.1 and 1% of their diet for 11 weeks and also to pigs at a level of 500 mg/kg 
for 3 days. The two pigs used weighed 122.4 and 138.9 kg. The dose level in both cases 
was beyond that which could possibly be classed as nutritionally relevant. As onions, 
one of the richest sources
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high dose or the fact that the rat tissues had not been perfused prior to analysis. 
Although the authors used a method for correcting for residual blood, by measuring 
ssue to estimate the amount of blood present and then 
subtracting the equivalent amount of quercetin they found in plasma from the total, it 
would 
rgans involved in metabolism and excretion quercetin concentrations 
id not exceed those found in plasma.  
udies had similar problems in that most of the catabolites formed from 
ese feeds are already present in urine from the normal metabolic functions of the 
n these studies to give an accurate estimate for the recovery of 
the initial dose. Nor did they attempt to estimate the level of intact metabolites in urine. 
In contrast in the present study we were able
the stomach of the 
 h rat was free quercetin. Along with the fact there were other compounds that no 
longer displayed flavonol-like properties 
levels of haemoglobin in ti
have been simpler and more accurate to have perfused the tissue to remove the 
blood in the first place. 
A feed of quercetin, at a dose of 50 mg/kg/d, was given to pigs over a four week 
period, in an attempt to learn if there was accumulation in tissues (Bieger et al., 2008a). 
Again this level of dose could not be described as “nutritional”. The finding were that 
apart from the o
d
 
There have been very few studies that try to look at the products formed from 
action of the colonic microflora. Gonthier et al., (2003) fed red wine polyphenols to rats 
and carried out analysis of phenolic acids in urine. Olthof et al., (2003) fed chlorogenic 
acid, rutin and black tea to human volunteers and measured the phenolic acids present in 
urine. Both st
th
body. It was not possible i
 to follow the radioactivity as it progressed 
through the GI tract, (see Figure 5-2) and also to identify the compounds it was 
converted into during its passage (see Table 5-2). As would be expected the bulk of the 
metabolites were formed in the duodenum and ileum in the 1 and 6 h samples. 
However, what was unexpected was the fact that 43% of the dose in 
1
making up a further 16% of the dose in the 
stomach. One of these compounds had mass spectral similarities to a proposed 
“oxidised quercetin” reported by Krishnamachari et al., (2002a). These compounds 
were no longer present in the duodenum. 
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Figure 5-9. Conversion of parent compound as ugh the  6 h r
eac
 it passes thro GI tract of 1 and 
h segment. 
ats. Quantities are as percentage radioactivity found in 
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It is also apparent from the data represented in Figure 5-9 that after 
deglycosylation the first metabolites formed are monoglucuronides. From their retention 
times one of the two must be quercetin-3´-glucuronide. This is the same as human 
metabolism were the 3′-conjugate is the major glucuronide found in the small intestine 
of ileal volunteers, as reported in Section 4.6. The pattern of reducing levels of 
quercet
 and the appearance of sulphate metabolites was 
detected.  
 
 
 to 
 was 
 
 
t via the 
 
he target 
 
se of 
 to 
 has reached the caecum no intact metabolites 
are present, and all the radioactivity is made up of phenolic acids. No hippuric acid was 
found in the GI tract at this time point. However, in the 12 h rat ileum/jejunum, hippuric 
acid was the only compound detected. Once the radioactivity had passed through to the 
caecum and colon, 3-hydroxyphenylacetic acid was the main compound present, (see 
in-4′-glucoside with an increase in glucuronide metabolites is seen in the 
ileum/jejunum of the 1 h rats, where diglucuronides and methyglucuronides are also 
detected. Unidentified compounds made up 19% of the dose in the stomach of the 1 h 
rats and this increased to 26% in the ileum/jejunum. In the ileum/jejunum of the 6 h rats 
none of the parent compound was found
  As previously reported (Mullen et al., 2002a), and in this study, the bulk of the 
recovered radioactivity, 95 and 84% remained in the GI tract after 1 and 6 h
respectively. Very little of the dose would appear to have been absorbed, as measured 
by levels excreted and circulating in plasma. However, Ueno et al., (1983) were able
show, by using bile duct cannulated rats, that a proportion of the absorbed dose
excreted back into the GI tract as quercetin glucuronides. The dose in parts of this study 
was a massive 630 mg/kg and some unmetabolised quercetin was excreted in the faecal
matter. At a normal, nutritionally relevant dose, quercetin is unlikely to be excreted in
faeces intact, and this calls into question whether excretion back into the GI trac
bile is also unlikely at a lower dose. This highlights the rational behind using such large
doses. It is easy to argue that the high dose is needed to be able to detect t
compound. But if the dose is so large that it alters the normal metabolism of the subject,
what use are the results? This is a common thyme in many studies including tho
(De Boer et al., 2005; Bieger et al., 2008b). and as a consequence their relevance
nutrition and health is unclear. 
 
In the 6 h rat by the time the dose
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Table 5-5). The presence of smaller amounts of hippuric acid may be explained by its 
excretion back into the GI tract via the bile.  
Within 24 h over 50% of the dose has been excreted in the urine in the form of 
phenolic acids. The presence of intact flavonol metabolites is no long seen after the 6 h 
sample, either as radioactivity or as detected in the mass spectrometer. This agrees with 
our data found in human feeding studies that excretion of intact metabolites from 
plasma occurs rapidly post-absorption (Mullen et al., 2006). By 48 h the level excreted 
has risen to over 60% of the administered dose and by 72 h reached almost 70
What is of interest here is the movement of substantial amounts of radioactivity 
from the GI tract to urinary excretion with no increase in the level of radioacti  found 
in plasma. This could be explained by the timing of the absorption and excretion falling 
between the 6 and 12 h samples. However, for such a high proportion of the dose to 
have been excreted so quickly with no increase in plasma radioactivity lev would 
seem unlikely. If this is the case then the body must process the colon derived phenolic 
acids very quickly.  
The metabolic profile changed during the course of the experiment. Initially, in 
the 12 h urine sample hippuric acid was the major metabolite along 3-
hydroxyphenylacetic acid. In the 24 h sample benzoic acid appeared a
metabolite. [
14C]Hippuric acid almost disappeared in the 48 h urine sam re 
benzoic acid appeared as the second largest peak. No radioactive hippuric acid was 
detected in the 72 h urine which contained only 3-hydroxyphenylacetic acid and benzoic 
acid in substantial amounts. 
Two possible explanations for this are possible. The first is that hippuric acid is excreted 
back into the ileum/jejunum and then further broken down into 3-hydroxyphenylacetic 
acid. The appearance of hippuric acid in the 12 and 24 h ileum/jejunum samp would 
add weight to this argument. The second possibility is that there was breakdown of the 
hippuric acid post excretion. Faecal contamination of the urine, which is more likely the 
longer the experiment progressed, could have occurred. Therefore, the later urinary 
samples, 24-48 h and 48-72 h could have seen breakdown of hippuric acid to benzoic 
acid. As no benzoic acid was found outwith the urine it must be formed post absorption, 
most likely from 3-hydroxyphenylacetic acid. There were up to 3 additio minor 
metabolites present throughout the time course but their identities are unknow
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5.5 Conclusion 
displayed flavonol like properties. The main metabolite excreted was 3-
ydroxyphenyacetic acid, accounting for over 32% of the radioactivity followed by 
ues was observed and, in this case, there was no sizable 
ccumulation in any organs. This is of great importance, as if this compound was to 
have so
This study gives the most comprehensive picture of the fate of [2-
14C] quercetin-
4´-glucoside in rats to date. At a nutritionally relevant dose, a minimum of 69% was 
absorbed and excreted in urine. A further 18% could be accounted for in faeces. The 
remaining 10% was distributed between the urine and faeces and recorded as found in 
the cage washes. The level of flavonol metabolites was below that which could be 
measured in the on-line radioactivity detector. However, mass spectrometric analysis 
revealed their presence. They were rapidly absorbed and excreted in the urine. The 
parent compound was seen to have been deconjugated in the stomach of the rat within 1 
h of receiving the dose. Furthermore, there were compounds present in the stomach that 
no longer 
h
hippuric acid which accounted for just over 21%. Benzoic made up 10% with three 
unknown peaks accounting for a further 6%. The remaining radioactivity contained in 
the cage washes was not analysed for the makeup of the radioactive components 
contained in it.  
The radioactivity was rapidly excreted with over 75% of the dose being excreted 
in the 12 h sample. In the 72 h rat, by 24 h 86% had been excreted, by 48 it had 
increased to 89% and by 72 h 96%. The slowing of the excretion rate post 24 h may be 
due to hippuric acid being excreted into the GI tract via the bile, where it could be 
further metabolised to benzoic or 3-hydroxyphenylacetic acid before being reabsorbed 
and excreted. 
 
This is the first quantitative study into the fate of a nutritionally important 
phytochemical. We were able to determine the total amount absorbed, the nature of the 
compounds absorbed and in what form they were excreted. The distribution of the 
compounds within the body tiss
a
me biological effect it would be need to reach a target organ in a concentration 
sufficient to cause this effect. Almost 70% of the dose was absorbed as phenolic acids 
with less than 1% accounted for by the intact metabolites. It may be that if this 
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compound does have some positive health benefits the role of phenolic acids may be of 
some importance, though due to their rapid excretion this may not be the case.  
ds. It may be that the catabolic products formed differ too. But 
withou
Quercetin is one of the most studied flavonoid and there is a body of associative 
evidence that it could have some health benefits due to it antioxidant properties. 
However, as seen in both rat and man the body goes to some lengths to conjugate the 
hydroxyl groups responsible for its antioxidant properties. In addition the part of the 
dose absorbed intact is very low and from the results reported here are not retained in 
the body.  
The findings of this study highlight the need for many more of the proposed 
biologically important compounds to be investigated in a similar manner. Once the 
major metabolic routes and metabolites formed have been found in animals it would 
then be possible to carry out studies using 
13C labelled compounds to determine levels 
of absorption, pharmacokinetic profiles and excretion in humans. It is also clear that rats 
and man do not produce the same metabolic profile, with the rat producing many more 
methylated compoun
t labelled studies the quantification of metabolite and catabolites formed will 
remain unknown. 
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Chapter 6  Summary and conclusion 
At the 
and most crucial point is with regard to the methodology used in the 
analysi
 method” and is in fact holding back our knowledge on A.D.M.E. 
search. 
availability of glucuronide and sulphate standards of quercetin the use of aglycone 
outset of this work the intended aim was to find out what happens to the flavonol 
conjugate quercetin-4´-glucoside, once ingested. The consumption of food containing 
quercetin conjugates has been associated with a reduction in the risk of CHD and 
strokes. Therefore, it would appear a reasonable assumption that a quercetin derived 
compound must act somewhere in the circulatory system to bring about this effect. 
Knowing what happens to quercetin after ingestion could make a valuable contribution 
to finding out if in fact quercetin conjugates play any part in causing the risk reduction. 
Without this knowledge we will only ever be able to speculate. 
 
There were several issues that, during the course of the work, became central to 
what I was trying to achieve. Although I will discus them as separate issues I think they 
are all linked. 
 
The first 
s (Hertog et al., 1993a). The pioneering work of Hollman, extending Hertog’s 
method to the investigation of in vivo quercetin, in the mid 1990’s provided the first 
way of investigating the levels of flavonols in biological matrices. The word pioneering 
is used because the work was at the forefront in this field of research and could easily be 
described as “state of the art”. However, almost 15 years later it is still being used as a 
“gold standard
re
The great advantage of the enzyme hydrolysis method was that the exact 
standard for generating the calibration line is available. In the methodology I used, 
many of the mono and diglucuronide conjugates were quantified as quercetin-3-
glucuronide equivalents. Therefore it can be argued that the enzymatic method must be 
more accurate. That is assuming complete hydrolysis of all conjugates has been 
achieved. From reports in the literature this is not necessarily the case (Gu et al., 2005a; 
Donovan et al., 2006). 
With the increased availability of tandem mass spectrometers and the 
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measurement should no longer be the method of choice for quercetin ADME studies. 
We now know that the major plasma metabolite is quercetin-3´-sulphate, which would 
be dete
in vitro are not necessarily welcomed by the host in vivo. While I 
admit that this is b
owed foods that contain measurable amounts of quercetin in them, 
en there must be an analytical problem. 
cted in the post- column fluorescence system described by Hertog et al. (1992a). 
As quercetin and (-)-(epi)catechin produce the most complex array of metabolites, other 
flavonoid A.D.M.E. should not be such a difficult task. 
I put forward a theory regarding the possibility that compounds that are 
powerful antioxidants 
ased on a small data set, if all the analysis in this thesis had been 
carried out using the enzyme hydrolysis method no theory could have been constructed. 
 
One of the other topics I have mentioned in this thesis is with regard to the 
probability that the results obtained in an analysis are an accurate reflection of what is 
actually in the sample. This is specifically where quercetin has been found in pre-feed 
plasma. If it is not the result of non-compliance with dietary instructions, or food being 
included in the all
th
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I have stated that there are four processes that are part of an analysis.  
em. However, the more involved the extraction, purification, 
separat
1. Extraction 
2. Purification 
3. Separation 
4. Detection 
Probability of accurate analysis                                      Factors affecting it
100%      Extraction
Detection
Purification
Separation
50% 
0% 
 
Figure 6-1.  Factors affecting the probability of an accurate analysis 
 
If all four of these processes are given adequate attention or weight (Figure 6-1) 
then the balance probability of obtaining an accurate result is maximised. Failure to pay 
attention to any one of these can lead to inaccuracies. It is very difficult to formulate 
what the minimum amount of “attention” must be paid to each of these processes. One 
level of “attention” may work for one compound in plasma whereas the same approach 
may not work for a different compound in the same matrix, due to co-elution and a non-
selective detection syst
ion and detection processes, the less likely the probability of having an 
inaccurate result. 
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I recently attended the Thermo mass spectrometer manufacturer users meeting, 
where one speaker told of a problem he had experienced in an analysis of a drug in 
plasma. The drug company he worked for had been running this validated analysis on a 
routine basis for some time using HPLC-MS
2 in SRM mode. However, a new batch of 
blank plasma contained a contaminant that co-eluted with the peak of interest and 
contained ions that matched the fragmentation pattern of the target compound. It being a 
validat
to revalidate the analytical method, which I am told, is not a simple procedure.  
A reduction in attention to one of the processes can be offset, in some occasions, 
by maximising one or more of the other three. However, it may not always be obvious 
that there is a contaminant. It also shows that a validated assay is not always accurate. 
A simple protein precipitation cannot selectively extract the compound of 
interest from a plasma sample. No purification steps means the extract must still contain 
a complex mixture of chemicals. An isocratic chromatographic system cannot separate 
more than a handful of compounds. Therefore, a non selective detection system cannot 
be expected to pick out the compound of interest from the other compounds present. 
This may be a one sided view of some the analytical methodology used in 
quercetin aglycone analysis, but I think it is arguably a reflection of what is being 
carried out. The system I used compensated for the lack of purification by using a 
comprehensive separation system and two detectors, one for quantification the other to 
ensure peak purity. The need for the two detectors was seen in the analysis in Chapter 3 
ed analysis he could not simply adjust the gradient to try and separate the 
compounds. Being a drug company he was able to add an additional interface to the 
mass spectrometer that separated compounds based on ion mobility in an electric field, 
rather than their mass to charge ratios. This achieved the desired result without having 
I think this was a good example of an assay that used a simple protein 
precipitation extraction procedure with no purification step that was relying on the 
separation and detection system to ensure the correct result. It worked, in the beginning, 
due to the lack of interfering compounds, not to the fact that they had been removed by 
sample purification or been separated from the target compound or not seen due to the 
selectivity of the detector.  
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where the mass spectrometer reported a compound that looked, in MS
2, like a quercetin 
glucuronide. However, by absorbance detection and MS
3 was seen to be a false positive. 
 
In Chapter 5 when analysing phenolic acids in urine, it was necessary to develop 
a second and third HPLC separation system ent the already top end reverse 
phase method linked to the PDA and  pectrometer. This was because urine 
is a very complex mixture of compounds and there was no extraction or purification 
steps in the analysis. Furthermore,  nds do not have good absorbance 
spectra that can provide additional information towards their positive identification.  
The separation system initially used for flavonols used a C12 column ( Synergi 
RP MAX) with acetonitrile and formic acid. This column was initially chosen due to the 
separation it gave for a range of flavonol compounds and the low bleed of ions into the 
mass spectrometer, even at low pH. The column has proven to be stable, in terms of 
resolution and ion bleed over a period of years. The second used a C18 column (Synergi 
Polar) this was successful in separating quercetin-3-glucuronide from quercetin-3-
glucuronide isomers that did not separate using the C12 system. However, these two 
systems are very similar in the separation selectivity and therefore a third method using 
a different selectivity process was used. This used a phenyl phase column (Gemini) 
which can separate compounds based on aromatic interactions with the stationary phase 
when using methanol as the organic solvent in the mobile phase.  
aving identified the compounds by HPLC-MS
2 in three different systems the 
probability of making a misidentification, I believe, is decreased substantially. 
 to augm
tandem mass s
these compou
H
The method of choice for phenolic acids is GC-MS. However, if this technique 
had been used there was no way of linking the radioactivity to the mass spectrometers 
results. In many of the samples hippuric acid and 3-hydroxyphenylacetic acid were 
present but not associated with any radioactivity. Therefore the radiolabelled tracer 
would have lost its advantage. 
Evidence for quercetin glucosides having a direct benefit to human health. 
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Previously I have discussed the probability of an assay providing an accurate 
result. The analogy could be used with regard to quercetin glucosides having a positive 
benefit in human health. 
The bulk of the evidence that an increased intake of flavonol-rich foods is 
responsible for reduction in the risk of CHD and strokes is associative. It was an 
epidemiological study that linked an increased intake of apples, onions and tea with a 
decrease in the incident of CHD and strokes (Hertog et al., 1993a). There then appears 
to be a jump in logic to conclude that this effect is due to the common flavonol, 
quercetin, contained in them. If this theory is correct then quercetin must be absorbed in 
a form and concentration that can cause such an effect. One of the few in vitro studies 
that has used a circulatory metabolite to investigate potential health benefits was carried 
out by 
efore the time it is available to the body to exert an effect is 
also minimal. 
rapidly from the large intestine to the urine with no increase in the level circulating in 
plasma. It would seem
the risk reduction seen by Hertog et al., (1993a) and in fact there is no common link. 
Shirai et al., (2001). This was looking at the inhibitory effect of quercetin-3-
glucuronide on lipid peroxidation. The lowest concentration used in this study was 20 
µmole/L, a one hundred fold increase on the actual level of this compound in plasma as 
reported in Chapter 4. Based on this finding the probability that this is the mode of 
action would be very low. The findings in Chapter 4 showed that quercetin is rapidly 
absorbed and excreted, ther
From the rat work it is clear that the vast bulk of the dose is absorbed as 
phenolic acids. Although these are still found in urine after 48 hours they seem to move 
 that the phenolic acids are either rapidly excreted into the urine 
or pass back into the intestine via the bile. So again the probability of these compounds 
exerting a health effect would appear to be low. Furthermore, radioactivity did not 
accumulate in any of the organs or tissues of the rat, making it unlikely that it could 
have any direct effect. 
It may be that onions do play a part in reducing the risk factors of CHD and 
strokes. However, the mechanism by which they do so are far from clear. Onions also 
contain alkyl cysteine sulphoxides and these could potentially be responsible for the 
reduction in risk factors. Apples also contain hydroxy-chalcones and black tea also 
contains theorubigins, it is possible that each of these compounds could contribute to 
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If we are serious about wanting to know the mode of action of flavonoids in 
human health a much more direct approach must be taken. If it is believed that these 
compounds exert protective effects on health they should be investigated in a similar 
manner to pharmaceuticals. No drug can reach the market without the manufacturer 
showin
ug 
companies must operate and the processes them must comply with for drug approval.  
 
g the complete fate and bioavailability of that compound being known. If it is a 
drug for heart disease the mode of action of the drug must be known and also be shown 
to reach the target site in a form and concentration that can cause the effect, and the 
dose required to produce this must also be known. Any drug company that submitted a 
report to the F.D.A. for approval of a drug based on measurements of the aglycone in 
plasma would be quickly refused. Maybe we can learn from the way the dr
An example of this type of problem is with regard to whether it is procyanidins 
that are the alleged active ingredients in red wine and cocoa products like dark 
chocolate. One school of thought claims they are not absorbed the other that there is no 
technique for extracting and detecting them in plasma. A radiolabelled compound, with 
the label in a suitable position, would answer this question. Furthermore, if these 
compounds are to play a role in maintaining epithelial function, animal studies using a 
radiolabelled compound would also seem like a suitable method to investigate this.  
Until there is a change in approach to investigations of diet and human health 
there probably will be little progress in the field. 
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